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Abstract 
Sol-gel derived bioactive glasses have been considered as one of the most promising 
materials for bone regeneration. However they are brittle, therefore composites are 
needed if bioactive materials are to share load with bone. One strategy for production 
of composites with tailored mechanical properties and congruent degradation rates is 
the development of inorganic/ organic hybrids. Hybrids are particular types of 
nanocomposite synthesised by introducing a polymer into the sol-gel process so that 
the silica and polymer chains interact at the nanoscale. Calcium must be incorporated 
into glasses and hybrids if they are to be bioactive (e.g. bone to bone). Calcium nitrate 
is conventionally used in the sol-gel process as the calcium source. However, there 
are many disadvantages of using it. Calcium nitrate causes inhomogeneity by forming 
calcium rich regions and it requires high temperature treatment (>400C) to be 
incorporated into the glass network. Calcium nitrate cannot be used in the synthesis of 
hybrids where the highest temperature used in the process is approximately 60C. 
Therefore, a different precursor is needed to improve homogeneity of glasses and for 
low temperature synthesis of hybrids. In this work, two alternatives were investigated 
and compared to the conventional approach of using calcium nitrate: calcium chloride, 
an alternative calcium salt, and calcium methoxyethoxide (CME), a calcium alkoxide. 
The structure of the gels and glasses were investigated over a range of final 
processing temperatures from 60C to 800C, corresponding to hybrid and glass 
process temperatures using advanced probe techniques such as solid state NMR. The 
temperature at which calcium was incorporated into the network was identified for 
70S30C (70 mol% SiO2, 30 mol% CaO) and 58S (60 mol% SiO2, 36 mol% CaO, 4 
mol% P2O5) compositions synthesised with the three different calcium precursors. 
Using calcium nitrate, calcium did not enter the silica network until temperatures 
greater than 380C were reached. When calcium chloride was used, the calcium did 
not seem to enter the network at any of the temperatures. In contrast, calcium from 
CME entered the silica network at room temperature, indicating CME is an improved 
calcium source for low temperature synthesis.  
 
An aim of this work was to synthesise poly(γ-glutamic acid)/ silica hybrids, 
containing calcium, using calcium chloride and CME. Calcium incorporation was 
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much improved when CME was used and mechanical properties were much improved 
compared a sol-gel glass or hybrids synthesised with other calcium sources. A 
hydroxycarbonated apatite (HCA) formed on the hybrids after immersion in simulated 
body fluid (SBF), indicating bioactivity. Polylactide was also trialled as the organic 
phase for hybrid synthesis, using polylactide-diol (PLAD). However, synthesis of 
PLAD/bioactive glass hybrid was not successful as it was difficult to incorporate the 
functionalised polymer into the sol. Calcium incorporation into the silica network 
using the sol-gel process is therefore possible but challenging. 
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1 Introduction 
Bone is a natural nano-composite with collagen (organic) and mineral hydroxyl 
carbonated apatite (inorganic). Due to an increasing average age of population, the 
number of people suffering from diseases and trauma increases every year. 
Worldwide, more than 2.2 million bone grafting procedures are performed annually 
and the market is estimated to be worth more than £1.6 billion [1]. Those bone 
grafting procedures can be classified as transplantation and implantation. 
Transplantation includes autograft (transplant of tissue from same individual) 
allograft (transplant of tissue from other humans) and xenograft (transplant of tissue 
from animals) [2]. Autografts are the gold standard for bone grafting but the donor 
sites are very limited and morbidity occurs at the donor site. Allografts have a larger 
source but present the risk of disease transmissions and immune reactions and as they 
are irradiated to remove biological tissue, their mechanical properties are inferior to 
autografts [3]. Because of those limitations synthetic biomaterials are being developed 
for implantation. 
The first generation of biomaterials for implantation inside the human body was 
developed during 1960s and 1970s. Those early biomaterials were termed as ―bioinert‖ 
materials which were designed to provide similar mechanical properties as the 
replaced tissue with minimum immune response to the foreign body [4]. With the 
second generation of biomaterials emphasis shifted from ―bioinert‖ to ―bioactive‖ [5] 
and ―bioresorbable‖ [4], which means those materials were designed to elicit a 
controlled action, reaction and safe degradation in the physiological environment. 
Second generation biomaterials reached clinical use by mid-1980s. Since neither of 
the first and second generation biomaterials can respond to changing physiological 
loads or biochemical stimuli, a third generation of biomaterials were designed with 
the aim to activate cells and genes that simulate ―regeneration‖ of living tissue [6]. 
Among various materials for bone repair, bioactive glass is a promising option, which 
is considered a third generation biomaterial. Its structure is based on a random 
network of silica tetrahedra containing Si-O-Si bonds, and can be synthesised with 
network modifiers such as Na, P, Ca etc. that will disrupt the network to increase 
bioactivity and dissolution rate and provide the factors for bone regeneration. The 
23 
 
 
surface of bioactive glasses forms a biologically active hydroxycarbonate apatite 
(HCA) layer that provides the bonding interface with the bone tissue upon immersion 
in physiological fluid [7]. The HCA layer is chemically and structurally similar to the 
mineral phase in bone. In vivo, new bone growth will occur around the bioactive glass 
and the bioactive glass will finally be resorbed by the body.  
Though bioactive glasses have good bioactivity, bioresorbability and stimulate cells, 
they do not have enough mechanical strength, especially in tension which restricts 
their clinical application to non-load bearing situations. One aim of this project is to 
design a bioactive scaffold that mimics both structure and mechanical properties of 
bone so that it can share load with the host bone. The strategy is to take inspiration 
from the structure of bone and creating organic/inorganic hybrids, where polymer 
chains will interact with the bioactive silica network at the nanoscale and enhance the 
mechanical properties of the scaffold. Hybrids are synthesised by incorporating a 
polymer into the sol-gel process.  
Calcium is very important in the bioactive glass system as it plays a key role in the 
formation of the HCA layer. It is also thought to act as a signalling agent to 
osteogenic cells as it is released from bioactive glass [6]. An important aim of this 
study was to find a suitable calcium source for hybrids and investigate its effect on 
degradation rate, bioactivity and mechanical properties of sol-gel glasses and hybrids. 
The use of calcium chloride (a calcium salt) and calcium methoxyethoxide (CME, an 
alkoxide) were compared.  
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2 Literature review 
2.1 Introduction 
This chapter aims to review current biomaterials for bone regeneration. The use of 
bioactive glass and use of the sol-gel process in synthesis of bioactive glasses are 
reviewed, including how processing variables affect the structure and properties 
during each stage. The concept of organic/inorganic hybrids is introduced and 
examples of hybrids that have been developed to date are reviewed. 
2.2 Human bone 
Bone is an important part of human body. The unique properties of bone are a result 
of the complex composition (Figure 2.1) and structure. 
 
Figure 2.1 Chemical composition of human bone: (a) weight percentage of each element in the 
bone; (b) amount in bone as percentage of the total amount in the body 
The types of human bone are classified as cortical (compact) and cancellous 
(trabecular or spongy) bone. Cortical bone is a dense compact structure and the 
cancellous bone is a porous supporting structure [8]. Porosity is an important feature 
of bone. It not only allows the ingrowth of blood vessels which supply nutrition, but 
also provides the space for body fluid and bone cells which maintaining the bone. The 
compact bone has a porosity of approximately 10% whereas that of the cancellous is 
much higher (50-90%).  
Bone can be considered as a natural nanocomposite (Figure 2.2). It is mainly 
composed of type I collagen (organic phase) which intimately associates with bone 
mineral (inorganic phase) at the nanoscale. Bone mineral is substituted hydroxyapatite 
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(HA) crystals [9]. The collagen is connected by covalent bonding and the HA like 
crystals are bound between the collagen fibrils [10]. The organic phase mainly 
contributes to the tensile stress of the bone and the inorganic phase takes the majority 
of compressive load.  
 
Figure 2.2 Complex hierarchical anisotropic structure of bone [11] 
Table 2.1 The mechanical properties of compact and cancellous bone [12] 
Mechanical property Compact Bone Cancellous Bone 
Compressive strength (MPa) 100-230 2-12 
Flexural, tensile strength (MPa) 50-150 10-20 
Strain to failure (%) 1-3 5-7 
Young‘s modulus (tensile, MPa) 7-30 0.5-0.05 
Fracture toughness (KIC, Pa m
1/2
) 2-12 n/a 
 
Mechanical properties are especially important to load-bearing bones (cortical bone). 
Table 2.1 summarises them. The proportion of organic phase and inorganic phase is 
affected by a number of factors such as the type of bone or the age of the person. 
Tensile and compressive strength decreases as age increases [13], Burstein et al. [14] 
reported the relationship between the stress and strain of cortical bone with the stress 
applied in transverse and longitudinal directions, as shown in Figure 2.3 (a). Keaveny 
et al. [15] also reported the mechanical properties of bone with different densities as 
illustrated in Figure 2.3 (b). 
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Figure 2.3 Relationship between stress and strain for bone (a) as a function of direction of 
applied load and (b) as a function of density [14, 15] 
Bone has the ability to heal itself thanks to the actions of osteoblasts and osteoclasts. 
if the damage exceeds certain critical dimensions. Therefore, biomaterials are 
developed in order to restore the continuity in the bone structure. 
2.3 Current bone tissue engineering strategies 
Tissue engineering is defined by Langer and Vacanti as ―an interdisciplinary field of 
research that applies the principles of engineering and the life sciences towards the 
development of biological substitutes that restore, maintain, or improve tissue 
function‖ [16]. It is based on combining knowledge from physics, chemistry, 
engineering, However the self-healing system is significantly retarded or even 
completely disabled materials science, biology and medicine in an integrated manner. 
Bone tissue engineering is based on the understanding of bone formation and 
regeneration, and aims to induce repair and regeneration of bone defects to their 
natural form rather than just to implant new spare parts [17]. It involves one or more 
of the following key ingredients: harvested cells, recombinant signalling molecules, 
and three-dimensional (3D) scaffolds that will act as temporary templates for bone 
growth. 
There are two promising approaches for bone tissue engineering [2, 18]. One 
approach is to implant a scaffold into the defected site directly and let the cells attach 
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and grow to the structure. It requires the scaffold to have similar mechanical 
properties to the host bone. The other approach is to harvests cells which are then 
expanded in culture and seeded on a scaffold rather before implantation. After the 
extracellular bone matrix forms in the shape of the scaffold, the tissue engineered 
construct can then be implanted into the patient [19]. Growth factors and proteins can 
be provided in the tissue culture system (bioreactor) to optimise the in vitro growth of 
the tissue, which increases the probability of a successful repairing. The scaffold will 
be finally resorbed and replaced by new tissue. The requirements of an ideal scaffold 
are reviewed in the section 2.5.5, but a general aim is to try to mimic the properties 
and hierarchical structure of bone. 
2.4 Biomaterials for bone graft procedures 
Biomaterials can be defined as ―implantable materials that perform their function in 
contact with living tissues‖ [20]. Current biomaterials for bone graft procedures 
include metals, ceramics, polymers, and composites. A large number of biomaterials 
have been developed for bone repair (Figure 2.4). Their mechanical properties were 
summarised using CES Edupack 2005 software and illustrated in Figure 2.5.  
 
Figure 2.4 Biomaterials for bone graft at different positions of the human skeleton 
 
Ear: HA, Al2O3, Ti, Silicone Cranial: 316L SS, Ti, Acrylic, HA, TCP
Maxillofacial reconstruction: 
Al2O3, HA, TCP, HA/PLA, 
Bioglass, Ti, Ti-Al-V
Spinal: Co-Cr-Mo, Ti, HA, UHMWPE
Load-bearing orthopaedic: 
Al2O3, Zirconia, 316L SS, 
Ti, Ti-Al-V, Co-Cr-Mo, 
UHMPE
Bone fixation: 316L SS, Co-Cr-Mo, 
Ti, Ti-Al-V, PLA/HA, PLA, PGA
Prosthetic joints: 316L SS, 
Co-Cr-Mo, Ti, Ti-Al-V, 
Silicone, UHMWPE, Acrylic
PLA = polylactide
PGA = polyglycolide
UHMWPE = ultrahigh 
molecular weight 
polyethylene
HA = hydroxyapatite
SS = stainless steel
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Figure 2.5 Range of modulus of elasticity (or stiffness) of cortical bone and cancellous bone 
compared to implant materials (CES Edupack 2005) 
Metals 
Metals are the conventional materials in the repair of diseased or damaged bone.  
Early metallic bone grafts were first generation biomaterials which were designed to 
be inert, whereas some later products were coated by ceramics to provide bioactivity. 
Common orthopaedic metals include alloys of titanium and cobalt chrome alloys. 
Metals provide excellent mechanical properties which are critical for bone grafts 
especially those used for load bearing area such as joint replacements, bone plates and 
screws. Foams can be produced so that there is a template for bone ingrowth, however 
metals are generally not bioresorbable. They are therefore used as bone augmentation 
devices rather than in regenerative approached. Metals can also exhibit problems in 
terms of systemic toxicity [21]. For example, nickel sensitivity is an inherent issue of 
metallic bone graft, only titanium alloys can have low levels of Ni (<0.1%). 
Ceramics and glasses 
Ceramics are the most biocompatible materials and can be obtained with biostable, 
bioactive or bioresorbable properties [20]. Early ceramics such as zirconia and 
alumina also belong to the first generation category. Though they have good 
biocompatibility, implants are surrounded by fibrous tissue [22]. As bone mineral is a 
hydroxyapatite, synthetic HA (Ca10(PO4)6(OH)2) was recognised as a bioactive 
29 
 
 
ceramic that can bond with bone [23]. Other calcium phosphates, such as -tri-
calcium phosphate (TCP) have been used. However, HA degrades very slowly and 
TCP degrades rapidly. Bioactive glass has been shown to bond to bone more rapidly 
than calcium phosphates and is also resorbable. Bioactive glass will be reviewed in 
more detail in section 2.5. Bioactive glasses and ceramics are thought to bond with 
bone via the formation of a biological like (calcium deficient) apatite on the surface of 
the material in contact with body fluid. A first assessment of bioactivity is usually 
carried out by immersing the material in simulated body fluid (SBF), which has ionic 
concentrations similar to blood plasma, and monitoring for formation of the apatite 
layer [24]. Apatite/wollastonite (A/W) glass ceramic is a composite of crystals of 
oxyfluoroapatite (Ca10(PO4)6(O,F2)) and wollastonite (Calcium metasilicate, CaSiO3) 
in a glass matrix [25]. It has better mechanical properties than Bioglass
®
 or HA, but 
still not high enough to be used in load-bearing areas, limiting its applications mainly 
to iliac spacers, artificial vertebrae, spinal and intervertebral spacers [26].  Although 
ceramic have very poor mechanical properties, they have had excellent clinical results 
for the filling of small defects.  
Polymers 
Polymeric devices are currently used as bone plates and screws providing temporary 
mechanical support to fractured bone. The polymers for these devices are mainly 
biodegradable and can provide certain toughness and flexibility. Poly(glycolide) 
(PGA), L-poly(lactide) (PLLA), poly(lactide-co-glycolide) (PLGA), poly(diacetylene) 
(PDA), poly(ε-caprolactone) (PCL) and poly(ortho ester) (POE) are common 
examples.  Similar to biodegradable ceramics, these polymers negate the need for 
removal of the device after completion of the healing procedure. However, their 
mechanical properties are too low in compression for load sharing applications. The 
degradation process is also often autocatalytic. This means that once degradation 
begins, the polymer degrades more rapidly due to a lowering of the pH by the 
degradation products, which are carboxylic acids. Another main drawback is that 
polymers are non-bioactive, which means they do not bond to bone. Composites are 
therefore needed to increase the mechanical strength of polymers and reduce the 
brittle nature of ceramics and glasses. 
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Composites and hybrids 
A composite is a combination of different materials or phases. Conventional bioactive 
composites have been produced with bioactive glass or ceramic microparticles 
dispersed in a degradable polymer matrix. For example, Roether et al. produced 
composite scaffolds by coating PDLLA foams with 5 µm Bioglass
®
 particles by 
slurry dipping and electrophoretic deposition (EPD) [27]. The composite scaffolds 
were found to form a thin HA layer after 7 days immersion in SBF, whereas the 
uncoated PDLLA had no HA crystals formed after 28 days, indicating the composite 
could be bioactive when incorporated with bioactive ceramics. However, the adhesion 
between the glass and the polymer was poor. Glass particles could be incorporated 
into a polymer matrix, but in this case the polymer may cover the glass such that cells 
would be in contact with the polymer rather than the bioactive glass after implantation, 
reducing the bioactive properties. The glass may be revealed once the polymer 
degrades, but the two phases normally degrade at different rates, so the glass particles 
may be lost from the polymer when the polymer degrades. The mechanical properties 
were not reported. Hybrid materials are designed to combine the advantages of 
bioactive glasses and polymers. The inorganic component can provide bioactivity and 
stiffness whereas the organic component provide toughness [28]. The hypothesis is 
that the inorganic and organic chains will interact at the nanoscale interaction and the 
introduction of bonding between the inorganic will make the composite behave as one 
phase. A hybrid material is different to a nanocomposite. A nanocomposite is a 
combination of 2 materials where one of the materials has at least one dimension in 
the nanoscale (<100nm) and the two components are still distinguishable. In a hybrid 
the two components interact at the molecular level are no longer distinguishable at the 
submicron scale or above. A detailed review is in section 2.7.  
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Figure 2.6 Classification of materials at different length scales [29] 
Kickelbick stated the differences between composites and hybrids, mainly according 
to the scale of the interactions between the components [30]. The Materials Science 
Society of Japan proposed a classification of hybrid materials and their related 
materials by their different length scales [29] (Figure 2.6). 
2.5 Bioactive glass 
2.5.1 Introduction 
Bioactive glass was first discovered by Professor Larry Hench in 1969. It is a melt-
derived bioactive glass designed (using phase diagrams) to provide a large amount of 
CaO with some P2O5 in a Na2O-SiO2 matrix [7]. In 1972, Hench et al. reported that 
45S5 (45 mol% SiO2, 24.5 mol% Na2O, 24.5 mol% CaO and 6 mol% P2O5) Bioglass
®
 
formed strong interfacial bond to bone, equal to or greater than strength of the host 
bone [31]. The first successful clinical use of bioactive glass was as a replacement for 
the bones of the middle ear to repair conductive hearing loss [32]. After nearly 40 
years of development, a number of bioactive glasses have been created and utilised in 
different clinical applications. Most clinical applications use bioactive glass in a 
particulate form. For instance, PerioGlas
®
 is a particulate for periodontal disease. And 
NovaMin
®
 is a fine powder incorporated into toothpaste. It is difficult to produce 
porous melt-derived bioactive glasses of the 45S5 composition because the glass 
crystallises on sintering [33]. 
In 1991, a ternary sol-gel derived bioactive glass 58S (60 mol% SiO2, 36 mol% CaO 
and 4 mol% P2O5) was developed by Li et al. [34]. The sol-gel process provides better 
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bioactivity and homogeneity compared to similar compositions prepared by the melt 
derived route. The composition of bioactive glass was then simplified into a binary 
70S30C (70 mol% SiO2 and 30 mol% CaO) by Saravanapavan and Hench [35]. In 
2002, the sol-gel foaming process was developed for the production of macroporous 
bioactive glass scaffolds that had interconnected pore structures suitable for bone 
regeneration [36]. Phosphate is not thought to be necessary since the phosphate free 
70S30C composition can stimulate the formation of mineralised bone nodules within 
2 weeks of in vitro culture of primary HOBs without the presence of supplementary 
growth factors in the medium [37]. It was also found to be more susceptible to the 
foaming process and was bioactive in simulated body fluid (SBF) [38]. Structural 
analysis of the phosphate containing sol-gel glass also revealed that the phosphate was 
present as orthophosphate, i.e. there are no Si-O-P bonds, the phosphate is separate 
from the network, charge balanced by calcium ions [38]. This means that the 
phosphate is loosely bound in the glass and is released almost immediately after 
contact with body fluid. There therefore seems little need in having it in the 
composition. 
2.5.2 Bioactivity of glasses 
Bioglass
®
 was the first material that was found to bond to bone. Hench termed this 
material bioactive and defined the concept of bioactivity as: ―A bioactive material is 
one that elicits a specific biological response at the interface of the material which 
results in the formation of a bond between the tissues and the material‖ [31]. In 1994, 
a new hypothesis was proposed, in which bioactive materials were classified into two 
types: Class A and Class B respectively [39]. Class B materials are those that 
stimulate osteoconduction only, which means the materials can provide a 
biocompatible interface through direct bonding to bone, along which bone migrates. 
Class A materials are both osteoconductive and osteoproductive. Osteoproduction was 
defined by Wilson as, ―The process whereby a bioactive surface is colonised by 
osteogenic stem cells free in the defect environment as a result of surgical 
intervention‖ [40]. Bioglass 45S5 is a Class A biomaterial. The bioactivity can be 
controlled by composition and surface chemistry, surface texture and morphology, 
which all affect dissolution of the glass and therefore bioactivity.  
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Traditional bioactivity theory suggested that the bioactivity of glass was determined 
by the glass composition. Only glasses with less than 60 mol% SiO2 form an apatite 
layer fast enough for bone bonding to occur [22]. Fibrous tissue surrounded the 
implant if HCA formation was too slow.  
The bioactivity mechanism was proposed as 11 reaction stages [41]. The first five 
stages occur very rapidly on the surface of the bioactive glasses, and result in a 
hydroxycarbonate apatite (HCA) crystal layer forming on the surface. These five 
stages were first proposed by Clark et al. [42] and were been well studied using 
Fourier Transform Infrared (FTIR) microscopy, X-ray diffraction (XRD), Auger 
electron spectroscopy and electron microprobe analysis [42]. These processes were 
not dependent on the presence of tissue, they were found to occur in tris-buffer 
solutions or simulated body fluids (SBF). The following 6 stages, which attempt to 
suggest a mechanism for why the HCA layer stimulates bone bonding and growth, 
were proposed by Hench, which resulted in the rapid formation of new bone [22]. 
However, there is little data to back up the final 6 stages. 
The suggested 11 stage process leading to bonding of bioactive glasses to bone are: 
1. Ion exchange: rapid ion exchange of metallic ions such as Na
+
 or Ca
2+
with H
+ 
or 
H3O
+
 from solution; pH increases as the number of OH
-
 ions in solution increases 
(Equation
 
2.1): 
Si-O-
 
Na
+
 + H
+
 + OH
-
 → Si-OH+ + Na+(aq) +OH
-
                            Equation
 
2.1 
2. Network dissolution: Si-O-Si bonds are broken due to high concentration of OH
-
 
ions (high local pH) releasing soluble Si(OH)4 into solution, followed by hydrolysis 
of Si-O-Si bonds and the continuous formation of Si-OH (silanol) groups at the silica-
solution interface (Equation
 
2.2): 
Si-O-Si + H2O → Si-OH + HO-Si                                                      Equation
 
2.2 
3. Silica-gel polymerisation: condensation and repolymerisation of a SiO2-rich gel 
layer on glass surface due to the increase of silanol group density, which provide a 
large number of sites for heterogeneous nucleation (Equation
 
2.3): 
Si-OH + OH-Si → Si-O-Si + H2O                                                      Equation
 
2.3 
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4. Chemisorption: Ca
2+
 and PO4
3-
 migrate to the surface through the SiO2-rich layer 
and nucleate from solution, forming a CaO-P2O5-rich film on top of the SiO2-rich 
layer. Nucleation is at Si-OH groups which have negative charge at pH > 7. 
5. Crystallisation: The amorphous CaO-P2O5 layer crystallised by interaction with 
OH
-
 and CO3
2-
 anions from solution to form an HCA layer. 
6. Adsorption and desorption of biological growth factors, in the HCA layer, which 
continues throughout the process (steps 7-11) to activate differentiation of stem cells. 
7. Action of macrophages to remove debris from the site. 
8. Attachment of progenitor cells, such as mesenchymal stem cells, on the bioactive 
surface. 
9. Differentiation of stem cells to form bone growing cells, such as osteoblasts. 
10. Generation of extra cellular matrix by the osteoblasts to form bone. 
11. Crystallisation of inorganic calcium phosphate matrix to enclose bone cells in a 
living composite structure of bone mineral and collagen extra-cellular matrix. 
Soluble silica also plays an important role in tissue repair and osteogenesis and may 
also affect collagen or polysaccharide cross linking, which leads to the tight bonding 
between the mineral apatite layer and collagen fibres [43]. 
Hill proposed an alternative way defining bioactivity of the glass, which was based on 
the network connectivity of the glass [44]. The network connectivity is the mean 
number of bridging oxygen (Si-O-Si) bonds. Glass network modifiers such as sodium 
and calcium reduce the network connectivity thus accelerate the glass dissolution and 
improve bioactivity. 
Though formation of a surface HCA layer is very useful for biomaterials, Hench 
stated that it is not the critical stage of reaction for bone regeneration [7]. The key 
factor is controlled rates of release of ionic dissolution products, especially critical 
concentrations of soluble silica and calcium ions [7].  
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2.5.3 Sol-gel and melt-derived bioactive glasses 
All early bioactive glasses and glass-ceramics were created via the melt-derived route. 
The glass phases are melted at high temperature and then cast as bulk implants or 
quenched as powders. Sol-gel processing uses lower temperatures than the melt 
process, and has the ability to control the material‘s surface chemistry which directly 
relates to the biological behaviour. Sol-gel derived bioactive glasses are inherently 
nanoporous and therefore have enhanced bioactivity due to specific surface areas up 
to 2 orders of magnitude higher than melt-derived glasses giving an extended 
bioactive composition range up to 88 mol% silica [45]. However surface area and 
pore size is not the only reason for enhanced bioactivity. Sol-gel glasses also contain 
OH groups, such that protons effectively act as additional network modifiers. The OH 
content decreases as final processing temperature increases. Therefore nominal 
compositions are not the actual compositions, due to the OH content and network 
connectivity is lower than the theoretical value, increasing dissolution rate and 
bioactivity [46].  
The sol-gel processing needs a longer synthesis period and it is difficult to produce 
large monoliths due to cracking during drying, which is caused by capillary pressures 
created by water molecules, which are a by-product of the drying process, passing 
through the pore network as they evaporate. Particles, fibres, foams, porous scaffolds, 
coatings and net shape monoliths can all be made by sol-gel processing. Figure 2.7 
illustrates the conventional steps of these two processes. The differences between 
bioactive glasses derived via these two processing are summarised in Table 2.2. 
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Figure 2.7 Diagram of main stages in the melting and sol-gel process to obtain bioactive glasses 
[47] 
 
Table 2.2 Properties of Sol-gel derived and melt-derived bioactive glasses 
Sol-gel derived bioactive glasses  Melt derived bioactive glasses 
Can develop HCA layer in SBF with SiO2 
content up to 88% 
Cannot develop HCA layer in SBF when 
SiO2 content over 60% 
Nanometer porosity  Dense 
Surface area 80-300 m
2
/g Surface area around 2-3 m
2
/g 
Higher dissolution rate Lower dissolution rate 
Relative high -OH content -OH groups only present on surface 
Can sinter without crystallising Many compositions crystallise on 
sintering 
 
 
Bioactive Glasses 
Sol-Gel Melt 
Network 
Formers 
Network 
Modifiers
ss 
Reactants Mixture: 
TEOS+TEP+Ca(NO3)2·4H2O 
Hydrolysis: H2O/HNO3 
Gel 
Sol 
Aged Gel 
Dry Gel 
Piece 
SiO2 P2O5 CaO Na2O 
Melting 
1400°C/1h 
Quenching 
Gelation (25°C) 
Aging (60-80°C)/48h 
Drying (150-180°C)/3h 
Grounding, sieving, processing 
Thermal stabilisation 
(700°C/3h) 
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2.5.4 Bioactive glass scaffolds 
An ideal synthetic bone graft material would be available off the shelf to the surgeon. 
Surgeons also want to be able to shape the scaffolds in the operating theatre. The 
requirements of an ideal scaffold for bone regeneration [48] are that  they should: 
(1) Act as template for bone growth in three dimensions, i.e. have macro-porous 
network with interconnect diameters in excess of 100 μm [49]; 
(2) Be biocompatible and promote cell adhesion, adsorption of biological metabolites 
[6]; 
(3) Absorb at the same rate as the tissue is repaired, with non-toxic degradation 
products [6]; 
(5) Bond to the host bone [6]; 
(6) Exhibit mechanical properties matching that of the host bone; 
 (7) Have the potential to be commercially producible and sterilisable to the required 
international standards: International Standards Organisation (ISO) or Food and Drug 
Administration standards (FDA). 
Sepulveda et al. firstly synthesised bioactive glass foams with pure silica 100S, binary 
70S30C and ternary 58S compositions [36]. The foams were achieved by agitating the 
sol vigorously before the gelling point to trap air bubbles into sol. The bubbles were 
stabilised by using a surfactant, which lowered the surface tension of the sol. The 
gelation time was reduced from the three days of conventional sol-gel to a few 
minutes, by using hydrofluoric acid (HF) as a catalyst, which acts by forming a 
complex with the silica.  As viscosity increased the foam became more stable and 
then set in place as gelation occurred. The hierarchical structure was obtained with 
macropores in excess of 500 μm connected by interconnects with diameters in excess 
of 100 μm. As the glass foams were sol-gel derived they also had a nanoporous 
texture (pore diameters of 10–20 nm). The macro-porosity of scaffold was further 
modified by Jones et al. to improve the mechanical properties by sintering at 800  °C 
[50]. They also found that the binary glass 70S30C was more susceptible to foaming 
compared to 58S [38]. 
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2.5.5 Summary 
Bioactive glass has excellent bioactivity and can be made into hierarchical scaffolds 
suitable for bone regeneration. There is one criterion that the bioactive glass scaffolds 
do not fulfil: they have poor mechanical properties. An ideal scaffold would combine 
the properties of the bioactive glass with toughness. A strategy for achieving this is to 
create a hybrid material (section 2.7). 
2.6 The sol-gel process for amorphous silica-based materials 
2.6.1 Introduction to the sol-gel process 
The sol-gel process is a wet-chemical technique which allows to synthesise ceramic 
materials at lower temperatures than the traditional process of fusion of oxides. It 
involves the transition of a system from a liquid "sol" (mostly colloidal) into a solid 
"gel" phase. It generally contains seven steps: mixing, casting, gelation, aging, drying, 
stabilisation and sintering [51]. In this project, the sol-gel method is not only applied 
to synthesise new bioactive glasses with alternative calcium sources, but also to 
synthesise new inorganic/ organic hybrids by incorporating a polymer. Therefore, it is 
important to understand the fundamental knowledge of the sol-gel process. Since 
foams are not used in this project, the sol-gel process reviewed in this section takes 
the synthesis of sol-gel derived glass monoliths as an example. 
2.6.2 Evolution of the sol-gel glass structure 
The first step of the sol-gel process is mixing of alkyl silicate precursor solution with 
water. Acid or base is added in water to control the pH value of the mixture, which 
will further control the whole sol-gel process. Two primary reactions take place at this 
stage: hydrolysis (Equation 2.4) and condensation (Equation 2.5 and Equation 2.6). 
Tetraethylorthosilicate (TEOS) is taken as an example for alkyl silicate.  
Si (OC2H5)4 + 4 H2O → Si (OH)4 + 4 C2H5OH   Equation 2.4 
Si (OH)4 + Si (OH)4 → (HO)3 Si-O-Si (OH)3 + H2O   Equation 2.5 
Si (OH)4 + Si (OC2H5)4 → (HO)3 Si-O-Si (OC2H5)3 + H2O  Equation 2.6 
The hydrolysis reaction replaces alkoxide groups (OR) with hydroxyl groups (OH). 
Subsequent condensation reactions involving the silanol groups produce siloxane 
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bonds (Si-O-Si), starting formation of the silica network. Under most conditions, 
condensation commences as soon as hydrolysis starts [52]. Several factors affect the 
kinetics of both reactions, including pH, type of catalyst, nature of solvent, R ratio 
(molar ratio of H2O to Si) and temperature [53]. Thus, by controlling these factors, it 
is possible to vary the structure and properties of the sol-gel derived inorganic 
network.  
The pH of the reaction determines the mechanism and rate of hydrolysis and 
condensation. In an acid catalysed process, protons attack the oxygen in silanol 
groups to form a protonated silanol species, which makes the silicon more 
electrophilic and thus more susceptible to SN2-type nucleophilic attack [53]. 
Therefore, condensation reactions may occur preferentially between neutral species 
and protonated silanols situated on the ends of chains.  
In base-catalysed hydrolysis, the OH
–
 ion is able to attack the silicon atom directly. 
Again, an SN2-type mechanism has been proposed in which the -OH displaces -OR 
with inversion of the silicon tetrahedron. Base-catalysed hybrolysis proceeds much 
more slowly than acid-catalysed hydrolysis at an equivalent catalyst concentration, 
since basic alkoxide oxygens tend to repel the nucleophile (-OH) [54]. However, once 
an initial hydrolysis has occurred, the following reactions proceed stepwise, with each 
subsequent alkoxide group being more easily removed from the monomer then the 
previous one [55]. Although hydrolysis in alkaline environments is slow, it still tends 
to be complete and is irreversible [56] [57].  
The pH of the sol not only determines the mechanism of the hydrolysis and 
condensation, but also influences the rate of the reactions. The relationship between 
pH value and two reactions was schematically illustrated as ―V‖ shape graphs [53]. 
Both hydrolysis and condensation reached their lowest rate at the isoelectric point 
(IEP), at which alkyl silicate or silanol group is zero-charged and catalysis is inhibited. 
The IEP of hydrolysis is at pH 7 and that of condensation is at between pH 2 to 4. pH 
values far from the IEP accelerate the reactions. Iler divides the polymerisation 
process into three approximate pH domains: ＜pH 2, pH 2-7,and ＞pH7 [57]. 
Below pH 2, the condensation rates are proportional to H
+
 concentration. The 
solubility of silica is low below pH 2 [57], so the formation and aggregation of 
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primary particles occurs. Primary particles are small particles comprised of clusters of 
rings and chains of three to four silica tetrahedra. Ripening (aggregation of small 
primary particles to secondary particles that contain at most 13 primary particles, 
reducing the number of primary particles) contributes little to growth after the 
particles exceed 2 nm in diameter. The radius of a primary particle is between 1 and 2 
nm [58] and that of a secondary particle is between 5 to 20 nm [59], as shown in 
Figure 2.8. 
 
Figure 2.8 Schematic representation of primary and secondary particles forming in the acid 
catalysed sol-gel process. 
Between pH 2 and pH 6, the condensation rates are proportional to OH
-
 concentration. 
Condensation occurs preferentially between more highly condensed species and less 
highly condensed neutral species. Further growth occurs by continued addition of 
primary particles to more highly condensed secondary particles either by conventional 
polymerisation or by aggregation of the condensed species to form chains and 
networks (ripening). Near the isoelectric point (pH ~2) where there is no electrostatic 
repulsion of particles, growth and aggregation occur simultaneously [53]. Particle 
growth stops when the particles reach 2-4 nm where solubility and size-dependence of 
solubility is greatly reduced. 
1 – 2 nm
5 – 20 nm
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Above pH 7, the condensation rates are slightly influenced by pH but mainly depend 
on particle size distribution. Growth occurs primarily by the addition of monomers to 
more highly condensed particles rather than by particle aggregation because all the 
condensed species are more likely to be ionised and therefore mutually repulsive. Due 
to the greater solubility of silica and the greater size-dependence of solubility above 
pH 7, growth of the primary particles continues by Ostwald ripening. Particles grow 
rapidly to a size that depends mainly on the temperature. 
Acidic catalysis (pH < 2), usually using nitric acid, is often preferred when structures 
larger than 1 µm are synthesised, to ensure complete hydrolysis of the TEOS, and 
basic catalysis, usually ammonia, is used to synthesise nano and sub micron particles 
[60]. Acidic catalysis will be used in this work to achieve rapid hydrolysis. 
Different catalysts can perform different effects even under same pH. Hydrofluoric 
acid (HF) is a widely used catalyst for sol-gel process which significantly increases 
both hydrolysis and condensation rate, as F
-
 has the ability to increase the 
coordination of silicon above four, but is more electron-withdrawing than OH
-
 [53]. 
The R ratio also affects hydrolysis and condensation kinetics, which will be further 
illustrated in the gelation section. Increasing the temperature above room temperature 
accelerates both hydrolysis and condensation by increasing systematic reactivity. 
Addition of other precursors or chemicals, and the pressure of environment also 
influence both reactions. Hench and West pointed out the nature and concentration of 
electrolyte is the domain factor controlling the kinetics of both reactions [51]. 
However, this factor could be considered as a combination of pH and nature of 
catalysts.  
This project investigated the effect of several of these variables on the evolution of the 
glass structure, such as the effect of using three different calcium precursors on two of 
the most common sol-gel compositions; the role of the thermal treatment and the use 
of HF as a gelation catalyst.  
2.6.3 Casting and Gelation of silica sols 
After the mixing stage, the sol is cast into moulds and left to gel. The viscosity of the 
sol increases as condensation progresses. Gelation is the process whereby the sol 
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becomes a continuous solid network gel, which ends at a gelation point where the 
solution suddenly loses its fluidity [51]. Consequently, the gelation time (tg) is hard to 
measure accurately. 
Since gelation time mainly depends on condensation rate, as described in section 2.6.2, 
the relationship between tg and pH appears as an ―S‖ curve with the maximum around 
the IEP of silica (pH ~2) and a minimum near pH 7 [57]. The pH also affects the 
structure of the gel, acid-catalysed sols develop a linear structure with very little 
branching whereas base-catalysed sols develop highly ramified structures.  
R ratio is another important factor influence on gelation time. For low water content 
(R<7), the gelation time decreases as water content increases as there is more water 
available for hydrolysis, although there is a dilution effect [61]. The gelation time is 
most rapid when the R ratio is around 7. For higher water content (R>7), the gelation 
time increases as R ratio increases [61]. All the other factors such as temperature and 
catalysts influencing hydrolysis and condensation further affect gelation time. 
The results obtained from Small Angle X-ray Scattering (SAXS) and Raman 
spectroscopy led to the conclusion that the gel structure is formed of very small 
clusters, or primary particles (1 ~ 2 nm diameter) that agglomerate in secondary 
particles (5-20 nm diameter according to different conditions), of silica tetrahedra [58]. 
Gelation occurs when the secondary particles are linked to each other, forming a 
three-dimensional network across sample (section 2.6.2).  
2.6.4 Aging of silica gels 
Aging of a gel is a syneresis (shrinkage) process which involves maintaining the cast 
gel in the pore liquid (the by-products of the consendation reaction) at room 
temperature or under hydrothermal conditions. During aging, polycondensation 
continues along with drainage of the pore liquid at interparticle necks, which 
increases the thickness of interparticle necks, decreasing the porosity [53]. The 
strength of the gel thereby increases with aging. These structures and property 
changes continue long after the gel point and have a profound effect on the 
subsequent processes of drying and sintering. Heating the gel in water also will reduce 
the surface area and can strengthen the gel structure, but no change of pore structure 
has been found between 80 – 100 ºC.  
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2.6.5 Drying of silica gels 
The liquid by-products of the gelation are removed from the interconnected gel 
network during the drying process. Large capillary stresses can develop when the pore 
sizes are < 20 nm, which can cause cracking unless the drying process is controlled by 
careful heating regimes and by obtaining monodisperse pore sizes via controlling the 
hydrolysis and condensation rates [51]. 
Tensile stress is caused by the difference in shrinkage rate between the inside and 
outside of the body [53]. It strongly depends on the gel thickness [62]. The 
relationship between drying stress and gel thickness is shown in the following 
equation: 
σx(L) ≈ LηL VE/ 3D                                                                              Equation 2.7 
where σx is the tensile stress, L is the thickness of gel, ηL is the viscosity of liquid, VE 
is evaporation rate, and D is the permeation of network [53]. Because small pores 
have low permeability, acid-catalysed gel has greater tensile stress. 
When drying stress exceeds the point where it reaches the maximum rate of shrinkage, 
drying failure occurs [51]. Since the drying stress is inversely proportional to the pore 
size, the most obvious way to avoid cracking is prepare gels with large pores such as a 
foam scaffold. Another way is to prepare gels with extremely uniform pores. 
Prolonged aging also helps to avoid cracking during drying due to the enhanced 
strength of gel.  
Other methods can be used as alternative to standard drying procedures, e.g. freeze-
drying, which can result in oriented elongated pores [63] and critical point drying, 
which results in the formation of highly porous (>99%) aerogels [64]. However this 
work focused on the standard drying process. 
2.6.6 Stabilisation of silica gels 
Stabilisation is the further treatment to improve the properties and stability of gels, 
including chemical stabilisation and thermal stabilisation. Stabilisation involves 
reducing the number of Si-OH bonds that remain due to the silica network forming in 
an aqueous environment. Reducing the –OH content encourages formation of Si-O-Si 
bonds in the network and can either be done chemically or, more commonly, by heat. 
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Thermal stabilisation involves enhances the gel strength by increasing the number of 
bridging oxygen bonds sufficiently to avoid reversible structural changes, thereby 
reducing the surface area [51].  
At about 170 °C, the physisorbed water can be eliminated and surface silanol groups 
start to condense. Between 170 °C to about 400 °C, the dehydration is completely 
reversible and organic residuals decompose. Above 400 °C, the dehydration is 
irreversible as a result of shrinkage and sintering across pores, and reducing of surface 
hydroxyl groups occur which is also irreversible. Above about 800 °C, only single 
hydroxyl groups remain [65]. Sol-gel silica will absorb water during the cooling stage, 
leading to the dilation of the gel volume, since the average bond length between 
neighbouring silicon atoms increase with the bonding of water. During stabilisation, 
other by-products are also removed, e.g. the nitrate from the use of calcium nitrate as 
a source of calcium. 
2.6.7 Sintering 
Depending on the glass composition, higher temperatures may be applied whih 
surpass the glass transition temperature of the glass, causing viscous flow sintering, 
which reduces nanoporosity [66]. Sintering is a process driven by interfacial energy 
which is a reduction in surface area. [53]. At least four mechanisms are responsible 
for the structural evolution during sintering: capillary contraction, further 
condensation, structural relaxation and viscous sintering [51]. During sintering, the 
small pores close first for some gels due to their small radius of curvature [51]. The 
specific surface area reduces as the densification progresses. It is advantageous to 
complete sintering before crystallisation, as this can affect degradation rate and 
bioactivity [53]. 
2.6.8 Summary 
The goal of the sol-gel process is to control the structure of a material on a nanometer 
scale from the earliest stages of processing [51]. The silica based sol-gel process is 
extremely important for tissue engineeringbecause silica networks form the basis of 
bioactive glasses that have high potential for bone regeneration. Calcium is also 
needed in the composition to make the silica bioactive. The silica sol-gel process is 
the production and assembly of nanoparticles that fuse together to form a silica 
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network at low temperatures. All the samples studied in this project utilised the sol-
gel silica process. 
2.7 Organic/ inorganic hybrids 
2.7.1 Introduction to hybrids 
The term hybrid material is used for many different systems spanning a wide range of 
different materials. In this thesis, it is defined as: a material comprising of inorganic 
and organic phases blended at the molecular scale such that the two components are 
not distinguishable at the sub-micron scale or above. Hybrids have the potential to 
degrade congruently as one material and have tailored mechanical properties. The fine 
scale interactions are hypothesised to allow cells to contact both phases when they 
attach to the surface. These aspects provide advantages over conventional composites 
of bioactive particles dispersed in a polymer matrix. Hybrid properties can be tailored 
for different applications by choosing suitable organic and inorganic sources. The 
hybrid structure also mimics bone, which can be thought of as a natural hybrid.  
The low temperature process of sol-gel method allows incorporation of polymer 
chains while the silica network is forming. For hybrid synthesis, the sol-gel process is 
utilised without the stabilisation stage and the drying temperature is normally below 
60 °C. This provides certain challenges, such as how to incorporate calcium, which 
this thesis aims to overcome. 
Numerous hybrids were created via sol-gel route in the past 15 to 20 years [67-80]. 
Many names of these materials have been used previously, e.g. Ceramers, Polycerams, 
Ormosils or Ormocers. The properties of these hybrid materials combine the 
properties of both phases with the role of the inner interfaces dominant.  
2.7.2 Classification of hybrids 
Hybrids can be divided into two major families: Class I and Class II [81]. In Class I 
hybrids the organic and inorganic components are linked together with physical bonds 
based on van der Waals forces, hydrogen bonds or electrostatic interactions. These 
hybrids materials present a large diversity in their structures and final properties. 
Class II hybrids gather the organic and inorganic components through strong covalent 
or iono-covalent chemical bonds. This bonding, or covalent coupling, is hypothesised 
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to allow control of degradation rates and mechanical properties. Class I hybrids are 
likely to dissolve rapidly in aqueous environments as the physical bonds are unlikely 
to be strong enough. However, the molecules used as starting building blocks in 
hybrid synthesis are not always simple. Some hybrids systems can have both Class I 
and Class II characteristics. The aim of this project is to create a Class II hybrid 
2.7.3 Hybrids synthesis strategies 
Several synthesis strategies for hybrid organic inorganic materials have been 
developed from a variety of disciplines. Briefly, those strategies can be classified into 
two approaches according to whether the precursors keep in their original integrity 
[30]. One approach is ―building block approach‖, in which the building blocks at least 
partially keep their molecular integrity throughout the process. In contrast, the other 
approach ―in situ formation of the components‖ is based on the chemical 
transformation of the precursors used throughout materials‘ preparation. The second 
approach is the method used in this project since it is simpler to use the commercially 
available materials (it is difficult to prepare the building blocks). The organic 
polymers are formed and the sol-gel process is applied to produce the inorganic 
component. 
 
Figure 2.9 Schematic of a class II hybrid material 
An organic/inorganic hybrid for bone regeneration requires the two phases of the 
material to interact at the molecular level thus behaving as a single phase in order to 
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obtain congruent dissolution. A schematic of a potential atomic structure of a hybrid 
material is illustrated in Figure 2.9. Silica clusters (inorganic phase) are linked 
together by polymer chains (organic phase). Since the development of hybrid in this 
project is based on the silica sol-gel process, only the alternative materials for organic 
phase (polymer candidates) and the calcium source need to be considered. Current 
polymers for medical application will be reviewed in section 2.7.4. Depending on the 
solubility of the polymer in the sol, a suitable solvent may be required to incorporate 
the polymers. In order to produce a class II hybrid with strong connectivity between 
the two phases, a coupling agent may also need to be used to covalently couple the 
organic phase and the inorganic phase. Modification of the polymer (functionalisation) 
before addition to the sol is one approach to achieve the required bonding. 
Functionalisation can also increase the solubility of the polymer in the sol [82-84]. 
Mechanical properties 
Since the hybrid materials to be developed in this project are for bone graft 
applications, they are required to have good mechanical properties to provide 
temperate support until the new tissue forms within the material. Several factors 
determine the mechanical properties of a hybrid material. First of all, if the polymer 
used to produce the hybrid has good mechanical properties, e.g. due to high molecular 
weight, it is expected to produce a hybrid with high mechanical properties. Water 
content also affects the strength of the hybrid system, e.g. hybrid materials prepared 
from the in situ polymerisation of N-isopropylacrylamide, methylenebisacrylamide, 
and tetramethoxysilane (TMOS) showed a swelling behaviour with water which 
affecting the strength [75]. It is hypothesised that strong covalent bond between the 
silica and polymer phase is another important factor, thus the polymer is required to 
have enough functional groups which are the ―attachment points‖ between the 
polymer and silica or coupling agent. Therefore an increase the number of 
―attachment points‖, i.e. functional groups, and the concentration of coupling agent 
may also increase the mechanical properties. These aspects will be investigated herein. 
Network connectivity of hybrids 
The network connectivity of the hybrid material was determined by the number of Q
n
 
and T
n
 species in the material. Q
n 
species are silicon atoms in the glass network that 
are connected to other silicon atoms by n bridging oxygen (oxygen atoms covalently 
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bond to two silicon atoms Si-O-Si) bonds, corresponding to the structures of 
Si(OSi)n(OR)4-n, where R is OH, CH3CH2O or O
-
, i.e. a non-bridging oxygen (NBO) 
[85-88]. Therefore, the Si(OSi)n(OH)4-n are denoted as Q
n
(H), while Si(OSi)n(O
–
)4-n 
with NBO‘s are labelled as Qn(Ca). Tn indicates the number of bridging oxygen bonds 
connecting to a Si that is connected to one C (i.e. the polymer). 
Degradation, bioactivity and biocompatibility 
An organic/inorganic hybrid for bone regeneration must be degradable. The 
degradation is designed to occur when the hybrid surface contacts with the human 
body fluid. The degradation mechanism of inorganic phase is thought to start from ion 
exchange and then followed by the stages similar to the degradation of the bioactive 
glass (described in section 2.5.2). The degradation of the organic phase mainly 
depends on the nature of the polymer. Chemical hydrolysis is the prevailing 
mechanism [89] but it can be triggered by an enzyme or by water, depending on the 
polymer. In polyesters, bulk degradation occurs when the water penetrates the 
material, the polymer swells and chain scission occurs at ester linkages reducing chain 
length. Ultimately, soluble fragments are released. Surface degradation occurs when 
the rate of water penetration is slower than that of conversion of the polymer into 
soluble materials. Some polymers (e.g. the poly glutamic acid used here) are degraded 
by specific enzymes. The first stage of hybrid degradation is likely to be dissolution 
by loss of polymer chains and loss of cations from the inorganic. Polymer chains may 
be lost from the material before degradation occurs, but this requires further 
investigation. The rate of hybrid degradation depends on either the properties of the 
hybrid and its components (e.g. polymer type and molecular weight; degree of 
covalent coupling between the components, calcium content) and the environmental 
conditions (e.g. pH, fluid flow, enzyme concentration). The degradation of the 
polymer may also change the pH value, e.g. the degradation of polyesters lowers the 
pH value which in turn accelerates the degradation of polymer [90].  
An organic/inorganic hybrid for bone regeneration must have controlled degradation 
rate. It is not only important for maintenance of mechanical properties and transfer of 
load during tissue regeneration, but also to control the immune system reaction. A 
class II hybrid with a homogeneous distribution of coupling agents between the 
polymer and the silica has the potential that the two phases act as one and degrade at 
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the same rate, i.e. congruently. Bioactivity is normally contributed by the inorganic 
phase. Thereby, in order to have good bioactivity, the bioactive inorganic particle 
should not be masked by the organic polymer, i.e. the presence of organic phase 
should not hinder HCA formation. The fabrication route influences whether the 
inorganic is masked by the organic or not.  
Solubility 
Since the hybrid development is based on the sol-gel process, the polymers selected 
for use must be soluble in the sol and withstand the shrinkage by drying without 
creating stress which would cause the composite to crack [91, 92]. The by-products 
formed during the sol-gel process (e.g. water or alcohol from hydrolysis or 
condensation) may affect the solubility of the polymers. Novak stated that polymers 
with basic functional groups are soluble (e.g. amines and pyridines) [92]. The 
solubility of polymers can be improved by using coupling agent which can react with 
both polymer and silica network, creating chemical bonds between them [91]. A 
suitable solvent that can work with the polymer and the sol may also be an approach 
to take the polymer into the sol-gel process. Solubility of the precursors during the 
sol-gel process is an extremely important factor to produce a homogeneous hybrid. 
The homogeneity will affect the mechanical properties, degradation, bioactivity and 
biocompatibility of the material. 
Coupling agent for class II hybrid synthesis 
 
Figure 2.10 Structures of possible coupling agents for the synthesis of class II hybrids: (a) 3-
(glycidoxypropyl) trimethoxysilane (GPTMS); (b) 3-isocyanatopropyl)triethoxysilane (ICPTES); 
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(c) 3-(methacryloxypropyl)trimethoxysilane (MSMA); (d) 3-aminopropyltrimethoxysilane 
(APTES). 
 A coupling agent is used to bond the organic phase and inorganic phase via covalent 
bonding. In order to achieve this function, a potential coupling agent normally has 
trialkoxysilane-groups and at least one functional group (e.g. vinyl, cyano, amino, 
epoxy). The trialkoxysilane-groups are used to connect with silica network after being 
hydrolysed, whereas the other functional groups are used to connect with the 
polymers. Some common coupling agent structures are illustrated in Figure 2.10. 
Polymers containing carboxyl groups, such as carboxylated polysulfone (C-PSF) [93] 
or acrylonitrile butadiene styrene (ABS) rubber after oxidation with hydrogen 
peroxide [94], can be functionalised with GPTMS (Figure 2.10a) by reacting its epoxy 
group (on GPTMS) with  the carboxyl groups of the polymer. Polymers containing 
amino groups can also be functionalised with GPTMS. ICPTES (Figure 2.10b) is used 
to link with polymers that contain –OH groups, e.g. DL-lactide oligomers [95] were 
functionalised and cross-linked in an acid catalysed sol–gel process; highly 
transparent hybrid materials containing polyurethane (PU), poly(methyl methacrylate) 
(PMMA) and SiO2 were prepared by a sequential in situ polymerisation of the three 
different polymers [96], ICPTES was used as coupling agent to covalent bond with 
PU and the inorganic network. MSMA (Figure 2.10c) is often incorporated by 
copolymerisation and can be universally applied in free radical polymerisations of 
acrylate-based systems [97] but also with other monomers, such as styrene [98]. 
Polyimides have also been prepared from 4,4-biphthalic anhydride and oxydianiline 
and blended with SiO2 by using APTES (Figure 2.10d) as coupling agent through the 
sol–gel process [99]. 
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Figure 2.11 Possible structures that can be obtained by functionalisation of organic polymers 
with trialkoxysilane groups [91] 
The coupling agent can be used either before the sol-gel process to functionalise the 
polymers (during or after the polymer preparation) or during the sol-gel process to 
react with the polymers and hyrolysing silica simultaneously. The structures of 
possible functionalised polymers are illustrated in Figure 2.11.  
2.7.4 Organic phase candidates for bioactive hybrid synthesis 
Biodegradable polymers are the most popular polymeric materials for clinical use. 
Thus biodegradable polymers with the required properties reviewed above will be the 
best choice for hybrid synthesis. The focus of this section will therefore be on current 
clinical used polymers. 
Polyglycolide  
Poly(glycolic acid), PGA, otherwise known as poly(glycolide) is the simplest linear 
aliphatic polyester. It was used to develop the first totally synthetic absorbable suture 
that has been marketed as DEXON since the 1960s [100]. PGA is normally prepared 
by the chain polymerisation of the cylic dimer of glycolic acid (hydroxyaceti acid) in 
the present of heat and a suitable catalyst (e.g. stannous octoate). (Fig 2.12) It is 
approved by FDA and can be processed using various manufacturing techniques to 
form fibres, films, rods, screws, plates, clamps etc to fit different applications. High 
molecular weight PGA is a hard, tough, highly crystalline polymer (45% - 55%) with 
a melting point of 220-225 °C and a glass tranition temperature of 35-40 °C [101]. 
Si(OR)3 (RO)3Si Si(OR)3
Si(OR)3 Si(OR)3
Si(OR)3 Si(OR)3
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Unlike closely related polymers such as poly(lactic acid), PGA has low solubility in 
organic solvents since its high degree of crystallisation. PGA is hydrolytically 
degradable and the degradation products (glycolic acid molecules) are metabolised via 
the citric acid cycle and finally eliminated by respiration. 
 
Figure 2.12 Synthesis of poly(glycolide) (PGA) 
PGA is also insoluble in water, which make it difficult to be incorporated into the sol-
gel process. There‘re one carboxyl group in one end of the PGA and a hydroxyl group 
in the other end, which provide PGA the ability to be modified by crosslinker. But the 
number of ―attachment point‖ may not enough to a strong bonding. 
PLA  
Poly(lactic acid), also known as poly(lactide), is a biodegradable polymer that has 
been used as biomedical material for tissue regeneration and matrices for drug 
delivery systems. It is normally prepared by the ring opening polymerisation of the 
cyclic dimer of lactic acid and can be processed as widely as PGA.  It is also approved 
by FDA for clinical use. Due to the chirality of lactic acid and lactide, the 
stereochemical structure can be modified by polymerising a controlled mixture of the 
L or D isomers. The proportion of D or L isomer in the polymer directly influences 
the degree of amorphous or crystalline regions, which will further affect the thermal, 
physical, mechanical and crystallisation properties. Common PLA exists as L-PLA 
(PLLA), synthesised of pure L isomers; and DL-PLA (PDLLA), synthesised of both 
D and L isomers [102]. 
Poly-L-lactide (PLLA) is a semicrystalline polymer. Similar to PGA, PLLA exhibits 
high tensile strength and low elongation and consequently have high modulus that 
makes them more applicable than the amorphous polymers for load-bearing 
applications. PLLA is about 37% crystalline with a melting point of 175-178 °C and a 
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glass transition temperature of 60-65 °C [89]. The degradation rate of PLLA is slow, a 
fibre may take more than 2 years to be completely absorbed [103]. PDLLA is an 
amorphous polymer that has lower tensile strength and higher elongation and much 
more rapid degradation rate making it mostly used as a drug delivery system.  
Degradation of PLA occurs by a hydrolytic process, and the degradation products can 
be incorporated into the carbohydrate metabolic cycle and thereafter converted into 
carbon dioxide and water. PLLA is more hydrophobic than PGA because of the 
presence of the methyl group, which sterically hinders ester bond cleavage. 
Combining its less chemically reactive, PLLA depredates slower than PGA. 
PLA is also insoluble in water. A suitable solvent is required if PLA is chosen as the 
organic phase for hybrid development. The ―attachment points‖ of PLA are also few 
in number, a polymer modification may be an approach to increase the number of the 
functional groups. 
Poly(lactide-co-glycolide)  
Poly(lactide-co-glycolide), PLGA, is the copolymer of PLA and PGA. It also 
approved by FDA for its biodegradability and biocompatibility. Though the properties 
of PLGA can be controlled by the ratio of both monomers, there is no linear 
relationship between the copolymer composition and the mechanical and degradation 
properties of the materials [89]. A copolymer of 50% glycolide and 50% DL-lactide 
degrades faster than either homopolymer [104]. 
PLGA can degrade by hydrolysis in the body to produce the original monomers, lactic 
acid and glycolic acid, which can then be eliminated by the metabolic cycle. Unlike 
the homopolymer PLA or PGA, PLGA can be dissolved by a wide range of common 
solvents including chlorinated solvent, tetrahydrofuran, acetone or ethyl acetate. 
PLGA also have only one hydroxyl and one carboxyl croup, which may not sufficient 
for a strong connection with the organic phase of the hybrid. 
Poly(ε-caprolactone) 
Poly(ε-caprolactone), PCL, is a semicryslalline polymer with good biocompatibility 
and can be used to form biocompatible blends with wide range of other polymers such 
as pactide and glycolide [105]. It is normally prepared by ring opening polymerisation 
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of ε-caprolactone, and its crystallinity decreases with a corresponding increase in 
molecular weight. The melting point of PCL is 59-64 °C, and glass transition 
temperature is -60 °C [89]. PCL is hydrolytically degraded under physiology 
conditions and the degradation products are taken up by macrophages and 
intracellularly degraded [106]. Therefore, the degradation rate of PCL is much slower 
than that of PLA and PGA.  
PCL is insoluble in water, and with only one hydroxyl and one carboxyl group in the 
ends, which make it difficult to be used in as a good organic phase for hybrid 
development. 
Collagen 
Since type I collagen is the main organic component of bone, it is important to 
consider collagen as a candidate of the organic phase for the hybrid development. The 
characteristics of collagen as a biomaterial are distinct from the synthetic polymers 
mainly in its mode of interaction in the body [107]. It plays an important role in the 
formation of tissues and organs, and is involved in various functional expressions of 
cells [108]. Due to its excellent biodegradability and biocompatibility [109], collagen 
has been applied to many medical applications [110]. Collagen is available in 
abundance and can be easily purified from living organisms including bovine, porcine, 
human placenta and fish [110]. However, it has potential for transfer of diseases and 
high quality collagen is expensive [111].  
Collagen molecule consists of three polypeptide chains twined around one another as 
a triple helix and each chain has an individual twist in the opposite directions [110]. 
Each chain is assembled with glycine in the centre of the triple helix and large amino 
acids pointing outwards. Hydrogen and covalent bonding are the main bonds holding 
the chains together [112]. Collagen can be solubilised into an aqueous solution and 
can be engineered to exhibit tailor-made properties. It can be degraded by specific 
enzymes, which makes it a degradable polymer [113]. Collagen also has many 
functional side groups (e.g. –NH2 and –COOH) which can be modified to achieve 
covalent bonding between the organic and inorganic phases, which is likely to 
improve the integrity and control the degradation rate to the composite. 
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Gelatin 
Gelatin, a derived protein, can be prepared from collagen by breaking apart the triple 
helix molecule [114]. It is the principal constituent of the commercial products 
―gelatine‖ and glue and is responsible for their gel properties [115]. Gelatin can be 
sourced from collagen of both mammal and fish. It is reported the fish gelatin has a 
lower gel modulus and melting temperature than mammal [116]. Since breaking apart 
collagen results in very inhomogeneous features of the resultant gelation, the tool of 
recombinant protein has been apply to prepare recombined collagen and gelatin with 
defined molecular weights, isoelectric point (IEP), guaranteed lot-to-lot 
reproducibility, and the ability to tailor the molecule to match a specific application 
[117].  
Gelatin is also enzymatically degradable. Gelatin has free amino groups (from glycine, 
almost 1 in 3 residues, arranged every third residue) which can be reacted with epoxy 
groups. Gelatin also contains a large number of carboxyl groups. Combining its 
solubility in the sol-gel process, gelatin has great potential to bond covalently with the 
inorganic phase of the hybrid after modified by an epoxy containing crosslinker such 
as GPTMS. 
Poly(glutamic acid)  
Poly(glutamic acid) is a polyanionic biopolymer that is polymerised linearly from 
glutamic acid, an amino acid [118]. It is known in Japan as the famous food ‗natto‘. γ-
PGA is the γ form of the poly(glutamic acid) and can be produced by several bacteria 
[119]. Bacillus subtilis produced γ-PGA has been approved by FDA as ―generally 
regarded as safe‖. γ-PGA is biocompatible and enzymatically biodegradable, and has 
been successfully utilised in diverse applications including medicine, food, plastics, 
and fertiliser industries [120].  
Glutamic acid is a chiral molecule thus the polymer may have three stereochemically 
different types in biopolymers: A homopolymer composed of D-glutamate (D-PGA), 
a homopolymer of L-glutamate (L-PGA), and a copolymer in which the D- and L-
glutamate units are lined up at random (DL-PGA) [121]. The molecular weight 
determines the properties and application of γ-PGA [120]. The free acid form of γ-
PGA is hydrophobic and is not soluble in water and is only soluble in 
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dimethylsulfoxide (DMSO). Since it is an anionic polymer, γ-PGA can be turned into 
salt form with a variety of cations (e.g. sodium, calcium, tetra ammonium) to make it 
soluble in water. The carboxyl group in each repeat unit allows γ-PGA to be modified 
with coupling agent and bond covalently to inorganic phase of the hybrid material. 
This thesis concentrates on the use of γ-PGA because it is biocompatible, can be 
degraded via enzyme action and contains –COOH groups along its backbone, making 
it possible to functionalise it and covalently couple it to sol-gel silica (class II hybrid). 
2.7.5 Current class II organic/ inorganic hybrids  
PCL/silica hybrid monoliths have been produced by Rhee et al. by sol-gel method 
[82-84]. The coupling agent ICPTES was used to functionalise the polymer by 
reacting its –N=C=O group with the two hydroxyl groups on α,ω-hydroxyl PCL. The 
molecular weight of the chosen PCL was 6693, and that of functionalised PCL was 
12723. Toluene was the solvent for functionalisation and tetrahydrofuran was the 
solvent of PCL for the sol-gel process. The weight proportion between the 
functionalised PCL to the inorganic sol was 60 to 40. Calcium nitrate was used as the 
calcium precursor. The resulting hybrid monolith was considered bioactive as an 
HCA formed after 1 week immersion in SBF, and degradable (evaluated in phosphate 
buffer solution, PBS). The effect of molecular weight of PCL on the bioactivity was 
also evaluated [83]. They found faster and more uniform nucleation and growth of 
apatite crystals was observed to occur in the hybrid used low molecular weight PCL 
(Mw=530) than that using high molecular weight one (Mw=2000). The effect of PCL 
content on the bioactivity and mechanical properties was investigated later [84]. 
Increasing the PCL content in the hybrid (from 40 wt% to 80 wt%) decreased the 
apatite-forming rate and showed polymer-like ductile–tough fracture behaviour, 
whereas, decreasing the PCL content in the hybrid increased the apatite-forming rate 
and showed ceramic-like hard–brittle fracture behaviour. The highest values of tensile 
strength (21 MPa) and Young‘s modulus (600 MPa) were achieved at intermediate 
PCL content (60 wt%), which is in the range of human trabecular bone. It also had 50% 
elongation before failure. The main drawback of their hybrids is that it has a potential 
to leave the silica particles after the preferential degradation of PCL in vivo. Besides, 
PCL requires over 1 year for the complete in vivo degradation due to its 
semicrystalline structure [122]. 
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Rhee et al. also tried using PLGA as the organic phase of hybrids [123]. Their Class II 
PLGA/ICPTES hybrid monoliths were achieved by firstly functionalising the polymer 
with ICPTES in dimethylformide (DMF), followed by adding 10 wt % calcium nitrate 
in dry tetrahydrofuran, and adding water and HCl for further reactions. Two PLGA 
copolymer compositions with low (90PLA10PLGA) and high (50PLA50PLGA) 
degradability were investigated in the experiment. They found the hybrids with high 
PLGA content showed no apatite forming ability in SBF after 28 days, whereas low 
content hybrids did in 3 days. The acidic degradation products of PLGA lowered the 
pH of the SBF, which in turn hindered HCA formation. They then pointed out that a 
suitable biodegradable polymer is extremely important for developing a bioactive, 
degradable composite for bone substitute materials. The mechanical property was not 
reported. But their hybrids had polymeric matrix (high percentage polymer content), 
which will yield poor compressive properties. 
Ren et al. synthesised gelatin/GPTMS hybrid foams by using a combined sol-gel 
processing and freeze-drying process [124, 125]. They suggested that the large 
amount of free amino groups on gelatin reacted with the epoxy groups on GPTMS, 
and the trimethoxysilane groups on GPTMS provided a silicate network. They used 
29
Si Nuclear Magnetic Resonance (NMR) to identify T
n
 species however it was not 
clear whether the reaction took place as they suggest or whether the GPTMS cross-
linked to itself to form T
n
 species. The large fraction of GPTMS yielded a great 
number of crosslink bonds, and constructed a rigid network. The glass transaction 
temperature (Tg) of the hybrids increased with increasing fraction of GPTMS. The 
calcium containing samples formed HCA within 14 days after immersed in SBF, 
whereas no HCA formed on the calcium free samples. They also stated the pore sizes 
of the hybrids can be well controlled by varying the freezing temperature. The by-
product of calcium nitrate is thought to be toxic to the hostage tissue. However in 
their report, the toxicity of nitrate by-product was not found when using the MC3T3-
E1 cells to evaluate the cytotoxicity and cytocompatibility. Calcium containing 
samples were reported had enhanced cellular activity comparing to the calcium free 
ones. The mechanical properties of those hybrids were not reported. It is however 
expected to be low due to the low mass percentage of inorganic silica in the hybrids. 
One disadvantage of their procedure is no TEOS was used inducing that the silica 
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content of the aiming material cannot be controlled independently of the crosslinker 
GPTMS. 
Mahony et al. created a novel silica-gelatin hybrid based on gelatin, TEOS and 
GPTMS via sol-gel processing and freezing-drying process [126].  TEOS was utilised 
to produce the inorganic silica phase instead of GPTMS. The silica content of the 
aiming hybrid can be thereby controlled by adjusting the amount of TEOS used in the 
process. GPTMS was used as coupling agent to covalently bonding gelatin and silica 
phase: epoxy ring of GPTMS opened and reacted with gelatin‘s carboxylic acid 
groups; and silanol groups derived from hydrolysing the methoxysilane groups of 
GPTMS reacted with the silanol groups derived from hydrolysing TEOS. The 
resulting hybrid was biocompatible, highly porous, and exhibit controlled degradation. 
The scaffolds made with 60 wt% gelatin, with a molar ratio of GPTMS: gelatin of 500, 
were very flexible and highly elastic, with a linear-elastic region up to 34% strain 
before the pores became compressed and the apparent stiffness increased. This 
indicates those scaffolds are also promising for soft tissue repair. They concluded the 
scaffold mechanical properties were heavily influenced by the degree of inorganic-
organic coupling, porosity and the relative proportions of inorganic and organic 
present in the hybrid. No calcium was added in these hybrids. 
Poologasundarampillai et al. created a γ-PGA/TEOS/GPTMS hybrid system via sol-
gel processing [127]. GPTMS was also used as coupling agent in their work: epoxy 
groups of GPTMS reacted with the carboxyl groups of γ-PGA and methoxysilane 
groups of GPTMS reacted with TEOS after both were hydrolysed. Calcium chloride 
was used to provide calcium. The hybrids were found to be not toxic to the 
osteosarcoma cells and the cells were able to spread and form large and multiple 
adhesion to the sample surface. The influence of the solvent DMOS and calcium on 
hybrid nanostructure, and influence of crosslinking on hybrid structure were studied.  
An SBF study showed HCA only formed on calcium containing hybrid samples. 
2.7.6 Summary of biomedical hybrid materials 
Though numbers of Class II hybrid systems have been created, they are still not good 
enough to be used for bond regeneration. The drawbacks include the poor mechanical 
properties, uncontrolled degradation and toxicity of the calcium precursor by-products. 
59 
 
 
This thesis will attempt to employ a modified PLA with high molecular weight as the 
polymer, and ICPTES as the coupling agent to synthesis a hybrid material. A new 
calcium source will also be tried to introduce calcium into the γ-PGA/silica hybrid 
system. 
2.8 Calcium source for sol-gel process 
Calcium is very important for bone regeneration as it plays an extremely important 
role in the formation of hydroxycarbonate apatite (HCA) layer which provides 
bonding with the bone [128]. It is also thought to act as a signalling agent to 
osteogenic cells as it is released from bioactive glass [6]. As reviewed in section 2.5.2, 
CaO in the glass system acts as network modifier which affects the network 
connectivity. It further affects the bioactivity by influencing the dissolution rate. The 
target concentration of calcium in the local body fluid is 88 to 100 ppm [7]. Thus a 
bone tissue engineering material must contain calcium. 
Calcium nitrate is the traditional calcium source for bioactive sol-gel glasses. It is 
easily soluble into the sol and allows for a one pot formation method. However, it 
requires to be heated over 550 °C to remove the toxic nitrate by-products [129]. This 
heat treatment is not suitable for hybrid synthesis as the polymer will be degraded and 
burned off. On the other hand, calcium starts to enter the silica network after 400 °C 
[46, 130], which is also too high for hybrid materials. 
Calcium nitrate (tetrahydrate) melts before decomposition [131]. It melts at 
approximately 42.7 °C and subsequent decomposition occurs at 350 ~ 400 °C in the 
liquid phase [46]. Fitzgerald et al. reported that Calcium nitrate crystallites were 
present until glass foams were heated to 600°C [130]. NO
3-
 anion has been reported 
that it breaks down at 675.85 °C when the heating rate is 10 °C/ min [131]. It has been 
concluded in two overlapping and interacting steps: nitrate   nitrite   oxide. The 
overall reaction may be approximately expressed as Ca(NO3)2  CaO + 1(1/2)NO2 + 
O2 +(1/4)N2. 
The fact that calcium does not enter the network until high temperatures are reached 
means that inhomogeneity appears even in sol-gel glasses when using the Ca(NO3)2 as 
calcium source.  Lin et al. reported calcium rich regions formed in the sol-gel glass 
monolith [129]. That was because during the gelling and aging stage, Ca(NO3)2 is 
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dissolved in the pore liquor and then expelled out of the gel due to the shrinkage. 
Ca(NO3)2 thereby deposits on the outer parts of the monolith and calcium cannot 
sufficiently diffuse into the inner part during stabilisation because of the long path 
[129]. A similar problem also has been reported by Saravanapavan and Hench in 2003 
[35]. Since calcium release from the implants needs to be slow, a homogeneous 
calcium distribution is important for the bone regeneration materials. 
Though calcium nitrate is not a desirable calcium source for hybrid synthesis, early 
hybrid development utilised it to provide calcium. Ren et al. tried using calcium 
nitrate as calcium source for a gelatin/GPTMS hybrid synthesis [125]. They stated the 
calcium containing samples showed in vitro bioactivity as they biomimetically 
deposited apatite whereas the calcium free samples failed. Chen et al. worked on a 
PDMS-modified CaO-SiO2-TiO2 system also using calcium nitrate as calcium source 
[132]. They also found the bioactivity in vitro was enhanced comparing the calcium 
free hybrid systems. Rhee has evaluated the effect of calcium nitrate content in their 
PCL/silica hybrid (ICPTES as coupling agent) on the nucleation and growth 
behaviour of apatite layer [133]. They found in SBF for 1 week, low calcium 
containing samples formed a densely packed and smooth apatite layer with similar 
Ca/P ratio to that of bone, whereas high calcium containing samples formed loosely 
packed and rugged apatite layer with higher Ca/P ratio than that of bone. The stated 
this behaviour can be explained by the degree of supersaturation of apatite in the SBF. 
It is clear that calcium is needed for bioactivity and that an alternative to calcium 
nitrate is needed. This could be an alternative calcium salt or a calcium alkoxide. 
Calcium chloride does not produce toxic by-products thus would be suitable for lower 
temperature process. It has been used in hybrids containing PMMA [134], PDMS 
[135] and chitosan [136]. They found the salt improved bioactivity compared to 
calcium free samples and helped in the hydrolysis of GPTMS and the condensation of 
silanol groups leading to a more condensed Si-O-Si network. However, for chitosan/ 
silica hybrids, the cell attachment was reduced by half and a more hydrophilic 
material was formed [123]. Poologasundarampillai created a PGA/silica hybrid 
(GPTMS as crosslinker) and also tried using calcium chloride as the calcium source 
[127]. He found calcium might be not incorporated into the system but recrystallised 
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to calcium chloride on the surface and pores. Calcium chloride was hygproscopic and 
resulted in increased water content in the material which reduced the ability to form a 
highly condensed silicate network. 
Calcium methoxyethoxide is a calcium alkoxide and normally exists as a solvent. It is 
normally obtained by reacting calcium with 2-methethoxyethonal (Figure 2.13). It is 
high sensitive to oxides and water. Pereira et al. were the first to use CME to 
synthesis sol-gel derived bioactive glasses. They reported the homogeneity was 
improved from 65% to 99% comparing to using calcium nitrate [137]. All 
compositions studied, in the CaO-P2O5-SiO2 system S60 (60 mol% SiO2, 36 mol% 
CaO and 4 mol% P2O5), S70 (70 mol% SiO2, 26 mol% CaO and 4 mol% P2O5) and 
S80 (80 mol% SiO2, 16 mol% CaO and 4 mol% P2O5), formed an HCA layer within 8 
h of immersion in both simulated body fluid (SBF) and Tris buffer [138]. Another sol-
gel derived bioactive glass 76SA (26 mol% SiO2, 23 mol% CaO and 1 mol% P2O5) 
made with CME has been reported by Ramila et al. in 2002. A more homogeneous, 
thicker and compact apatite layer formed than conventional bioactive glasses [139]. 
Both previous studies used excess water in the reaction to gel the glasses whereas in 
this study CME mixed with water directly. 
 
Figure 2.13 Schematic of the synthesis of calcium methoxyethoxide 
2.9 Objectives of the thesis 
There were two main aims in this work: 1) to find a suitable calcium source for both 
sol-gel derived bioactive glasses and organic/inorganic hybrids; 2) create PLA/silica 
hybrids. The works would be separated into 4 sections. Firstly, three different calcium 
precursors (calcium nitrate, calcium chloride and CME) would be tested to investigate 
the effect of calcium source on the structure and properties of sol-gel bioactive glasses. 
Secondly, since the incorporation of calcium into the glassy network is another 
critical point for the calcium source, different techniques (XRD, ICP and NMR) 
would be applied to study the incorporation and review the temperature at which 
calcium incorporated. After tested calcium sources on bioactive glasses, calcium 
Ca
O
O
O
O
O
OHCa
H2+ 2
+
2-methodxyethonal calcium methoxyethoxide
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chloride and CME would be tested as calcium source to provide calcium for the γ-
PGA/ silica hybrids. The method how to incorporation calcium into these hybrids 
would be determined, and the structure and properties of the synthesised hybrids 
would also be characterised. Last, another organic/inorganic hybrid containing PLA 
would be synthesised and characterised, to determine whether it was a potential 
design for bone regeneration. 
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3 New sol-gel derived bioactive glasses synthesised with alternative 
calcium sources 
3.1 Introduction 
Since the use of calcium nitrate as the calcium source causes inhomogeneity in sol-gel 
derived bioactive glasses and cannot be used in hybrids (Section 2.8), a new calcium 
source is required. Calcium chloride and calcium methoxyethoxide are the potential 
candidates. In this project, sol-gel derived bioactive glass composites 70S30C (70 mol% 
SiO2, 30 mol% CaO) and 58S (60 mol% SiO2, 36 mol% CaO, 4 mol% P2O5) made 
with three different calcium precursors at a series of temperatures (from 60 °C to 
800 °C) were tested. The study of calcium incorporation will be described in a 
separate section (Chapter 4). 
3.2 Materials and methods 
3.2.1 Materials 
Tetraethyl orthosilicate (TEOS, 98%), nitric acid (HNO3 69%), hydrochloric acid 
(HCl, 2N), calcium nitrate tetrahydrate (Ca(NO3)2·4H2O, 99%), calcium chloride 
dihydrate (CaCl2·2H2O, 99%), calcium acetate (99%), triethyl phosphate (TEP, 99%), 
hydrofluoric acid (HF, 48%), calcium granular particles (Ca, 0.2-3 mm), 2-
methoxyethanol (99.8%) were purchased from Sigma-Aldrich. Initially, calcium 
methoxyethoxide (CME) was purchased from Gelest Inc. (USA), but it was found to 
have inconsistent properties, e.g. gelation rate on reaction with water was variable. 
HNO3 was diluted in deionised water to make the concentration of 2N, and HF was 
diluted in deionised water to make a concentration of 5 vol%. All the other chemicals 
were used as purchased form without further process. The water in Ca(NO3)2·4H2O 
and CaCl2·2H2O was ignored during calculation since their amounts were extremely 
low.  
3.2.2 Synthesis of bioactive glasses with different calcium sources 
When samples were synthesised with commercial CME, the CME was found to have 
inconsistent properties, so CME was prepared following Pickup et al. method 
described in [140]: 1 g of calcium metal was reacted with 24 ml of 2-methoxyethanol 
in argon atmosphere at 80 °C for 24 h. The resultant solution was centrifuged at 6000 
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rpm for 10 min to remove unreacted calcium metal. The concentration of CME in 
solution was confirmed gravimetrically by heating to 1050 °C for 12 h where the 
solvent evaporated and the CME converted to CaO. This revealed the CME solution 
concentration to be 0.001 mol/ml. 
Table 3.1 Types of samples in comparison (√-samples prepared, x- samples not prepared) 
Samples 60  °C 700  °C 800  °C 
60  °C 
HF 
700  °C 
HF 
800  °C 
HF 
70S30C-Ca(NO3)2 x √ √ x √ √ 
70S30C-CaCl2 √ √ √ √ √ √ 
70S30C-CME √ √ √ √ √ √ 
58S-Ca(NO3)2 x √ √ x √ √ 
58S-CaCl2 √ √ √ √ √ √ 
58S-CME √ √ √ √ √ √ 
 
Glasses were made of the bioactive 70S30C (70 mol% SiO2, 30 mol% CaO) and 58S 
(60 mol% SiO2, 36 mol% CaO, 4 mol% P2O5) compositions. Three calcium 
precursors (Ca(NO3)2, CaCl2 and CME) were used to produce each of the glasses. 
Calcium acetate was also used in pilot studies. Sol-gel solutions were gelled with and 
without hydrofluoric acid (HF) and different heat treatments were applied to the 
gelled samples (Table 3.1). Samples that were only dried at 60 C and not taken to 
higher temperatures were not synthesised with calcium nitrate as the nitrate by-
products would remain. Table 3.2 shows the reagents used for each type of glass. 
Table 3.2 Reagents used in the sol-gel synthesis (250 ml sol each, 3 ml HF per 50ml sol) 
Samples 
H2O 
(ml) 
HNO3 
(ml) 
HCl 
(ml) 
TEOS 
(ml) 
Ca(NO3)2 
(g) 
CaCl2 
(g) 
CME 
(ml) 
TEP 
(ml) 
70S30C-Ca(NO3)2 135.90 22.68 – 141.12 63.72 – – – 
70S30C-CaCl2 135.90 – 22.68 141.12 – 39.67 – – 
70S30C-CME 62.23 – – 64.27 – – 123.48 – 
58S-Ca(NO3)2 129.60 21.60 – 134.40 85.01 – – 13.60 
58S-CaCl2 129.60 – 21.60 134.40 – 52.92 – 13.60 
58S-CME 50.85 – – 52.52 – – 141.25 5.33 
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Calcium nitrate containing samples were synthesised by the traditional sol-gel method 
[35] (Figure 3.1, inorganic route). Briefly, deionised water and nitric acid (2N) were 
mixed together and stirred for 5 min followed by addition of tetraethyl orthosilicate 
(TEOS) into the mixture. The R ratio (molar ratio of water : TEOS) was 12. For the 
58S samples, after 1 h stirring, triethyl phosphate (TEP) was added and stirred for a 
further 30 min. The appropriate calcium precursor was then added and stirred for 
another 1 h. For 70S30C samples, no TEP was added.  
 
Figure 3.1 Flow chart of sol-gel methods used 
To investigate the effect of a gelation catalyst, HF was added to selected samples at a 
ratio 1.5 ml of HF (0.5 w/v) to 50 ml of sol. The samples were immediately sealed. 
Samples prepared without HF were also sealed and left to age at room temperature for 
3 days. For the preparation of the samples containing CaCl2 as the calcium precursor 
the Ca(NO3)2 was replaced with CaCl2 and 2N hydrochloric acid (HCl) was used in 
place of 2N HNO3. The glass with calcium methoxyethoxide (CME) was synthesised 
by first mixing TEOS and CME in a nitrogen atmosphere (Figure 3.1, organometallic 
route). After 1h of being stirred, the sol was hydrolysed by mixing with water inside a 
hermetic container. The final volume of each sample was measured to 250 ml and 
placed in a Teflon mould before heat treatment. The samples in the Teflon moulds 
Sol-Gel Method
Inorganic Route Organometallic Route
Hydrolyzed Reagents Mixture
TEOS + Ca(NO3)2 + H2O + HNO3
Reagents Mixture
TEOS + Ca(OCH2CH2OCH3)2
Sol Hydrolysis + Gelation
Gelling (25 oC)
Ageing (60 oC)
Drying (60 oC→130 oC)
Stabilisation (600 oC)
Sintering (800 oC)
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were then left to age at room temperature for 3 days. Some of the Ca(NO3)2, CaCl2 
and CME samples were taken through the full sol-gel heat treatment (dried at 
60~130 °C and stabilised at 700 °C, some sintered at 800 °C after stabilisation) to 
enable direct comparison with conventional sol-gel glasses prepared via the nitrate 
route. All the samples were ground in a ball mill and sieved to particles size ranges 
between 38-90 µm in order to allow comparison between samples in terms of surface 
area, dissolution rates and bioactivity, which all depend on particle size. 
3.2.3 Characterisation of sol-gel glasses 
Composition 
The lithium metaborate fusion dissolution method was used to determine the 
composition of the samples by measuring the ratio of three critical elements - Si, Ca, 
and P (if present) [141]. The samples for this test were stabilised at 700 °C to remove 
moisture. Briefly, 0.1 g of each sample was mixed with 0.5g of anhydrous lithium 
metaborate in a clean dry platinum-gold crucible and then fused at 1400 °C for 30 min. 
After cooling to room temperature, the crucible was immersed in a 250 ml beaker 
filled with 80 ml 10 vol% nitric acid and stirred over night with a magnetic stirrer. 
The solution was then transferred to a 100 ml polypropylene volumetric flask and 
filled up to the mark with 10 vol% nitric acid. The concentrations of Si, Ca, and P 
were then analysed by inductive coupled plasma (ICP), which was carried out using 
an iCAP 6000 Series ICP-OES spectrometer (Thermo). The proportion of SiO2, CaO 
and P2O5 (if present) was then obtained by comparing the molar ratio, which was 
calculated from the concentration of Si, Ca, and P. 
Inductively coupled plasma optical emission spectrometry (ICP-OES), also referred to 
as inductively coupled plasma atomic emission spectroscopy (ICP-AES), is an 
analytical technique used for the detection of elements in solution. It is a type of 
emission spectroscopy that uses inductively coupled plasma, which generates a 
temperature of approximately 8000 °C. When an aqueous sample passes over the 
plasma, it emits electromagnetic radiation (light) at wavelengths characteristic of a 
particular element. This light is collected by the spectrometer and passes through a 
diffraction grating to resolve the light into a spectrum of its constituent wavelengths. 
Within the spectrometer, this diffracted light is then collected by wavelength and 
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amplified to yield an intensity measurement that can be converted to an elemental 
concentration by comparison with calibration standards.  
Surface area and pore size  
Meso-scale porosity was analysed by using gas sorption, which was performed on a 
six port Quantachrome AS6B-KR Autosorb gas sorption system using nitrogen gas. 
The samples were first degassed at room temperature over night to remove physically 
adsorbed gases, in particular water vapour, from the samples surfaces. The surface 
area was calculated from the Brunauer Emmett Teller (BET) method [142] and pore 
size distributions determined by applying the Barrett Joyner Halenda (BJH) [143] 
method to the desorption branch of the isotherm [144]. 
Sing et al. established a system for the interpretation of different shapes of isotherm 
graphs obtained from nitrogen adsorption [144]. The nitrogen adsorption-desorption 
technique can characterise micropores, smaller than 2 nm, and mesopores, between 2 
and 50 nm. 
The BET method uses adsorption to determine the surface area of the material based 
on BET theory, which can be calculated by linear form BET equation (Equation 3.1): 
 
        
 
 
  
  
 
     
  
  
 
  
                                                                       Equation
 
3.1  
where C is a constant that describes the shape of  the isotherm,    is the amount 
adsorbed at the relative pressure p/p
0
 and   
  the monolayer capacity [144]. Once the 
monolayer capacity has been determined, the specific surface area can be calculated 
by using the close packed nitrogen molecules, assuming each molecule occupies a 
surface area of 0.162 nm
2
. This equation must be applied in the linear region of the 
isotherm typically within a relative pressure of 0.05 to 0.30 to achieve an R squared 
value greater than 0.999. 
The BJH method used the adsorption or desorption data of the isotherm to determine 
the volume pore size distribution. A cylindrical pore model is assumed, with the 
further assumption of open-ended pores and absence of pore networks, so the volume 
of adsorbed liquid is the pore volume. Since the pore size is derived from the ratio of 
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the pore volume and surface area at a given pressure [145], the Kelvin correlation is 
applied to determine the pore size (Equation 3.2): 
   
      
        ⁄  
                                                                                        Equation
 
3.2 
where    is the Kelvin radius,  
   is the surface tension of the liquid condensate,    is 
its molar volume [144]. 
Dissolution and bioactivity 
Examination of apatite formation on the surface of a material in simulated body fluid 
(SBF) is useful as a first screening tool for predicting the in vivo bone bioactivity of 
the material. SBF has similar pH and ion concentrations as natural body fluid. It is 
also used to study the dissolution rate of the materials by analysing the concentration 
of ions released into the solution. The SBF used in this work was prepared following 
the Kokubo protocol [24]. The ingredients and procedures to prepare 1000 ml SBF 
solutio are summarised in Table 3.3.  
Table 3.3 The ingredients and procedures of SBF preparation (1000 ml) 
Order Ingredients Amount  
1 Deionised Water 750ml 
2 NaCl 7.996g 
3 NaHCO3 0.350g 
4 KCl 0.224g 
5 K2HPO4·3H2O 0.228g 
6 MgCl2·6H2O 0.305g 
7 
HCl aqueous solution 
(1M) 
30ml 
8 CaCl2·2H2O 0.368g 
9 Na2SO4 0.071g 
10 (CH2OH)3CNH2 6.057g 
11 Deionised water Fill the bottle to the 1 litre mark at 37 °C 
12 
HCl aqueous solution 
(1M) 
Adjust pH to 7.40 at 37 °C  
with HCl drops 
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The effects of different calcium precursors and synthesis routes on the dissolution and 
bioactivity of glasses was investigated in a simulated body fluid (SBF) solution at a 
pH of 7.40 at 37 °C. A previous study found the ratio of material to SBF of 0.075 g to 
50 ml was suitable for bioactivity tests [146]. This ratio was used as the standard in 
this study. Aliquots of 75 mg of each powder were immersed in 50 ml of SBF and 
placed in an orbital shaker at 37 °C, for 2, 8, 24, 72, 168, 336 and 672 h at an 
agitation rate of 120 rpm. Three samples of each glass were run per test, with the 
mean values reported. Error bars were calculated from the deviations from the mean. 
Si, Ca and P concentrations in the SBF solutions obtained after filtration (1 µm paper) 
were analysed by ICP-OES. The filtered powder was rinsed with acetone to terminate 
any ongoing reactions, dried and then evaluated by XRD and Fourier-transform 
Infrared spectroscopy (FTIR) analyses for the formation of a hydroxycarbonate 
apatite (HCA) layer.  
XRD is a versatile, non-destructive analytical technique that reveals the information 
about the crystallographic structure, chemical composition, and physical properties of 
materials and thin films. It is based on the elastic scattering of X-rays from structures 
that have long range order, which follows Bragg‘s Law (Equation 3.3): 
                                                                                                Equation 3.3 
where n is an integer, λ is the wavelength (X-rays  1x10-10m), d is the plane spacing 
and θ is the incidence angle. When the Bragg equation is satisfied diffraction will 
occur and the X-rays will be scattered. By using X-rays with a set wavelength the 
angle of the beam to the sample can be varied. By changing the angle the X-rays will 
diffract off a number of atomic planes. This will give a number of peaks on the 
spectrum that can be used to identify the crystal composition. In this work, XRD was 
carried out with a PANalytical X‘Pert Pro MPD series automated spectrometer, using 
a step scanning method with Cu kα radiation, at 40 kV and 40 mA, with a 0.040° 2θ 
step and a count rate of 50 s per step, from 2θ values of 5° to 75°.  
FTIR is a powerful tool to indentify functional groups by passing infrared waves 
through a sample. All covalent bonds with a dipolar moment vibrate at several 
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specific frequencies when the energy of the infrared waves equal to the difference of 
two energy state of electrons in a covalent bond (Equation
 
3.4): 
                                                                                                 Equation
 
3.4 
where E1 is the first state energy and E0 is the ground state energy, h is the Planck 
constant, c is the speed of light and l is the wavelength of light. The presence of 
different functional groups in a material can therefore be detected. In this work, FTIR 
spectra were obtained with a Bruker Vector 22 thermal gravimetric-infrared 
spectrometer (TGA-IR). Glass samples were finely ground with potassium bromide 
(KBr) in a 1 to 100 weight ratio. The resulting powder was pressing into a pellet with 
7 tonnes of pressure. The sample was measured in transmission mode with a 
wavelength of 633 nm and in the range of 400 to 1600 cm
-1
. 
Microscopy 
The scanning electron microscope (SEM) is a type of electron microscope capable of 
producing high resolution images of a sample surface by scanning it with a high-
energy beam of electrons in a raster scan pattern. The electrons interact with the 
atoms that make up the sample producing signals that contain information about the 
sample's surface topography, composition and other properties such as electrical 
conductivity. Secondary electron imaging (SEI) is the most common detection mode 
which can examine physical features with dimensions from several microns down to a 
few nanometers. Due to the manner in which the image is created, SEM images have 
a characteristic three-dimensional appearance (due to good depth of field) and are 
useful for judging the surface structure of the sample. 
In this work, SEM on chromium coated specimens was used to examine the 
morphological and textural features of those glass samples stabilised at 700 °C, which 
was performed on a Leo 1525 with Gemini column fitted with a field emission gun at 
5 kV. The working distance was between 5-10 mm and the aperture of the inlens 
secondary electron detector (SEI) was 30 µm. All the samples were coated with 
chromium and attached on aluminium sample holders via carbon tape. Sputtering was 
done for 2 min with a sputtering current of 65 mA. The sputtering rate for the 65 mA 
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current was 13-15 nm/min, therefore the final coating thickness was approximately 30 
nm.  
3.3 Results and discussion 
3.3.1 Composition  
The sol-gel compositions as determined by the lithium metaborate fusion dissolution 
method (Table 3.4). All the compositions were within 1-2 % of the nominal 
composition for samples stabilised at 700 C. 
Samples were synthesised with calcium acetate in pilot studies, and they formed gels, 
however during drying, reprecipitation of the calcium acetate occurred, leaving visual 
deposits on the samples. No further investigation of the use of calcium acetate was 
carried out. 
Table 3.4 Compositional analysis as determined by the lithium metaborate fusion dissolution 
method 
Samples SiO2 CaO P2O5 
70S30C nominal 70 30 - 
70S30C‐Ca(NO3)2 69.9 30.1 - 
70S30C‐CaCl2 71.3 28.7 - 
70S30C‐CME 70.7 29.3 - 
58S nominal 60 36 4 
58S‐Ca(NO3)2 59.1 36.6 4.3 
58S‐CaCl2 59.3 35.5 5.2 
58S‐CME 58.2 37.3 4.5 
 
3.3.2 Surface area and pore size 
Table 3.5 summarises the data of specific surface area (SSA) and modal pore diameter 
(dmode) of the samples. Table 3.5 shows that the composition, final processing 
temperature and calcium precursor used all affected the pore size and surface area. 
Traditional sol-gel methods use a stabilisation temperature of 700 C. The 70S30C 
glasses made with calcium nitrate and stabilised at 700 C had a SSA of 158 m2g-1 
and a dmode of 17.5 nm. The addition of HF did not affect these values. After sintering 
at 800 °C, the SSA and dmode for the HF free samples decreased due to further cross-
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linking of the SiO2 network under viscous flow of the glass during sintering. Sintering 
the samples made with HF did not change the pore size although the SSA decreased 
from 156 m
2
g
-1
 to 58 m
2
g
-1
. The addition of phosphate (58S composition) caused a 
decrease in dmode to 12.4 nm, for stabilisation at 700 C (again HF made little 
difference), and a slight increase in SSA, perhaps due to some phase separation (see 
Section 3.3.3). Increasing the sintering temperature to 800 C decreased dmode to 9.3 
nm. When calcium chloride was used instead of calcium nitrate, to produce glasses 
stabilised at 700 C, SSA reduced (44.8 m2g-1 rather than 156 m2g-1) but the dmode was 
similar (17 nm). As sintering temperature increased to 800 C, the pore size was no 
longer measureable by the BJH method, due to low adsorption of N2, i.e. there were 
no pores present or they were very small (< 2 nm). Again this was due to densification 
by viscous flow. When HF was used, the SSA decreased to less than 20 m
2
g
-1
 for 
sintering temperatures above 700 C. An aim of using calcium chloride was that it 
could be used for low temperature synthesis, therefore samples with a final processing 
(drying) temperature of 60 C were synthesised, which had an SSA of 13.3 m2g-1 and 
no measurable pores. By visual inspection, the samples were very fine powders, 
indicating that the silica network formation was inhibited. Adding the HF seemed to 
improve silica network formation, increasing SSA to 75.6 m
2
g
-1 
and dmode to 17.5 nm. 
The addition of phosphate into the glass composition again reduced dmode to the point 
that it was not measurable. It therefore seems that the calcium chloride crystals filled 
the interstitial pores between silica nanoparticles that fuse together during silica 
network formation and the calcium did not enter the silica network. In contrast, using 
CME with a final drying temperature of 60 C produced 70S30C gels with SSA of 
394 m
2
g
-1
 and a dmode of 9.4 nm. Adding HF caused a small increase in dmode  to 12.4 
nm. After thermal stabilisation of the glass at 700 C, the SSA and dmode changed 
relatively little (338 m
2
g
-1
 and 9.6 nm respectively), indicating a glass more similar to 
the traditional 70S30C glasses made with nitrate that those made with calcium 
chloride. Generally, nanopores form in the sol-gel process due to disruption of the 
silica network, e.g. by incorporation of calcium and consequent evaporation of the 
liquid by-products of condensation (gelation). Therefore the presence of nanopores in 
the CME samples at low temperature, and the similar SSA and dmode values between 
gels dried at 60 C and glasses stabilised at 700 C, indicate that the calcium 
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integrated into the silica network at low temperature. Sintering the glasses made with 
CME had a dramatic effect, reducing SSA and dmode to 47.5 m
2
g
-1
 and 3.4 nm 
respectively, indicating that the glass flows more than the same composition made 
with calcium nitrate. It is therefore likely that using CME in place of other calcium 
sources lowered Tg of the glass. HF had little effect on the glasses. 
Table 3.5 Surface area and modal pore diameter data collected from N2 sorption 
Samples 
70S30C 
Ca(NO3)2 
58S 
Ca(NO3)2 
70S30C 
CaCl2 
58S 
CaCl2 
70S30C 
CME 
58S 
CME 
60 °C - HF - HF - HF - HF - HF - HF 
Surface Area (m
2
/g) N/A N/A N/A N/A 13.3 75.6 31.6 89.3 394.1 326.5 337.1 328.6 
Modal Pore Diameter  
(nm) 
N/A N/A N/A N/A - 17.5 - - 9.5 12.4 - 7.8 
700 °C - HF - HF - HF - HF - HF - HF 
Surface Area (m
2
/g) 157.8 155.7 181.8 177.6 44.8 17.7 - - 337.5 122.7 338.8 123.1 
Modal Pore Diameter  
(nm) 
17.5 17.4 
12.4 
7.8 
12.4 
7.8 
17.6 17.2 - - 9.6 7.8 14.0 11.6 
800 °C - HF - HF - HF - HF - HF - HF 
Surface Area (m
2
/g) 62.0 58.0 129.1 84.8 31.1 15.3 25.5 28.4 31.8 47.5 34.0 48.4 
Modal Pore Diameter  
(nm) 
12.4 17.2 9.3 7.8 - - - - 3.4 5.6 3.8 5.9 
 
3.3.3 XRD 
It is important that the new synthesis methods do not cause crystallisation of the silica 
network as this will change the bioactivity of the materials. Previous work has shown 
70S30C made with calcium nitrate to be amorphous after heating above 400 C and 
below 850 C. Below 400 C, XRD showed calcium nitrate to be present, indicating 
the calcium was not incorporated. Above 850 C, the glass crystallised to wollastonite 
[46]. 
Figure 3.2a shows XRD spectra for 70S30C and 58S glasses synthesised from 
different calcium precursors and stabilised at 700 C. The spectra show that for the 
58S composition, phase separation occurred and hydroxyapatite (HA, PDF 00-09-
0432) formed during synthesis. HA was detected in 58S samples made with Ca(NO3)2 
after heat treating at 400 °C, 700 °C and 800 °C (Figure 3.2b). 
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Figure 3.2 XRD patterns of (a) bioactive glass samples after stabilised at 700 °C (b) 58S bioactive 
glass synthesised using Ca(NO3)2 at different final processing temperatures. (*) signifies the 
crystals of hydroxyapatite. 
Solid state
 31
P magic angle spinning nuclear magnetic resonance (MAS NMR) 
measurement on 58S-Ca(NO3)2-500°C indicates the presence of calcium 
orthophosphate (Chapter 4). Calcium orthophosphate has previously been observed in 
58S foam scaffolds synthesised with an R ratio of 8 [38]. Sol-gel derived bioactive 
glasses contain a high concentration of hydroxyl groups [46], it is therefore possible 
to form HA during gelation and aging. In this work the 58S glasses were synthesised 
with an R ratio of 12, which could provide the higher OH content necessary for the 
conversion of calcium orthophosphate to HA. It seems that an R ratio of less than 8 is 
needed to produce 58S glass. The heating temperatures may be another important 
factor as no HA was detected in 58S-Ca(NO3)2-130°C. 
Hydroxyapatite – Ca10(OH)2(PO4)2
Hydroxyapatite – Ca10(OH)2(PO4)2
Hydroxyapatite – Ca10(OH)2(PO4)2
Hydroxyapatite – Ca10(OH)2(PO4)2
Hydroxyapatite – Ca10(OH)2(PO4)2
(a) (b)
*
*
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* * * * *
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*
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Figure 3.3 XRD patterns of (a) 70S30C and (b) 58S bioactive glass synthesised using CaCl2 at 
different temperatures, (+) signifies the crystals of calcium chloride hydrate. 
Figure 3.3 shows that phase separation occurred in both the 58S and 70S30C 
(unidentified peaks) glasses made with CaCl2 when heated to above 700 °C, 
indicating that calcium chloride is not a suitable calcium source for bioactive glass 
synthesis. The 58S samples dried at 60 C contained calcium chloride (PDF 01-070-
0385), indicating that calcium was not incorporated into the silica network and that 
calcium chloride is not a suitable calcium source. 
In contrast, both compositions that were synthesised with CME were amorphous after 
stabilisation at 700 C (Figure 3.2a). Phase separation was not observed in the XRD 
of the 58S composition when synthesised with CME, indicating excellent 
incorporation of calcium into the network. This is possibly because the hydrolysis of 
CME used the excess water, so there was no spare water to form HA, or the calcium 
was incorporated into the silica network so it was not available to form HA. An 
alternative is that Si-O-P bonds formed. This will be discussed further in terms of the 
(a) (b)
70S30C CaCl2 58S CaCl2
+
+ +
+
+ +
+ +
+
++
+
+ +
+
+ +
+ +
+
++
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NMR data in Chapter 4. Sintering at 800 C did not cause any further phase changes 
in any of the samples (Figure 3.2, 3.3. 3.4). These results meant that it was worth 
investigating the temperature at which the calcium enters the silica network during the 
process when CME is used and whether there is potential for its use in low 
temperature synthesis of hybrids. It is also important to determine whether the new 
materials can form an HA layer in SBF.  
 
Figure 3.4 XRD patterns of (a) 70S30C and (b) 58S bioactive glass synthesised using CME at 
different temperatures and after reaction in SBF for 4 weeks. (*) signifies the crystals of 
hydroxyapatite, (°) signifies the crystals of cuspidine, and (·) signifies the crystals of calcium 
floride. 
Figure 3.4 shows the XRD spectra of materials synthesised with CME as a function of 
drying and stabilisation temperature. It also includes XRD spectra of each material 
following 4 weeks immersion in SBF. The spectra from samples synthesised with HF 
contained Bragg peaks representing CaF2 (PDF 01-077-2096, 2 values of 28°, 47°, 
56°, and 69°). This was attributed to the HF reacting with Ca from CME to form CaF2. 
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This is not of too much concern as the amount of fluoride used in the process is low 
and Fluoride-releasing bioactive glasses are of interested in both orthopaedic and 
dental applications as they can form fluoraptite [147-149]. When the gels were heated 
to 700 C, the CaF2 seemed to become cuspidine (PDF 00-041-1474). Samples not 
synthesised with HF remained amorphous at all temperatures. All spectra that were 
collected from samples after 4 weeks immersion in SBF had peaks corresponding to 
HA (PDF 00-09-0432), indicating potential for bioactivity, however the relative 
intensity of the peaks decreased as sintering temperature was increased from 700 C 
to 800 C. This is likely to be due to densification of the silica network, the driving 
off of OH groups which act as network modifiers to the silica network and nucleation 
sites for HA nucleation. For potential hybrid synthesis, it is encouraging to see 
amorphous spectra after drying at 60 C and even more encouraging to see HA 
formation after immersion in SBF. These low temperature gels also seem to form 
fluorapatite in addition to HA after 4 weeks in SBF.  
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3.3.4 Bioactivity 
 
Figure 3.5 Bioactivity of 70S30C CME 60 °C assessed by (a) FTIR (b) XRD 
Figure 3.4 indicates that gels and glasses synthesised with CME have the potential to 
be bioactive. An important aim was to determine whether hybrids synthesised with a 
final drying temperature of 60 C have the potential to be bioactive. For a calcium 
precursor has potential for bioactive hybrid synthesis it should incorporate into the 
silica network below 60 C and the gel should form apatite in SBF within 3 days. 
Figure 3.5 shows FTIR and XRD spectra of 70S30C gels synthesised with CME and 
dried at 60 C (without HF), Figure 3.5a exhibits Si-O-Si stretch and Si-O-Si bend 
bands at 1030 and 470 cm
-1
, respectively. An amorphous P-O peak was present at 
approximately 600 cm
-1
 [150] in spectra of the samples after reaction with SBF for 2h 
and 8h. The amorphous peak could present the presence of either octocalcium 
phosphate (OCP) or amorphous calcium phosphate (ACP) [151]. XRD analysis 
Si-O-Si
Stretch
Si-O-Si
bend
P-O 
Amorphous
P-O
bend HACalcite
(a) (b)
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confirmed this for the 2h sample as illustrated in Figure 3.5b, whereas for the 8h 
sample, a small HA peak was detected at a 2θ value of approximately 31°, indicating 
HCA had formed within 8h. This might not have been detected in FTIR if not all the 
surface of the glass particles was covered with HCA[152] and XRD has higher 
sensitivity than FTIR. FTIR spectra collected from samples reacted in SBF for 24h 
and 72h showed very clear double peak (P-O bending at 602 cm
-1
 and 579 cm
-1
), 
corresponding to crystalline of HCA formation, which was confirmed by XRD. A 
calcite peak at a 2θ value of approximately 29° was detected by XRD, indicating 
calcite might have deposited on the glass surface at the expense of the HCA layer. 
3.3.5 ICP 
 
Figure 3.6 ICP plots of SBF following immersion of bioactive gels dried at 60 °C and made with 
different precursors (a) without HF  (b) with HF. 
Figure 3.6 shows the release profiles of soluble silica, calcium and phosphorous 
species from gels made with CME and CaCl2 precursors and dried at 60 °C. CME-
60°C and CME-60°C-HF have very similar release profiles of soluble silica and 
calcium. Except at round 8h, CME-60°C has slight higher concentration of soluble 
silicon and calcium comparing to CME-60°C-HF. This is attributed to HF decreasing 
(a) (b)
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the surface area thus decreased the release rates. The formation of CaF2 may also 
decrease the Ca release rate from CME-60°C-HF. XRD confirmed the existence of 
CaF2 in all of the 60 °C samples using HF as catalyst. The 58S samples released 
phosphate ions over the first 2 h of immersion and then phosphate species nucleated 
on the surface, shown by a decrease in SBF phosphorous concentration after 2 h of 
immersion. The phosphate content of the SBF decreased immediately after 70S30C 
gels were immersion, from ~ 33 µgml
-1 
to ~ 10 µgml
-1
 and all the phosphorous was 
removed from the SBF by 72 h, indicating possible calcium phosphate nucleation.  
Samples made with CaCl2 had similar release profiles of all three species to those 
CME samples, except they had slightly lower silica and calcium ion release rates. 
Especially for those samples synthesised without HF (Figure 3.6a), over the first week 
of immersion in SBF, calcium content of the SBF was approximately 50 µgml
-1
 
higher (at 257.3 µgml
-1
 for 70S30C-CME and 260.8 µgml
-1
 for 58S-CME)
 
for 
samples synthesised with CME compared to those synthesised with CaCl2 (at 206.8 
µgml
-1
 for 70S30C CaCl2 and 238.0 µgml
-1
 for 58S CaCl2). This is either due to the 
gels made with CME samples releasing more calcium ions or due to the gels made 
with CaCl2 nucleating more calcium species, e.g. HA. 
Both 70S30C and 58S samples made with CaCl2 at 60°C had much smaller surface 
areas but similar release profiles of all the three species comparing the corresponding 
samples made with HF. This might be because the fine powders of CaCl2-60°C had 
lower connectivity and the silica was easier to be dissolved into SBF solution. 
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Figure 3.7 ICP plots of SBF after immersion of bioactive glasses stabilised at 700 °C made with 
different precursors (a) without HF (b) with HF. 
Figure 3.7 shows the dissolution profiles in SBF following immersion of the glasses 
stabilised at 700 °C. The silica release rate was slightly lower than for the gels. The 
glasses synthesised with calcium chloride samples had the lowest release rate of 
soluble silica (around 30 µgml
-1
 after 8 h). The reason for this is that the glasses 
synthesised with calcium chloride had SSA values significantly smaller (up to an 
order of magnitude) than those made with calcium nitrate or CME. Glasses made with 
calcium nitrate and CME had similar dissolution rates, with CME glasses slightly 
higher at approximately 70 µgml
-1
 after 8 h. The reason for the higher dissolution of 
CME glasses is attributed to their higher SSA (Table 3.5). The phosphorous 
concentration in the SBF decreased rapidly immediately after immersion for all 
samples, reaching zero by 24 h, indicating possible HA formation. The 58S samples 
did not release phosphate, perhaps because all the phosphate formed insoluble HA as 
phase separation occurred during stabilisation. This will be further studied by MAS 
NMR and described in Chapter 4.  
(a) (b)
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For the glasses that were gelled with HF, the release profiles were similar except that 
the silica and calcium ion release rates were slightly lower, e.g. 70S30C synthesised 
with CME, silica release was 52.1 µgml
-1
 after 8 h for glasses gelled with HF 
compared to 66.1 µgml
-1 
for glasses gelled without HF. This is due to the significant 
decrease of surface area from ~340 m
2
g
-1
 (without HF) to 120 m
2
g
-1
 (with HF). When 
the glasses were sintered to 800 °C, the dissolution of the glasses decreased, e.g. 
70S30C synthesised with CME released 31.5 µgml
-1 
of soluble silica
 
after 8 h 
immersion when sintered at 800 °C compared to 66.1 µgml
-1 
when stabilised at 
700 °C. This is again due to densification of the silica network and SSA from 340 
m
2
g
-1
 to 32 m
2
g
-1 
during sintering. As a result of this, the phosphate precipitation of 
the SBF was slower, indicating slower HA formation, which seems to form at around 
3 days of immersion. 
 
Figure 3.8 ICP plots of SBF after immersion of bioactive glasses sintered at 800 °C made with 
different precursors (a) without HF  (b) with HF. 
Figure 3.8 shows the dissolution profiles in SBF following immersion of the glasses 
sintered at 800 °C. For the samples made without HF (Figure 3.8a), release rates of 
soluble silicon and calcium species all decreased comparing to the corresponding 
(a) (b)
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700 °C samples. This effect was greatest for the CME samples and corresponded to 
the sharp decrease in surface area. The release rate of soluble silica was similar for all 
glasses sintered at 800 °C. Samples made with CME at this temperature still had the 
highest concentration of Ca whereas the samples made with CaCl2 had the lowest. 
Calcium ion concentration of 70S30C-CME-800°C was much lower than 70S30C-
CME-700°C because surface area decreased significantly from 337.6 m
2
g
-1
 to 31.8 
m
2
g
-1
. The concentrations of phosphorous ions decreased slower than CME-700 °C 
which indicated lower speed of HCA formation.  
The samples made with HF after sintering at 800 °C also had lower release rates of 
soluble silicon and calcium comparing the corresponding samples stabilised at 700 °C 
(Figure 3.8b). The concentration of phosphorous ion was higher than CME-700°C-HF, 
which may be due to the lower deposition rate. CME-800°C-HF had slightly higher 
concentration of soluble silicon compared to CME-800°C due to the slightly higher 
surface area of HF samples. The surface area of 58S-Ca(NO3)2-800 °C decreased 
from 129.1 m
2
g
-1
  to 84.8 m
2
g
-1
 after addition of HF, which resulted in the decrease of 
calcium ion concentration. 
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3.3.6 Microscopy 
 
Figure 3.9 SEM images of 70S30C glass samples stabilised at 700 °C, (a) 70S30C Ca(NO3)2, (a) 
70S30C Ca(NO3)2 HF, (c) 70S30C CaCl2, (d) 70S30C CaCl2 HF, (e) 70S30C CME, (f) 70S30C 
CME HF. 
Figure 3.9 shows the surface of the 70S30C samples stabilised at 700 °C at the 
nanoscale. Sol-gel glass networks form by the agglomeration of nanoparticles and 
formation of covalent bonds by condensation. The SEM images showed that samples 
made with calcium chloride comprised of larger nanoparticles than the glasses made 
with other two precursors, which resulted in the much lower SSA values. The addition 
70S30C Ca(NO3)2 700 °C                          70S30C Ca(NO3)2 700 °C HF                        
70S30C CaCl2 700 °C                             70S30C CaCl2 700 °C HF                         
70S30C CME700 °C                           70S30C CME 700 °C HF                         
(a) (b)
(c) (d)
(f)(e)
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of HF further increased the size of glass particles, which decreased the SSA value 
from 44.8 m
2
g
-1
 to 17.7 m
2
g
-1
. The glass samples made with CME seemed to have 
homogeneous particles at the surface, the distribution and size of the particles seemed 
to be highly homogeneous. 70S30C-CME-700°C showed smallest nanoparticle size, 
resulting in the highest SSA value (337.5 m
2
g
-1
). Addition of HF decreased the 
surface area by increasing the particle size. Traditional sol-gel derived bioactive 
glasses made with calcium nitrate showed particle sizes between those of the glasses 
made with calcium chloride and CME, resulted in a middle surface area. Addition of 
HF didn‘t affect the structure. 
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Figure 3.10 SEM images of 58S glass samples stabilised at 700 °C, (a) 58S Ca(NO3)2, (a) 58S 
Ca(NO3)2 HF, (c) 58S CaCl2, (d) 58S CaCl2 HF, (e) 58S CME, (f) 58S CME HF. 
Figure 3.10 shows the surface of the 58S samples stabilised at 700 °C imaged at the 
nanoscale. The samples made with calcium chloride showed very compact surface 
structures, which is because they crystallised at this temperature. Thereby those 
samples had no porosity detectable by nitrogen sorption. The samples made with 
CME and calcium nitrate were similar to the corresponding 70S30C samples. 
 
58S Ca(NO3)2 700 °C                            58S Ca(NO3)2 700 °C HF                     
58S CaCl2 700 °C                               58S CaCl2 700 °C HF                         
58S CME 700 °C                               58S CME700 °C HF                           
(a) (b)
(c) (d)
(f)(e)
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3.4 Summary 
CME was successfully used as calcium source to synthesise bioactive glasses. Various 
sol-gel derived bioactive glasses were synthesised in different compositions (70S30C 
and 58S), different calcium precursors (calcium nitrate, calcium chloride, CME), 
different thermal treatment temperatures (from 60 °C to 800 °C), and their properties 
were compared. The effect of using HF as catalyst was also studied.  Calcium chloride 
was found not to be a suitable calcium source for synthesis of glasses or hybrids. 
CME has been considered as a potential calcium precursor for bioactive materials. 
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4 Calcium incorporation into network 
4.1 Introduction 
One critical characteristic of the calcium source is whether the Ca is incorporated into 
the silica network at a low temperature. In this section, XRD analysis, NMR and 
dissolution tests were carried out to determine the temperature at which the Ca is 
incorporated into the silica network. The aim was to investigate how the final 
processing temperature affected calcium incorporation and consequently calcium 
release. Water was chosen as the dissolution medium because SBF contains calcium. 
4.2 Materials and methods 
4.2.1 Materials 
The materials used for this section were the same as described in Section 3.2.1. 
4.2.2 Synthesis 
The glasses for calcium distribution assessment were those dried at 130 °C (via the 
same route as described in Section 3.2.2, before stabilisation). The samples were 
ground and placed in a preheated oven for one hour. The samples and preheated 
temperatures are listed in Table 4.1. All the samples were also ground and sieved to a 
particle size range of 38-90 µm. 
Table 4.1 Processing temperatures for XRD and dissolution analysis 
Samples  Temperatures ( °C) for XRD  Temperatures ( °C) 
for dissolution  
70S30C-Ca(NO
3
)
2 
 
130, 200, 300, 320, 340, 360, 380, 
400, 420, 450, 475, 500, 525, 550,  
600, 625, 650, 675, 700  
130, 380, 450, 700  
70S30C-CaCl
2 
 
130, 150, 200, 220, 240, 260, 280,  
300, 320, 340, 360, 380, 400, 420,  
450, 475, 500, 525, 550  
130, 500  
70S30C-CME  130, 200, 300, 400, 500, 600  60, 130, 500, 700  
58S-Ca(NO3)
2 
 130, 200, 300, 360, 380, 400  130, 400  
58S-CME  130, 200, 300, 400, 500, 600  130, 500  
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4.2.3 Characterisation 
XRD 
Calcium distribution was assessed by X-ray diffraction (XRD), which was carried out 
at University of Kent. The X-ray diffraction data was collected using a Bruker D8 
Advance X-ray diffractometer with an incident wavelength of 1.54 Å. All 
measurements were taken at room temperature. The sol-gel samples were measured 
after a series of heat treatments.  The heat treatment was undertaken by placing the 
samples inside a preheated oven for 1 hour before slowly cooling to room temperature. 
The sample was then placed inside the X-ray sample holder and run. This process was 
repeated for each temperature required up until the point of crystallisation. The XRD 
patterns of these glass samples treated at different temperatures were compared to 
determine the temperature Ca enters the silica network. A dissolution test was then 
carried out to evaluate the release speed of soluble Si, Ca, and P for samples with 
different final processing temperatures. These temperatures were chosen to be above 
and below the temperature predicted to be the temperature at which calcium was 
incorporated according to the XRD patterns and are summarised in Table 4.1.  
Dissolution test (ICP) 
The particles were immersed into deionised water and then placed in a shaker at 37 °C 
and agitation rate of 120 rpm. At each time points (1, 2, 4, 8, 24, 72, 168, 336 and 672 
h), 1 ml extracts were taken out and 1 ml deionised water was put back to keep same 
water content. The ratio of sample to solution was 0.15 g to 100 ml (100 ml per 
sample). The concentration of Ca, Si and P were also analysed by ICP. 
MAS NMR 
Solid state MAS NMR was carried out at University of Warwick. The aim here was to 
determine why the high temperature treated (above 130 °C) 58S samples did not 
release P during the dissolution test. 
29
Si, 
1
H, 
31
P MAS NMR were applied to 
determine the structures of selected samples (58S-Ca(NO3)2-130°C, 58S-Ca(NO3)2-
400°C, 58S-CME-130°C, 58S-CME-500°C). The 
1
H MAS NMR spectra were 
recorded using a Bruker 500 MHz (11.7 T) spectrometer operating at 500.1 MHz.  
MAS spectra were recorded with a Bruker 4 mm probe at 12.5 kHz, using 5s recycle 
delay and a 2.50 μs (90° tip angle) pulse. The chemical shift was referenced externally 
to adamantane (C10H16) at 1.8 ppm. The hydrogen content determination has been 
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described in literature [46]. 
31
P MAS NMR and 
31
P Cross-polarisation (CP) MAS 
NMR spectra were measured on a Bruker 500 MHz magnet, operating to 202.48MHz 
using a Bruker 4 mm probe, at a spinning speed of 12.5 kHz. For MAS NMR spectra 
3.0 μs (90° tip angle) pulse and 3s pulse delays have been used. For the CP MAS 
NMR spectra, a 3 ms contact pulse was used and a 3 s recycle delay collected under 
1
H decoupling. Ammonium dihydrogen phosphate, NH4H2PO4, has been used as 
external reference at 0.9 ppm. 
29
Si MAS NMR spectra were collected on a Varian 
InfinityPlus 300 MHz spectrometer operating at 59.62 MHz. A 30 s recycle delay and 
a 3 μs (30° tip angle) were used which produced relaxed spectra. 29Si spectra were 
referenced to TMS at 0 ppm. 
4.3 Results and discussion 
4.3.1 XRD 
The obtained XRD data was plotted as a function of Q, which was defined as shown 
in equation 4.1: 
                                                                                              Equation 4.1 
where λ is the wavelength. Q is used instead of 2θ here is because Q is wavelength 
independent it is possible to directly compare diffraction patterns taken using different 
wavelengths. If presenting the data as a function of 2θ it is possible to only compare 
with other diffraction data taken using the CuKα wavelength. 
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Figure 4.1 X-ray diffraction patterns of 70S30C glass prepared using a Ca(NO3)2 precursor. The 
upper patterns are taken from samples with final heat treatments of between 130 °C and 380 °C. 
The central patterns are taken from samples heated to 400 °C and 420 °C whilst the bottom 
patterns are taken from samples heated to temperatures between 450 °C and 700 °C 
Figure 4.1 shows the diffraction patterns from the 70S30C sample prepared using the 
Ca(NO3)2 precursor. The spectra can be divided into 3 categories as follows. The first 
subset which have two clear maxima correspond to the as prepared 70S30C prior to 
heat treating through to samples heat treated up until 380 °C. The second region 
corresponds to samples heat treated to 400 °C and 420 °C where a transition occurs 
between the first and third regions. The third region which has a single maximum at 
~Q = 2.1 Å
-1
 corresponding to samples heat treated above 450 °C and below the point 
of crystallisation. The diffraction pattern for the third region is consistent with 
previous diffraction data after heat treating at 600 °C [46]. This is attributed to the 
nitrate decomposing and calcium entering the glass network. The temperatures 
thereby selected for dissolution tests were: 130 °C, 380 °C, 450 °C and 700 °C.  
400 & 420 °C
130 – 380 °C
450 – 700 °C
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Figure 4.2 X-ray diffraction patterns of 70S30C glasses prepared using a CME precursor. Data 
was collected after drying the glass at 130 °C and then after heating the glass to a range of 
temperatures from 200 - 600 °C in 100 °C intervals. 
Figure 4.2 shows the diffraction patterns for the 70S30C sample prepared using the 
CME precursor. As shown there is no change in the diffraction pattern following heat 
treatments with increasing temperatures. A single main feature occurs at ~ Q = 2.1 Å
-1 
showing that calcium has already entered the glassy network at 130 °C. Dissolution 
tests were run at 60 °C and 130 °C, 500 °C and 700 °C. 
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Figure 4.3 X-ray diffraction pattern of 70S30C glasses prepared using a CaCl2 precursor. Data 
was collected after drying at 130 °C and then after heating the glass to a range of temperatures 
from 200 - 550 °C. The diffraction pattern collected at 575 °C showed crystallisation. 
Figure 4.3 shows the diffraction patterns for the 70S30C sample prepared using the 
CaCl2 precursor. Calcium failed to enter the glassy network during the heat treatment 
up to 550 °C and the glasses crystallised at 575 °C. To compare between 
compositions, dissolution tests were run on samples heated to 130 °C and 500 °C.  
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Figure 4.4 X-ray diffraction pattern of 58S glasses prepared using a Ca(NO3)2  precursor. Data 
was collected after drying at 130 °C and after heating the glass to a range of temperatures  from 
200 - 400 °C. Bragg peaks were present after the initial drying stage at 130 °C. No crystallisation 
was present for the sample heat treated to 200 and 300 °C. The samples were found to crystallise 
above 360 °C. 
Figures 4.4 shows the diffraction patterns of 58S prepared using Ca(NO3)2 precursors. 
58S prepared using the Ca(NO3)2 precursor showed Bragg peaks after the initial 
drying stage at 130 °C. No crystallisation occurred in the samples heat treated at 200 
and 300 °C. The samples were found to crystallise above 360 °C. Dissolution tests 
were run at 130 °C and 400 °C.  
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Figure 4.5 X-ray diffraction patterns of 58S glasses prepared using a CME precursor. Data was 
collected after drying at 130 °C and then after heating the glass to a range of temperatures from 
200 - 600 °C in 100 °C intervals. 
Figures 4.5 shows the diffraction patterns of 58S prepared using CME precursors.  
58S prepared using the CME precursor showed the characteristic feature in the region 
2 – 2.1 Å-1 confirming that calcium entered the glassy network during the drying 
process at 130 °C. Dissolution tests were performed on samples heated to 130 °C and 
500 °C. 
The XRD results show the effect of heat treating the 70S30C sol-gel samples. 
Ca(NO3)2 is not incorporated into the glassy network until heat treating at 
temperatures above 420 °C. This is consistent with previous results which suggested 
the nitrate is incorporated above ~ 380 °C [46]. Samples heat treated between 130 °C 
and 380 °C show no signs of calcium being incorporated into the glassy network. 
Calcium was found to enter the glassy network during the drying process for 70S30C 
prepared using CME, conversely when using the CaCl2 precursor calcium failed to 
enter the glassy network prior to crystallisation.  
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Calcium was also found to enter the glassy network directly during the drying process 
at 130 °C for the 58S sol-gel when using the CME precursor. The 58S sample 
prepared using Ca(NO3)2 was found to be prone to crystallisation and crystallised 
prior to calcium entering the glass network. 
4.3.2 Dissolution: ICP  
 
Figure 4.6 ICP plots of 70S30C Ca(NO3)2 dissolution in deionised water 
Figure 4.6 shows the dissolution profiles of 70S30C-Ca(NO3)2 as a function of final 
processing temperature. The lines can be divided to two regions (130 °C and 380 °C; 
450 °C and 700 °C). Results show samples with final processing temperatures of 
450 °C and 700 °C have distinctly higher soluble silica release rate but lower calcium 
release rate compared to samples processed at 130 °C and 380 °C. This is attributed to 
calcium entering the glass network at the higher temperatures. For the samples 
97 
 
 
processed at 130 °C and 380 °C, Ca existed as Ca(NO3)2 and was deposited on the 
outer part of the samples, resulting in a higher calcium release rate. Ca(NO3)2 started 
to decompose above 400 °C, followed by Ca entering the SiO2 network, thus reducing 
the dissolution rate of Ca from samples processed at 450 °C and 700 °C. As Ca enters 
the SiO2 network strong Si-O-Si bonds are broken and replaced by weaker Si-O-Ca 
bonds. This causes higher release rate of soluble silica from the samples processed at 
450 °C and 700 °C samples. Release rate of calcium ions from the sample processed 
at 450 °C is slightly slower than 700 °C sample, suggesting not all of the Ca fully 
entered the network at 450 °C. 
 
Figure 4.7 ICP plots of 70S30C CME dissolution in deionised water 
Figure 4.7 shows the dissolution profiles of 70S30C-CME as a function of final 
processing temperature. The spectra show that all the samples had very similar release 
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rate of soluble silica and calcium. The concentration of these two species (Si 100-120 
µgml
-1
, Ca 70-100 µgml
-1
) are very close to that of 70S30C-Ca(NO3)2 (450 °C & 
700 °C) after 24 h immersion in water. All the data support the hypothesis that Ca 
from CME entered the SiO2 network at low temperature. 
 
Figure 4.8 ICP plots of 70S30C CaCl2 dissolution in deionised water 
Figure 4.8 shows the dissolution profiles of 70S30C-CaCl2 as a function of final 
processing temperature. The results show at both 130 °C and 500 °C, the release rate 
of soluble silica and calcium were similar. The results of 70S30C-Ca(NO3)2 and 
70S30C-CME indicate that Ca entered the SiO2 network and immerson in SBF for 
24h resulted in concentrations of soluble silica of ~110 µgml
-1
 and calcium of ~80 
µgml
-1
. But for 70S30C-CaCl2 samples, the concentration of soluble silica was ~80 
µgml
-1
 and the concentration of calcium ~200 µgml
-1
, which were lower than that of 
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70S30C-Ca(NO3)2 heated to 130 °C and 380 °C. This indicates Ca in both 130 °C and 
500 °C samples had not entered the SiO2 network when calcium chloride was used as 
the calcium source. 
 
Figure 4.9 ICP plots of 58S Ca(NO3)2 dissolution in deionised water 
Figure 4.9 shows the dissolution profiles of 58S-Ca(NO3)2 in distilled water as a 
function of final processing temperature. Release rate of calcium from the glass 
heated to 400 °C was slower than from the 130 °C sample, whereas the release rate of 
soluble silica from the 400 °C sample was slightly faster than from the 130 °C sample. 
This is because the calcium incorporated in a similar way to that described for 
70S30C-Ca(NO3)2. The difference between samples processed at 130 °C and 400 °C 
was very small, this may be because the Ca may not have been fully incoporated into 
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he network at 400C. No phosphate release was detected from 58S-Ca(NO3)2-400 °C 
as the formation of insoluble HA. 
 
Figure 4.10 ICP plots of 58S CME dissolution in deionised water 
Figure 4.10 shows the dissolution profiles of 58S-CME in distilled water as a function 
of final processing temperature. The release rate of calcium from the 500 °C sample 
was similar to the 130 °C sample, whereas the release rate of soluble silica from the 
500 °C sample was much slower than that from the 130 °C sample. The lower release 
rate of soluble silica may be attributed to the greater number of Q
3
 and Q
4
 structure of 
the 500 °C sample as shown by the 
29
Si MAS NMR (see Appendix). No phosphate 
release was detected from 58S-CME-500 °C either. 
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4.3.3 MAS NMR 
The 
1
H MAS NMR spectra of samples synthesised from calcium nitrate and calcium 
methoxyethoxide as calcium precursors, as shown in Figure 4.11. The hydrogen 
content as was obtained from the integrated intensity of the spectra is shown in Table 
4.2. 
 
Figure 4.11 
1
H MAS NMR spectra of 58S samples synthesised by inorganic and metallogranic 
routes 
Table 4.2 The hydrogen content as determined from 
1
H MAS NMR 
Sample (Nitrate) Hydrogen content (mol/g) 
58S Ca(NO3)2 130°C (2.31±0.76)·10
–2
 
58S Ca(NO3)2 400°C (6.76±2.23)·10
–3
 
58S CME 130°C (2.86±0.94)·10
–2
 
58S CME 500°C (1.38±0.46)·10
–2
 
 
For samples synthesised at low temperature (58S-Ca(NO3)2-130°C) with calcium 
nitrate and CME (58S-CME-130°C), the spectra show residues from the alkoxide 
chains, i.e. CH3 resonance at 1.3 ppm [53] and the CH2O at 3.3 ppm for CME samples 
[53]. The peak at 4.6 ppm in samples synthesised using calcium nitrate is due to 
physisorbed water. The sharp peak at 4.1 ppm found in the spectra for samples made 
58S CME 500 °C
58S CME 130 °C
58S Ca(NO3)2 400 °C
58S Ca(NO3)2 130 °C
CH3 (1.3)
CH2O (3.3)
fluid like water (4.1)
Si-OH (1.1)
Si-OH (2.1)
physisorbed water (4.6)
Si-OH (1.9)
Si-OH (2.1)
P-OH (0)
102 
 
 
with calcium nitrate and heated to 400ºC and in both samples made with CME and 
heated to 130 ºC and 500 ºC can be due to the fluid-like water inclusions. It seems 
that fluid water is present in the samples dried at 130°C and when the samples were 
heated to 400°C the water is physisorbed water. This is due to the hydrophilic nature 
of the surface (Si-OH bonds). 
With increasing the temperature, the peaks corresponding to an alkoxide chain do not 
appear in the spectra, suggesting that any residual alkoxides were removed by thermal 
treatment. This is also supported by the hydrogen content decrease as shown in Table 
4.2. The sharp peaks at 1.1, 1.9 and 2.1 ppm can be due to Si-OH groups [153]. The 
peak at 0 ppm in 58S samples made with calcium nitrate is due to the P-OH bonds. 
The peak position is similar to those found in HA, suggesting the formation of 
structures similar to HA at this temperature for sample synthesised from nitrate as 
calcium precursor. The peak is absent in the spectrum of CME sample. This agrees 
with the XRD (section 3.3.3) and dissolution studies (section 4.3.2). 
31
P MAS NMR spectra of the samples are shown in Figure 4.12a. The deconvolution 
of the spectra has been performed using DMFIT software [154] and is presented in 
Table 4.3.  
 
Figure 4.12 (a) 
31
P MAS NMR spectra of 58S samples and (b) a comparison between MAS and 
CP spectra of 58S samples made with calcium nitrate and dried at 130C. 
For the 58S-Ca(NO3)2-130°C sample, phosphorous was found in 4 different 
environments, corresponding to chemical shifts as presented in Table 4.3. The peak at 
0.5 ppm is very narrow and can be assigned to phosphorous atoms in O=P(OH)3 or 
58S CME 500 °C
58S CME 130 °C
58S Ca(NO3)2 400 °C
58S Ca(NO3)2 130 °C 58S Ca(NO3)2 130 °C CP
58S Ca(NO3)2 130 °C MAS
(a) (b)
calcium orthophosphate (3.6)
calcium orthophosphate (2.7)
pyrophosphate (-10)
calcium tris(ethyl) phosphate complex (2.5)
monomers from TEP (0.5)
calcium tris(ethyl) phosphate
complex (-3.3)
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O=P(OCH2CH3)3 which correspond to hydrolysed or unhydrolysed monomers from 
the TEP. TEP hydrolysis is slower than TEOS and some phosphorous monomers 
similar to those in the starting material (TEP) are trapped in the pores when the pores 
shrink during the heat treatment. The chemical shifts for O=P(OCH2CH3)3 and 
O=P(OH)3 are –1.5 ppm and 0 ppm, respectively. The peak at 2.7 ppm is due to 
calcium orthophosphate, which agrees with the presence of HA as found from XRD 
(sections 3.3.3). The peak at –10 ppm can be assigned to dimeric pyrophosphate units 
(P2O7
4–
) [155], where the phosphate tetrahedron connects with another phosphate 
tetrahedron. Pyrophosphate exists in human cells, tissues and blood plasma and is 
thought to help bone generation. As TEP hydrolysis is slower than TEOS some TEP 
monomers can complex with calcium ions with the formation of a calcium phosphate 
complex, with a chemical shift at –3.3 ppm. As calcium ions shield the phosphorus 
nucleus, the value of chemical shift moves to more negative values as in the case of 
TEP (–1.5 ppm). This may be due to polyphosphate acting as a chelator for Ca2+.  
CP MAS NMR was applied to enhance the signal of nuclei with a low gyromagnetic 
ratio by magnetisation transfer from nuclei with a high gyromagnetic ratio. In the CP 
spectrum of this sample (Figure 4.12b), the main component is at 0.5 ppm and the 
peaks corresponding to orthophosphate at 2.7 ppm and pyrophosphates are absent 
suggesting that it corresponds to 
31
P sites far from hydrogen. The sharpness of the 
peak at 0.5 ppm suggests that the phosphorous sites are protonated and strongly 
dipolar coupled to protons, while the phosphorous sites corresponding to the peak at –
3.3 is unprotonated but dipolar coupled. This confirms the assumption that the peak at 
0.5 ppm is due to hydrolysed monomers from TEP, while the peak at  –3.3 is due to 
the calcium tris(ethyl) phosphate complex, where the phosphorous monomer is from 
TEP ((C2H5O)3PO···Ca···OP(OH5C2)). The formation of a P=O···Ca bond can also 
be interpreted by the value of chemical shift toward more negative value, compared to 
free TEP.  
The peak at 0.5 ppm could be attributed to β-tricalcium phosphate (β-TCP). As β-TCP 
polarises from more distant hydrogens, such as water or HO, the fact that the 0.5 ppm 
peak in the CP spectrum has highest intensity does not support the presence of β-TCP. 
Also in XRD no evidence of the β-TCP has been found. 
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With increasing the temperature to 400 °C the peak corresponding to free hydrolysed 
TEP monomers became broader, suggesting that these species were either more 
disordered or had restricted mobility compared to the same material dried at 130 °C.  
The peak at –3.3 ppm was not present as the temperature increased to 400 C, 
probably due to cleavage of coordinative Ca-O bonds in the complex with 
concomitant hydrolysis of (C2H5O)3PO groups and the formation of calcium 
orthophosphate. This is supported from the 
31
P MAS NMR data in Table 4.3 where 
the concentration of orthophosphates at 3.1 ppm increased to 64%. The peak from 
apatite was reported to be 2.9 ppm. The peak at 5.6 ppm is also characteristic of 
orthophosphate environments. This peak has been reported for substituted apatites.  
The peaks at 3.1 and 5.6 ppm together with the 
1
H NMR data, suggest the formation 
of a substituted apatite. A small amount of pyrophosphate was still present at –9.3 
ppm.  
For samples synthesised from CME as calcium precursor, the main component 
((C2H5O)3PO···Ca···OP(OH5C2)) was the calcium tris(ethyl) phosphate complex with 
monomers from TEP at –2.5 ppm. The higher concentration of these complexes 
compared to the phosphate in samples synthesised with calcium nitrate can be due to 
the fact that calcium methoxyethoxide is a reactive alkoxide and favours the 
formation of the calcium tris(ethyl) phosphate complex, which is more stable in CME 
samples. The presence of pyrophosphate is evident at –6.5 ppm, as it was for samples 
synthesised with calcium nitrate. With increasing the temperature to 500 °C, the 
formation of orthophosphate takes place, shown by a chemical shift at 3.6 ppm, with 
calcium as the charge balancing cation. The line width was broader than for samples 
synthesised with calcium nitrate, suggesting a more disordered orthophosphate 
environment. The calcium complex was still present, but in lower concentration (4%), 
suggesting that the cleavage of Ca
+-
O bonds in the complex took place with the 
formation of orthophosphate. The pyrophosphates are still present in the system, in 
lower concentration, thus some of the P-O-P bridges opened with the formation of 
orthophosphate. These results could indicate that there could have been HA-like phase 
separation in the glasses made with CME. However the XRD spectra (Figure 3.3.3) 
did not show the presence of HA or any crystalline phases. In fact, the peak in the 
NMR spectrum corresponding to orthophosphate was much broader than the 
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orthophosphate peak found in the NMR spectrum for 58S glasses synthesised with 
calcium nitrate. Therefore although the phosphate is present as orthophosphate 
(charge balanced with Ca
2+
) in 58S glasses synthesised with CME, the orthophosphate 
was dispersed throughout the glass so as not to be considered phase separated. This 
should mean that the glass is more homogeneous that the 58S glasses synthesised with 
calcium nitrate. 
The results obtained from 
29
Si MAS NMR spectroscopy provide a better 
understanding of the effect of calcium on the connectivity of silica network by the 
distribution of silicon Q
n
 species. 
29
Si MAS NMR spectra of samples synthesised by 
inorganic and alkoxide routes are shown in Figure 4.13.  
 
Figure 4.13 
29
Si MAS NMR spectra of 58S samples synthesised with calcium nitrate and CME. 
To quantify the Q
n
 distribution the 
29
Si MAS NMR spectra were deconvoluted by 
Gaussian fitting using DMFIT software [154]. The results of deconvolution are shown 
in Table 4.4. 
The 58S sample synthesised using calcium nitrate and dried at 130 °C (58S-
Ca(NO3)2-130°C) showed a well polymerised silica network at this stage as is 
58S CME 500 °C
58S CME 130 °C
58S Ca(NO3)2 400 °C
58S Ca(NO3)2 130 °C
Q2(H), Q3(Ca)
-95.4 Q3(H)
-95.4
Q4
-112.7
Q4
-112.1
Q2(Ca)
-85.9
Q2(H), Q3(Ca)
-93.4
Q3(H)
-102.8
Q1(Ca)
-95.4
Q2(Ca)
-80.6
Q2(H), Q3(Ca)
-88.4
Q3(H)
-99.6
Q2(Ca)
-81.5
Q2(H), Q3(Ca)
-88.9
Q3(H)
-98.9
Q4
-110.4
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illustrated by the concentration of Q
4
 (62%) and Q
3
(H) (31%) in Table 4.4. This can 
be explained by the fact that at this stage calcium is not yet part of the silicate network. 
With increasing the temperature at 400 °C, a small increase in the Q
4
 species is 
observed with the appearance of a peak at –85.9 ppm. This peak can be attributed to 
Q
2
(Ca), as Q
1
(H) is unlikely to be formed in the system. This can also be supported by 
the fact that calcium ions interact with two silanols and increase the rigidity of the 
network. 
As the silicate network becomes more rigid, the bridging and non-bridging oxygens 
become more covalent. As a consequence the silicon nucleus becomes more shielded 
and chemical shift moves toward more negative values. Therefore, as the 
concentration of Q
4
 is not decreased, just a small amount of calcium ions as a network 
modifier, entered in silica network at this temperature. This also explains the peak 
broadening comparing the sample thermal treated at 130 °C. This reaction of calcium 
with silanols can generate new sites capable of water adsorption and diminishes the 
total number of surface hydroxyls, as was shown in Table 4.4, where a decrease in 
Q
3
(H) and Q
2
(H) was observed. This is also supported by our 
1
H NMR spectra where 
the signal from water was increased at 400ºC (Figure 4.13). 
For samples synthesised using CME, as the calcium alkoxide is highly reactive, 
calcium ions can interact with Si-OH in the early stages of gel formation and form 
SiO
–+
Ca
+–
OSi and stiffness the network increases. The absence of Q
4
 species in the 
samples dried at 130 °C can be explained by the fact that Ca ions donated from 
hydrolysed CME is incorporated into the silica network at room temperature. This is 
supported by the presence of Q
2
(Ca) and Q
1
(Ca) in the system. With increasing the 
temperature to 500 °C, the formation of new siloxanes bridges took place (Table 3, 
Figure 3), where now some Q
4
 species formed and the concentration of Q
3
 (H) and 
Q
2
(H) increased. Also at this temperature Q
1
(Ca) was absent. As the 
31
P NMR data 
(Table 4.3, Figure 4.12a) showed at this temperature, the main component was 
orthophosphate. Therefore a portion of calcium ions were involved in the balancing of 
orthophosphate species, and they were removed from the silicate network. As an 
effect, the silica network repolymerises with the formation of new Si-O-Si bridges. 
Thus, phosphorous acts as a scavenger and removes calcium from the silicate network, 
and the effect is increasing its polymerisation.  
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In all the samples, the Si-O-P bonds were absent from 
29
Si NMR spectra, suggesting 
that P does not copolymerise with the silicate network (no Si-O-P bonds), and just P-
O-P bonds are formed, as the 
31
P NMR data suggests.   
  
Table 4.3 
31
P MAS NMR data for 58S glasses made with calcium nitrate and CME, giving the spectral deconvolution into different Q
n
 species. 
Sample 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
58S Nitrate 130 - - - 2.7 4.4 8 0.5 1.6 19 –3.3 5.1 65 –10.8 9.3 8 
58S Nitrate 400 5.6 3.4 11 3.1 3.0 64 0.5 2.6 19 - - - –9.3 7.0 6 
58S CME 130 - - - - - - - - - –2.3 4.8 92 –6.5 3.6 8 
58S CME 500 - - - 3.6 5.5 91 - - - –2.1 5.3 4 –7.3 9.4 5 
FWHM, δ and I represent the linewidth full-width half-maximum, 31P chemical shift and relative intensity, respectively.  
Errors associated with measurements are — FWHM ± 1 ppm, δ ± 2 ppm and Integral ±2%. 
 
 
Table 4.4 
29
Si MAS NMR data for 58S glasses made with calcium nitrate and CME, giving the spectral deconvolution into different Q
n
 species. 
Sample 
 Q
1
(Ca) Q
2
(Ca)    Q
2
(H), Q
3
(Ca) Q
3
(H) Q
4
 
δ 
 (ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
 (ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
 (ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
 (ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
 (ppm) 
FWHM 
(ppm) 
I 
(%) 
58S Nitrate 130 - - - - - - –95.4 7.3 7 –104.0 6.9 31 –112.7 9.0 62 
58S Nitrate 400 - - - –85.9 6.1 2 –93.4 8.7 6 –102.8 9.2 27 –112.1 10.0 65 
58S CME 130 –73.5 9.7 6 –80.6 7.9 11 –88.4 8.7 55 –99.6 9.3 28 - - - 
58S CME 500 - - - –81.5 5.9 6 –88.9 7.7 46 –98.9 10.4 42 –110.4 7.0 6 
FWHM, δ and I represent the linewidth full-width half-maximum, 29Si chemical shift and relative intensity, respectively.  
Errors associated with measurements are — FWHM ± 1 ppm, δ ± 2 ppm and Integral ±2%. 
  
 
4.4 Summary 
CME seems to be a viable alternative to calcium salts for incorporation of calcium 
into a silica network at processing temperatures below 60 ˚C. The hypothesis for the 
mechanism of incorporation of the calcium is that the CME hydrolyses when it is 
added to the sol, which is hydrolyses TEOS, and incorporates calcium in the wet silica 
gel. As gelation and drying proceed, the silica network continues to cross-link but 
maintains the calcium in the network. In contrast, when calcium salts are used they 
remain in solution until drying and then reprecipitate during drying, only being 
incorporated when they are broken down thermally at high temperature, or in the case 
of calcium chloride, the calcium is not incorporated at all. The use of calcium nitrate 
in the sol-gel process has recently been showed to cause inhomogeneity in the 
calcium distribution [129, 156], therefore CME is therefore a promising alternative 
for production of more homogeneous glasses and in the synthesis of sol-gel hybrid 
materials containing organic polymers. 
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5 Poly--glutamic acid hybrids synthesised with calcium methoxyethoxide 
5.1 Introduction 
The previous two chapters show that CME is potentially an improved calcium 
precursor for hybrid material synthesis over calcium salts. In this section, CME will 
be incorporated into a -PGA/silica hybrid recently created by Poologasundarampillai 
et al. [127]. The properties of those hybrid samples made with CME will be compared 
with samples made with calcium chloride. The main challenge for using CME is its 
high sensitivity to water, which was also used to hydrolysis the TEOS and GPTMS. 
5.2 Materials and methods 
5.2.1 Materials 
Poly-γ-glutamic acid was purchased in the free acid from Natto Biosciences (Quebec, 
Canada). The polymer had 95% free acid γ-PGA and 5% water by weight. 
3-(glycidoxypropyl) trimethoxysilane (GPTMS, 98%, 1L) and dimethylsulfoxide 
(DMSO, 99.6%, 1L) were purchased from Sigma-Aldrich. TEOS, hydrochloric acid, 
calcium chloride dihydrate, hydrofluoric acid and CME used in this section were the 
same as described in section 3.2.2. 
5.2.2 Synthesis of hybrids 
Both class I and II hybrids were synthesised with either CME or calcium chloride as 
the calcium source. The weight percent of organic/inorganic was 40/60 while the 
molar ratio of Si/Ca was 70/30 to make the inorganic the same composition as the 
70S30C (70 mol% SiO2, 30 mol% CaO) bioactive glasses. Class II hybrid was 
produced using GPTMS as a coupling agent.  
Figure 5.1 shows a flow chart of the process to make these hybrids. The γ-PGA was 
dissolved in DMSO to create a polymer solution. The inorganic silica sol was 
prepared by hydrolysing TEOS with H2O and HCl (2N), mixing for 30 min.  
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Figure 5.1 Flow chart of synthesis of Class I and Class II γ-PGA/bioactive silica hybrids 
Class I hybrids using calcium chloride were made by mixing the γ-PGA solution with 
calcium chloride solution first. After mixing for 30 min, the hydrolysed sol was added 
and then mixed for another 1 h. Half of the water was used to dissolve the calcium 
chloride so the sol was hydrolysed by the remaining water (Si
4+
 : H2O : H
+
 = 1: 6 : 2). 
Class I hybrids using CME were made by mixing the organic polymer solution with 
the sol first. The molar ratio of Si
4+ 
: H2O : H
+
 in the sol was 1 : 2 : 2. After 30 min of 
mixing, CME solution and HF were added and then mixed for another 1h. The CME 
solution was prepared by diluting the CME by same volume of DMSO. Class II 
hybrids were synthesised by firstly functionalising the γ-PGA by reacting with 
GPTMS in DMSO under argon atmosphere at 80˚C for 12 h. The molar ratio of γ-
PGA to GPTMS was investigated for hybrids synthesised with calcium chloride: 2:1 
(termed 2ECCaCl), 10:1 (10ECCaCl) and 50:1 (50ECCaCl); All hybrids made with 
CME had a γ-PGA: GPTMS ratio of 2:1(2ECCaME & 2ECCaME*). * signifies HF was 
not added. All the samples used for this work were listed in Table 5.1. 
 
 
 
+ + + + 
+ + + 
H2O + HCl +TEOS  
H2O + HCl +TEOS 
Class Ⅰ Class Ⅱ 
H2O + HCl +TEOS 
H2O + HCl +TEOS 
Ageing (60˚C, 3 days) 
Drying (60˚C, 10 days) 
70S30C-CaCl2-Ⅰ 70S30C-CaCl2-Ⅱ 
 
70S30C-CME-Ⅰ 70S30C-CME-Ⅱ 
 
γ-PGA  
(in DMSO) 
γ-PGA + GPTMS  
(in DMSO) 
 
γ-PGA + GPTMS  
(in DMSO) 
+ 
CME  
(in DMSO)  
CME 
(in DMSO) 
γ-PGA 
(in DMSO) 
 
H2O + CaCl2 H2O + CaCl2 
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Table 5.1 Class II γ-PGA/bioactive silica hybrids synthesised with calcium chloride (CaCl) or 
calcium methoxyethoxide (CaME) with molar ratios of -PGA : GPTMS of 2, 10 and 50 with 
processing temperature of 60 °C. 2 traditional bioactive glasses synthesised with calcium chloride 
(CaCl) or calcium nitrate (CaN) with processing temperature of 700 or 800 °C were added for 
comparison. (*) signifies HF was not added. 
Sample 
name 
Composition 
molar ratio of 
γ-PGA to 
GPTMS 
Calcium 
precursor 
Whether 
use HF 
Final processing 
temperature 
2ECCaME* 70S30C 2 : 1 CME No 60 °C 
2ECCaME 70S30C 2 : 1 CME Yes 60 °C 
2ECCaCl 70S30C 2 : 1 CaCl2 Yes 60 °C 
10ECCaCl 70S30C 10 : 1 CaCl2 Yes 60 °C 
50ECCaCl 70S30C 50 : 1 CaCl2 Yes 60 °C 
70Si30CaCl 70S30C - CaCl2 Yes 700 °C 
70Si30CaN 70S30C - Ca(NO3)2 Yes 800 °C 
The procedures for making class II hybrids using CaCl2 and CME were different. 
Figure 5.2 shows a schematic of class II hybrid synthesis using CaCl2. CaCl2 solution 
was firstly mixed with the functionalised γ-PGA solution and then mixed with the 
silica sol for 1h. The large amount of DMSO was then removed using a rotary 
vacuum evaporator before the polymer solution was added. The resultant solution was 
placed in Teflon moulds and then gelled with the addition of hydrofluoric acid (HF) at 
room temperature with a ratio of 3 ml 5wt% HF to 50 ml solution.  
 
Figure 5.2 Schematic of Class II γ-PGA/bioactive silica hybrid synthesis with CaCl2 
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Figure 5.3 Schematic of Class II γ-PGA/bioactive silica hybrid synthesis with CME 
Figure 5.3 shows a schematic of class II hybrid synthesis using CME. TEOS was 
initially hydrolysed for 30 min by water using R=2 (R is the molar ratio of H2O to 
TEOS). It was then mixed with functionalised γ-PGA solution at room temperature in 
Teflon moulds followed by slow addition of CME. DMSO was not evaporated to 
assist with the homogenous dispersion of CME in mixture. The mixture gelled in 20 
min without HF. For those synthesised using HF, HF was added before CME and 
mixed with the mixture for 2 min. The mixture also gelled in 20 min. The Teflon 
moulds were placed into oven directly and aged at 60˚C for 72 h then dried at 60˚C 
for 10 days. 
5.2.3 Characterisation 
Atomic scale (MAS NMR) 
29
Si MAS NMR spectra were collected on a Varian InfinityPlus 300 spectrometer 
(7.05T) operating at 59.62 MHz, using a Varian 7.5 mm probe spinning at 4 kHz. A 
4.5 µs pulse (~45°) was applied with a 30 s recycle delay. 
29
Si MAS NMR spectra 
were referenced to TMS at 0 ppm. To quantify the Q
n
 distribution the 
29
Si MAS NMR 
spectra were deconvoluted by Gaussian fitting using DMFIT software [154]. 
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Topography (SEM) 
SEM on chromium coated specimens was used to examine the morphological and 
textural features of the hybrids, which was performed on a Leo 1525 with Gemini 
column fitted with a field emission gun at 5 kV. The working distance was between 5-
10 mm and the aperture of the inlens secondary electron detector (SEI) was 30 µm. 
All the samples were coated with chromium and attached on aluminium sample 
holders via carbon tape. 
Mechanical test 
The compressive strength was determined using a custom-built cable driven tester 
with displacement accuracy of ±0.1 m and 250 N load cell. Hybrid monolithic 
samples for mechanical testing were rectangular with approximate dimensions 10 x 5 
x 5 mm. Uniaxial compression was performed at 0.5 mms
-1
 to failure. A conventional 
sol-gel derived bioactive glass using calcium nitrate, gelled with HF and sintered at 
800˚C (70Si30CaN) was added as a control. 
Dissolution and bioactivity (pH, ICP, FTIR, XRD) 
Bioactivity was tested by soaking samples in simulated body fluid (SBF) to determine 
the rate of inorganic dissolution and the formation of HCA on the surface of the 
materials. Monoliths of 0.15 g were immersed in 100 ml of SBF and placed in an 
orbital shaker with an agitation rate of 120 rpm at 37˚C. 1 ml of each sample was 
collected at each time point (1, 2, 4, 8, 24, 72, 168, 336 and 672 h) for analysis with 
inductive coupled plasma optical emission spectroscopy (ICP-OES, Thermo iCAP 
6000 Series) and 1 ml SBF was refilled to keep the solution volume of 100 ml. The 
pH was measured from each solution (37˚C) by Oakton® 11 series pH meter at each 
time point. Three samples of each material were run per test, with the mean values 
reported. A conventional sol-gel derived bioactive glass, gelled with HF and stabilised 
at 700˚C (70S30C made with calcium chloride) was used as a control. 
After 4 weeks soaking in SBF, the samples were filtered (1 µm paper) and the 
monoliths were rinsed with acetone, dried and then evaluated by XRD and Fourier-
transform infrared spectroscopy (FTIR) analyses for the formation of a HCA layer. 
Samples for XRD was ground and then carried out with a PANalytical X’Pert Pro 
MPD series automated spectrometer, using a step scanning method with Cuka 
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radiation, at 40KV and 40mA, with a 0.040° 2θ step and a count rate of 50 s per step, 
from 2θ values of 5° to 75°. Samples for FTIR were ground with potassium bromide 
(KBr) with a 1 to 100 weight ratio. The resultant powder was pressed into a pellet 
with 7 tonnes of pressure. FTIR was then performed on a Bruker Vector 22 thermal 
gravimetric-infrared spectrometer (TGA-IR) through transmission with a wavelength 
of 633 nm and in the range of 400 to 1600cm
-1
.  
Polymer release data of each sample was obtained by bicinchoninic acid (BCA) 
protein assay. The BCA assay is a biochemical assay for determining the total level of 
protein in a solution, which primarily relies on two reactions: 1. the peptide bonds in 
protein reduce Cu
2+
 ions (from the reagent) to Cu
1+
 under alkaline condition (the 
mount of transfer is proportional to the amount of protein in the solution); 2. two 
molecules of bicinchoninic acid (from the reagent) chelate with each Cu1+ ion, 
forming a purple-colored product which strongly absorbs light at a wavelength of 562 
nm. The amount of protein can then be quantified by using colorimetric techniques. 
Since γ-PGA contains peptite bonds, the BCA assay can be applied to measure the 
amount of γ-PGA presented in the solution. The standards was prepared by firstly 
converting γ-PGA free acid to the sodium salt form (reacting with NaOH in deionised 
water, molar ration of Na
+
 to γ-PGA was 1 to 1) and dissolving it in deionised water 
to make a series concentration (0, 0.0625, 0.125, 0.25, 0.5, 1, 2 mg/ml). 50 µl of each 
test solution collected was pipetted into a 96 well plate. Each standard or sample was 
duplicated to three wells. The Pierce
®
 BCA assay kit was used to prepare the samples 
before evaluation by colorimetric techniques. BCA Protein Assay Reagent A 
(bicinchonic acid and tartrate in an alkaline carbonate buffer) and Reagent B (4% 
copper sulfate pentahydrate solution) were mixed with a molar ratio of 50:1, and then 
200 µl of the resultant mixture was added to 50 µl of each collected solution. The 96 
wells plate was placed in the same incubator for 30 min. After cooling to room 
temperature, an Anthos 2020 spectrophotometer with measurement filter of 570 nm 
was used to analyse the absorbance of each sample. The polymer release was 
calculated by comparing the absorbance data with the standards. 
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Cell study 
To examine the effect of the hybrids on cell toxicity and growth primary human adult 
osteoblasts (hOBs) were used. Cell culture was carried out by Dr Olga Tsigkou. The 
cells were seeded and cultured directly on the surface of the hybrids. The hOBs were 
cultured in low glucose phenol red free Dublecco‘s Modified Eagle Medium 
(DMEM), supplemented with 10% fetal bovine serum (FBS), 2mM L-glutamine, 
50U/ml penicillin, 50 µg/ml streptomycin and 2.5µg/ml amphotericin B (all from 
Invitrogen, UK) (cell culture medium) in a humidified incubator at 37 °C and 5% CO2. 
Prior to cell seeding hybrid monoliths were sterilised by exposure under ultraviolet 
(UV) light for 2 h each side followed by incubation in DMEM medium, supplemented 
with 50 U/ml penicillin, 50 µg/ml streptomycin and 2.5µg/ml amphotericin B, at 37°C 
overnight (preconditioning). To ensure attachment of most of the cells, hOBs were 
resuspended in a small volume (20 µl of cell culture medium), seeded on the surface 
of the hybrids and incubated for 1h at 37 °C and 5% CO2. Then the appropriate 
amount of medium was added to cover the each hybrid (i.e. 0.5ml/well for 48 well 
plate). The seeding density used was 1x10
4 
cells/cm
2
 for all experiments. 
Cytotoxicity was evaluated with the LIVE/DEAD viability/cytotoxicity assay 
(Molecular Probes, UK) which was performed according to the manufacturer‘s 
instructions. Stained samples were examined under an Olympus BX-URA2 
fluorescence microscope. Images were captured using a Zeiss Axiocam digital camera 
and analysed using KS-300 software (Imaging Associates).  
For cell growth, the Alamar Blue assay was used to measure the metabolic activity 
and consequently the rate of cell growth after 4 and 12 d of culture. As a positive 
control hOBs were seeded on tissue culture plastic cultured in parallel with the 
hybrids. For each Alamar Blue measurement the hybrids were moved to a new plate 
and incubated at 37 °C and 5% CO2 for 2 h with phenol free DMEM (without added 
serum) containing 10% (v/v) Alamar Blue solution (Invitrogen, UK). Then, 100µl of 
each sample was transferred to a new black-with-clear bottoms 96-well plate and the 
fluorescent intensities were measured using a microplate reader, with fluorescence 
excitation and emission wavelengths of 570 and 610 nm, respectively. To determine 
the effect of the dissolution products released over time by the hybrids on hOBs, the 
metabolic activity of the cells on the plate was measured as well with the Alamar Blue 
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assay. The fluorescence values obtained were averaged, and the average was 
expressed as a percentage of the cells on cell culture plastic at day 4. Experiments 
were performed in triplicate, 6 hybrids for each experiment. The statistical 
significance of the obtained data was assessed by one-way ANOVA variance analysis 
using the Sigma stat software. Level of significance was set at p < 0.05. 
5.3 Results and discussion 
5.3.1 Procedure determination 
The main aim of this work was to determine how to incorporate calcium into a γ-
PGA/ silica hybrid. It was difficult to make homogeneous hybrid samples with CME 
since CME was highly sensitive to water which must be used to hydrolyse the TEOS 
and GPTMS. Thus the water used for hydrolysing TEOS was kept as low as possible  
(R = 2).  
Several systematic trial and error experiments were needed to devise a viable method 
of incorporating CME. CME was found to react with functionalised polymer solution 
and functionalised TEOS to cause premature and heterogeneous gelation. This is 
because CME is highly active to water and oxidisers. There are a large number of 
hydroxyl groups in functionalised γ-PGA, and also many of that on each hydrolysed 
TEOS (maximum 4 per silicon). Those hydroxyl groups hydrolysed the CME to form 
gel. The gelation occurred immediately when CME was mixed with the functionalised 
polymer solution (-PGA + GPTMS). However, mixing CME with hydrolysed TEOS 
(R=2) gelation occurred after several min. Therefore when making Class II hybrids 
with CME, functionalised polymer solution was firstly mixed with hydrolysed TEOS. 
The duration of TEOS hydrolysis was set to 30 min (rather than the conventional 1h), 
thus less condensation has started, in order to improve the homogeneity when mixing 
with the functionalised polymer solution and reduce the risk of gelation when CME 
solution was added.  
Diluting CME with the same volume of DMSO and adding the diluted CME solution 
slowly into the mixture were also found to improve the homogeneity of the reactions. 
HF was only mixed with the mixture for 2 min and was added before the CME 
solution was added. The gelling time of these hybrids reduced to 20 min when using 
CME as calcium precursor, due to the gelling property of CME (when using CaCl2 
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gelling time was longer than 3 days). Addition of HF did not affect the gelation, 
which might be due to HF being inhibited by the strong gelling ability of CME. HF 
samples synthesis and characterisation continued as HF is used for gelation when 
scaffolds are made by the foaming process, so it was important to investigate when 
the use of HF affected the inherent structure of the materials.  
When making Class II hybrids using calcium chloride, water was separated to two 
parts. Half was used to dissolve calcium chloride and half was used to hydrolyse 
TEOS before mixing. Calcium chloride solution does not react with the functionalised 
polymer so it was added before the hydrolysed TEOS was added, in order to try to 
achieve homogenous dispersion of calcium into the polymer solution. The hydrolysed 
TEOS was then added to react with functionalised polymer. HF was added at the last 
step to ensure rapid gelation only occurred after the sol was homogenously mixed. 
Addition of HF reduced the gelling time from several weeks to 3 d. 
In summary, the procedure was designed to gel the mixture after the reagents were 
homogenously mixed. The resulting hybrid samples were brown in colour but all 
transparent. The samples using higher ratio of GPTMS had darker colour and lower 
transparency.  All the Class I hybrid samples found to decompose in 15 s after 
immersed in SBF solution. Thus further characterisation was focused on the Class II 
hybrids. 
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5.3.2 MAS NMR 
 
Figure 5.4 
29Si MAS NMR spectra of Class II γ-PGA/bioactive silica hybrids synthesised with 
calcium chloride (CaCl) or calcium methoxyethoxide (CaME) with molar ratios of -PGA : 
GPTMS of 2, 10 and 50 with processing temperature of 60 °C. (*) signifies HF was not added. 
Class II γ-PGA/ silica hybrids containing calcium were successfully synthesised using 
CME as the calcium precursor. Solid state MAS NMR was used for analysing the Q 
and T species of the samples (Figure 5.4). The results of the 
29
Si MAS NMR are 
summarised in Table 5.2. Table 5.2 shows the presence of T and Q species. The 
presence of T
2
 and T
3
 species indicate that covalent bonds successfully formed 
between hydrolysed GPTMS (functionalised γ-PGA) and silica network. Comparing 
the three class II hybrid samples made with CaCl2, the relative number of T species 
increased with increasing amount of GPTMS used in synthesis, e.g. 2ECCaCl (highest 
GPTMS) 12 % T
3
 and 2% T
2
, compared to 4% T
3
 and no T
2
 for 10ECCaCl. The 
relative number of Q
4
 units also decreased from 62% to 53% as the coupling agent 
concentration increased from 10ECCaCl to 2ECCaCl, while the relative number of Q
3
 
units remained approximately constant. This implies that the addition of the GPTMS 
disrupted the formation of the silica network. It may be also because a small ratio of 
δ (ppm)
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GPTMS cross-linked to itself, which needs to be confirmed by further detailed NMR 
analysis.  
Table 5.2 Chemical shifts and relative proportions of T
n
 and Q
n
 species in Class II γ-
PGA/bioactive silica hybrids synthesised with calcium chloride (CaCl) or calcium 
methoxyethoxide (CaME) with molar ratios of -PGA : GPTMS of 2, 10 and 50 with processing 
temperature of 60 °C. (*) signifies HF was not added. 
Samples  
T
1 
 T
2 
 T
3 
 Q
2 
 Q
3 
 Q
4 
 
δ  I  δ  I  δ  I  δ  I  δ  I  δ  I  
(ppm)  (%)  (ppm)  (%)  (ppm)  (%)  (ppm)  (%)  (ppm)  (%)  (ppm)  (%)  
   2ECCaME* -  -  –58.3  10  –66.4  25  –92.2  2  –101.7  24  –110.8  39  
   2ECCaME -  -  –58.2  8  –66.6  25  –92.4  4  –101.7  23  –110.9  40  
2ECCaCl  -57.2  1  -57.1  2  -65.6  12  -93.0  4  -102.8  28  -111.4  53  
10ECCaCl  -  -  -  -  
-65.5  
-61.1  
2  
2  
-93.6  5  -102.1  29  -111.6  62  
50ECCaCl  -  -  -  -  -61.1  1  -92.1  6  -101.5  33  -111.1  60  
 
In samples made with CME (2ECCaME), the relative number of Q
4
 units was lower at 
40% compared to 53% for hybrids made with calcium chloride. This indicates that the 
calcium incorporated into the silica network to a higher degree than when calcium 
chloride was used. The relative proportion of T
3
 and T
2
 species (25% and 10% 
respectively) were also higher for the hybrids made with CME, indicating increased 
incorporation of the functionalised polymer. This could be improved due to the 
calcium disrupting the silica network and encouraging condensation with the silanol 
groups from the functionalised polymer. Very little difference was found between the 
2ECCaME* sample and 2ECCaME sample, indicating the usage of HF did not affact the 
network formed, other than the rate of gelation. 
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5.3.3 Mechanical testing 
 
Figure 5.5 Compressive stress/ strain curves for Class II γ-PGA/bioactive silica hybrid monoliths 
synthesised with calcium chloride (CaCl) or calcium methoxyethoxide (CaME) with molar ratios of 
-PGA : GPTMS of 2, 10 and 50 with processing temperature of 60 °C. (*) signifies HF was not 
added. Traditional 70S30C bioactive glass synthesised with calcium nitrate (CaN) with a 
processing temperature of 800C was added for comparison. 
Compressive mechanical testing was performed on all class II hybrid monoliths to test 
the strength and toughness of the hybrids. The strength of a material is its ability to 
withstand an applied stress without failure, whereas the toughness of a material is its 
energy of mechanical deformation per unit volume prior to fracture. The toughness 
can be determined by measuring the area underneath the stress-strain curve. The 
maximum compressive strength (ζmax) and strain to failure (the amount of strain a 
material can withstand before it fails) are the most interested data of those tested 
samples.  Previous work has shown bioactive glass scaffolds (70 mol% SiO2, 30 mol% 
CaO, termed as 70Si30CaN in this section) to have optimal compressive strength when 
the glass was sintered to 800C [66]. Therefore monoliths of this glass were used as a 
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comparison. Figure 5.5 shows typical stress strain behaviour of the hybrids and that of 
sol-gel glass monoliths. The glass monolith (70Si30CaN) had a maximum 
compressive strength (ζmax) of 37-89 MPa at a strain to failure of 4.2%. The strain to 
failure of the class II hybrids greatly increased compared to the glass monolith due to 
the incorporation of the polymer phase. Hybrids synthesised with calcium chloride 
had strain to failure measurements from 17.5 – 29 %, whereas their compressive 
strength was significantly lower (4.1 – 10.2 MPa). Compressive strength and strain to 
failure both increased as covalent coupling increased; 50ECCaCl had the lowest 
compressive strength (4.1 MPa) and strain to failure (18.1 %), while 2ECCaCl had the 
highest compressive strength (10.2 MPa) and strain to failure (29 %), indicating the 
toughness was increased by the increasing of covalent coupling. Although the 
compressive strength of the hybrid monoliths synthesised with calcium chloride (2.4 – 
10.5 MPa) was low compared to 70S30C (32 - 89 MPa) and to that of cortical bone 
(100 – 230 MPa) [12] the extended elastic behaviour and elongation is highly 
promising in terms of increased toughness. 
The replacement of calcium chloride with CME as calcium source for class II hybrid 
synthesis caused a significant increase in both compressive strength and strain to 
failure. The compressive strength reached 84.2 MPa (as high as some of the sol-gel 
glass monoliths), and the strain to failure reached approximately 40% (bigger than 
that of the hybrids samples synthesised with calcium chloride). This suggests using 
CME as calcium source can significantly increase the toughness of hybrid materials. 
This could be due to increased connectivity between the organic and inorganic species 
in the system as indicated by the NMR results (Table 5.2). 
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5.3.4 XRD 
 
Figure 5.6 XRD spectra of Class II γ-PGA/bioactive silica hybrids synthesised with calcium 
chloride (CaCl) or calcium methoxyethoxide (CaME) with molar ratios of -PGA : GPTMS of 2, 10 
and 50 with processing temperature of 60 °C. (*) signifies HF was not added, (·) signifies crystals 
of calcium floride. 
Figure 5.6 shows XRD spectra of all class II hybrid samples. CaF2 at 2 values of 28°, 
47°, 56°, and 69° was detected in all those samples. The formation of CaF2 is due to 
the use of HF as catalyst. The spectra showed the intensity of CaF2 peak increased as 
the amount of coupling agent (GPTMS) decreased. High cross-linking between 
inorganic and organic phase might block the detection of CaF2 since the very low 
amount of HF was utilised. 
·
·
· ·
·
·
· ·
·
· · ·
· · · ·
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5.3.5 Dissolution and bioactivity 
 
Figure 5.7 Dissolution profiles from ICP of Class II γ-PGA/bioactive silica hybrids synthesised 
with calcium chloride (CaCl) or calcium methoxyethoxide (CaME) with molar ratios of -PGA : 
GPTMS of 2, 10 and 50 with processing temperature of 60 °C. Traditional 70S30C bioactive glass 
synthesised with calcium chloride (CaCl) with processing temperature of 700 °C was added for 
comparison. (*) signifies HF was not added. 
Figure 5.7 shows the inorganic dissolution profiles for the class II hybrids, as function 
of immersion time in SBF, for hybrids synthesised with each calcium precursor. 
Bioactive glass 70Si30CaCl (70 mol% SiO2, 30 mol% CaO) synthesised with calcium 
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chloride and stabilised at 700ºC was used for comparison. Dissolution profiles are the 
ionic concentration of silicon, calcium and phosphorus in SBF as a function of 
soaking time. The error bars are standard deviations from the mean calculated from 
triplicate results.  
Soluble silica 
The concentration of soluble silica in SBF increased as soaking time increased for 
each sample due to the dissolution of the silica network. The rate of silicon release 
decreased as the solution neared saturation and the concentration gradient decreased.  
The glass that was stabilised at 700 ˚C had the lowest silicon release rate due to the 
stabilisation process increasing the network connectivity than the hybrid samples 
which were dried at 60˚C.  
In hybrids synthesised from calcium chloride, the hypothesis was that increasing the 
amount of covalent coupling (50ECCaCl < 10ECCaCl < 2ECCaCl) would decrease the 
dissolution rate of the silica network due to increased bonding between the organic 
and the inorganic, however this did not occur and higher amounts of soluble silica 
was released from the 2ECCaCl (9.5 µgml
-1
) and 10ECCaCl (17.6 µgml
-1
) samples 
after 8 h immersed in SBF solution. The soluble silica release from 50ECCaCl was 
lowest (5.9 µgml-1), which had the highest total proportion of Q4 and Q3 units which 
may be due to the low concentration of coupling agent (Table 1). The resulting in 
soluble silica release were 10ECCaCl > 2ECCaCl > 50ECCaCl after two weeks in SBF. 
The 2ECCaCl hybrid had significantly lower Q
3
 and Q
4
 than the 50ECCaCl hybrid, but 
the total of T
3
, Q
3
 and Q
4 
in
 
2ECCaCl totalled the same as the relative amounts of Q
3
 
and Q
4 
in 50ECCaCl. It is also not clear from the NMR data as to why 10ECCaCl had a 
more rapid silica release than the others. Mahony et al. reported silica release 
decreased with increasing ratio of GPTMS of the calcium free Class II gelation 
hybrids [126]. The use of calcium in this work might be the reason for the change the 
release behaviour of silica. 
From the NMR data, hybrids synthesised with CME might be expected to have the 
more rapid loss of soluble silica as the percentage of Q
4
 species was lowest for these 
materials, indicating a more disrupted silica network. However, until 72 h immersion 
126 
 
 
in SBF, the soluble silica release from the CME samples was similar to that of the 
2ECCaCl and 50ECCaCl samples and lower than the 10ECCaCl samples. After 1 week 
immersion the soluble silica release was similar to the 10ECCaCl samples, but after 
that the silica release increased for the hybrids made with CME, reaching saturation at 
approximately 100 µgml-1. The lag time in silica release from the hybrids made with 
CME could be due to the high proportion of T
3
 species cross-linking the network. 
Calcium 
SBF contains approximately 80 µgml-1 calcium ions. For all the samples, the calcium 
ion concentration in the SBF increased in the first 8 h (167.4 µgml-1 from 2ECCaCl, 
165.5 µgml-1 from 10ECCaCl and 123.7 µgml
-1
 from 50ECCaCl) at a similar rate and 
then decreased until 168 h of immersion and thereafter it levelled off. This might 
because Ca didn‘t incorporated into the silica network and most of Ca was in the outer 
layers of the monolith. 
The irregular rates of Ca release indicate the calcium was not really bonding into the 
silica network. The 50ECCaCl hybrid showed lower Ca content than the 2ECCaCl and 
10ECCaCl hybrids. For the 70S30C glass, a similar trend was observed until 72 h of 
immersion, after which the Ca concentration of the SBF increased and remained 
approximately constant after 168 h. After 72 h of immersion, the Ca content in SBF 
containing 70S30C glass was much higher than for the SBF containing hybrids and 
approximately double that of the 50ECCaCl hybrid. A decreased Ca content of the 
SBF implies Ca is depositing on the materials. The P concentration in the SBF 
decreased for all the samples, with the 70S30C glass causing the most rapid decrease, 
indicating that phosphate deposits on the glass more rapidly than on the hybrids, 
which could be due to the mesopores providing more sites (Si-OH groups) for apatite 
nucleation. The hybrids 2ECCaCl and 10ECCaCl have the second largest rate of 
decrease of phosphate in the SBF and after 72 h a 60 % decrease in SBF phosphate 
content was observed. For the SBF containing the 50ECCaCl to reach a similar value, 
immersion for 168 h was required. 
2ECCaCl and 10ECCaCl had the highest calcium release rate at the first 24 h, whereas 
50ECCaCl had lower, which might because higher coupling agent reduced the number 
of free O to bond Ca on the hybrid system. After 24 h of soaking in SBF, the Ca
2+
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concentration of three chloride hybrid samples started to decrease. This might cause 
by the formation of HCA on the surface of the hybrid samples and the deposition rate 
of calcium exceeded the release rate from the samples. For all the class II hybrids 
using CaCl2, the calcium ion concentration in the SBF increased in the first 12 h at a 
similar rate and then decreased until 168 h of immersion and thereafter it levelled off. 
The similar rates of Ca release indicate the calcium was not really bonding into the 
silica network. 
CME hybrids had the lowest calcium release rate, presenting Ca incorporated into the 
silica network and the hybrid system. The slow release suggests a better bonding 
between Ca and the silica network. After 24h, the concentration of Ca
2+
 in SBF 
started to decrease because of the same reason happen to chloride hybrid samples. But 
after 1 week, the Ca
2+
 concentration started to increase again, which might because 
the decomposition of silica network increasing the decomposition rate of the whole 
hybrid system after soaking in SBF for 1 week. 
Phosphate 
All the samples for dissolution test do not contain phosphorus, but the concentration 
of phosphorous ions in SBF is approximately 30 µg/ml. For all samples the 
concentration of P
5+
 kept decreasing in SBF due to the formation of HCA layer. The 
decreasing rate of 50ECCa was distinct slower comparing to the others, presenting 
crosslinking between inorganic and organic species contributed to trap the non-
hydrolysed TEP in the hybrid system, but easier released from 50ECCa. After 1 week 
the concentration of P
5+
 started to increase again since the decomposition of the 
hybrid system. 
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Figure 5.8 (a) FTIR (b) XRD spectra of Class II γ-PGA/bioactive silica hybrids immersed in SBF 
for 4 weeks 
FTIR spectroscopy was used to monitor the formation of the HCA layer. Figure 5.8a 
shows FTIR spectra of all non-reacted class II hybrid samples and samples soaked in 
SBF for 4 weeks at 37 C. The spectra contained wide vibrational bands 
corresponding to Si-O-Si stretch at 1060 cm
-1
 and Si-O-Si bending at 480 cm
-1
. A 
small amorphous P-O peak was presented of the non-reacted samples at 
approximately 600 cm
-1 
[150]. The amorphous peak could present the presence of 
precursors to hydroxyapatite, either octacalcium phosphate (OCP) or amorphous 
calcium phosphate (ACP), which was confirmed by XRD analysis as shown in Figure 
5.8b. After reacted in SBF for 4 weeks, sharp phosphate peaks at 571 cm
-1
 and 603 
cm
-1
 (P-O bending) were detected, together with carbonate peaks at 875 cm
-1
, 
indicating HCA formation. The formation of HCA was also confirmed by XRD 
analysis, with a main peak at 2θ value of approximately 31°. 
(a) (b)
FTIR XRD
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5.3.6 pH 
 
Figure 5.9 pH change profile of Class II γ-PGA/bioactive silica hybrids in SBF 
The pH variation in both SBF and deionised water for all class II hybrid samples were 
tested to determine the grade of each sample changing the pH in different solutions. 
Figure 5.9 shows the pH profile of all class II hybrid samples as function of time. The 
pH of SBF was approximately 7.40 and started to decrease after soaking the hybrid 
samples. pH decreases of SBF with higher cross-linked samples were much less than 
the lower cross-linked samples, indicating the connectivity between inorganic and 
organic species was an important factor to affect the pH, in other words, the release of 
the organic species was the main factor to change the pH (The polymer release profile 
was obtained by BCA assay, higher crosslinked sample had lower polymer release 
rate). The pH changing profiles of the class II hybrid samples made with CME were 
very similar to 10ECCaCl. 
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Figure 5.10 pH change profile of Class II γ-PGA/bioactive silica hybrids in water 
Figure 5.10 shows the pH changing profile of all class II hybrid samples in deionised 
water. The starting pH of deionised water was approximately 5.7. After soaking with 
the hybrid samples, pH decreased as what happened when soaking in SBF. For the 
calcium chloride hybrid samples, pH dramatically deceased within 1 h, followed by 
almost no change afterwards. The order of pH value was the same as in SBF 
(2ECCaCl > 10ECCaCl > 50ECCaCl). For the CME hybrid samples, pH change was 
very slow and small, taking around 24 h to bring down the pH to lower than 5, and 
then kept stable afterwards.  
This was very different to the pH change profile of CME samples in SBF. Also by 
visual recording, the CME sample had visible swell at the surface after 72 h soaked in 
SBF, whereas almost had no visible change after 4 weeks soaking in deionised water. 
This might be because of the higher connectivity between inorganic and organic 
species in the CME hybrid system. When placed the CME hybrids sample in SBF, the 
element in SBF had reaction with the inorganic species, which was a trigger then 
followed by the decomposition of the whole hybrid system. Whereas in deionised 
water, because of the lack of reaction between the solution and the inorganic species, 
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the organic species acted as shell of the hybrid system, resulting in very few release 
from the hybrid system to affect the pH of the solution. 
5.3.7 BCA assay for polymer release 
 
Figure 5.11 Polymer release profile of Class II γ-PGA/bioactive silica hybrids in water in SBF 
Figure 5.11 is the polymer release profile of the class II hybrid samples in SBF. The 
concentration of polymer released from three calcium chloride hybrid samples from 
high to low followed by the order 50ECCaCl, 10EccaCl and 2ECCaCl, indicating 
hybrids with more covalent coupling had lower polymer release rate than those with 
lower coupling. CME hybrid samples had similar polymer release rates to the hybids 
made with calcium chloride within 8h immersion in SBF. But after 24h, CME hybrid 
samples had the highest polymer concentration released in SBF, which might be 
because of the lower silica network connectivity again. The higher decomposition 
speed of inorganic species in CME hybrid samples accelerated the decomposition of 
the whole hybrid system, resulting in higher polymer release rate after a certain time 
soaked in SBF. The same situation happened to calcium chloride hybrid samples after 
72 h. The concentration of polymer released from 2ECCaCl became the highest of the 
three, due to the larger decomposition of hybrid system started after 72 h soaked in 
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SBF. And this happened later than CME hybrid samples due to the higher network 
connectivity of the inorganic species. 
5.3.8 Cell study 
 
Figure 5.12 Human primary adult osteoblast vibility on 2ECCaME. (a) LIVE/DEAD assay of the 
hOBs cultured on the hybrids’ surface for 7 d (live cells = green, dead cells = red). (b) Metabolic 
activity as measured with the Alamar Blue assay after 4 and 7 d in culture.   
To determine whether the hybrid samples are cytotoxic to cells, human primary adult 
osteoblasts were cultured on 2ECCaME and the viability was examined by the 
LIVE/DEAD assay after 7 d (Figure 5.12a).  The assay revealed that there were 
numerous live hOBs on the hybrids (green cell) and only a couple dead ones (red). 
Also from the LIVE/DEAD assay it was observed that the cells were well spread on 
the hybrids after 7 days in culture, indicating a favourable cell attachment. To further 
examine the effect of the hybrids on cell viability and growth the Alamar Blue assay 
was used to measure the cell metabolic activity after 4 and 7 d in culture. The 
metabolic activity of the cell monolayer around the hybrid samples was also measured 
to check if release from the samples resulted in cell death or number reduction (Figure 
5.12b). The Alamar Blue assay confirmed that the hybrids were not toxic to the hOBs 
and further demonstrated that the cells grew on the hybrids over the period of 7 days 
indicating a favourable cell response. In addition, the dissolution products of the 
hybrids were also not toxic and also allowed the hOBs to grow over time indicating 
that there was no hindering of cell growth (Figure 5.12b).  
0
50
100
150
200
250
300
4 7
%
 F
lu
o
re
n
ce
Days
Hybrids
Dissolution products
Cell culture plastic
200µm
a) b)
133 
 
 
5.3.9 SEM 
 
Figure 5.13 SEM images of 2ECCaME: Class II γ-PGA/bioactive silica hybrids synthesised with 
calcium methoxyethoxide (CaME) with molar ratios of -PGA : GPTMS of 2 with processing 
temperature of 60 °C with HF. 
Figure 5.13 shows the surface of 2ECCaME. The 2ECCaME sample seems to have a 
very compact surface texture, which caused the sample has almost no nitrogen 
sorption during the surface characterisation and therefore little porosity. The compact 
2ECCaME
2ECCaME
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surface structure was also coordinated to the high mechanical properties of the 
samples made with CME. 
5.4 Summary 
Hybrid materials were successfully produced using CaCl2 and CME as the Ca 
precursors. The CME was found to induce gelling on mixing with the 
organic/inorganic mixture. Once controlled, this was beneficial as rapid gelation is 
usually achieved using HF as a catalyst, which is a hazardous reagent. Also very little 
difference was found between the class II CME hybrids whether using HF or not, 
suggesting CME eliminates the need to use HF as a gelling agent. 
29
Si MAS NMR 
showed T-species in the hybrids and the T-species content increased with increasing 
the ratio of coupling agent and showed that calcium from CME incorporated better 
with the hybrids system than using CaCl2. Hydroxyl-carbonate apatite (HCA) was 
formed on all class II hybrids in SBF, indicating all the samples had bioactivity. 
Hybrid dissolution rate was strongly influenced by the connectivity of silica network, 
whereas the polymer release rate was the main factor determining change in pH. Class 
II hybrids synthesised with CME showed excellent compressive strength and 
elongation to failure, indicating CME as a promising calcium source for hybrid 
synthesis. 
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6 Polylactide/ silica hybrids materials 
6.1 Introduction 
Poly--glutamic acid has great potential for use in hybrid synthesis, but translation to 
clinic may take time as the -PGA is synthesised by bacteria. Ideally, a synthetic 
alternative would also be found. PLA was the chosen polymer as a candidate synthetic 
degradable polymer as it is approved for use as an implant material. It also has the 
potential to achieve a very high molecular weight, which is thought to be beneficial 
for synthesis of a hybrid with good mechanical properties. However, PLA (and other 
polyesters) are insoluble in the sol-gel process and therefore must be functionalised 
with silanes to produce a hybrid. In order to have control over the chemistry of the 
polymer, the polymer was first synthesised by ring opening polymerisation. In order 
to produce a class II polymer, the polymer structure has to be modified by introducing 
additional hydroxyl group aiming to add more ―attachment points‖. 
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Figure 6.1 Synthesis methods for high molecular weight PLA [157] 
Though there are three synthesis routes have been developed to produce PLA: (1) 
condensation polymerisation of lactic acid; (2) azeotropic dehydration condensation 
of lactic acid; (3) ring opening polymerisation of lactide, (Figure 6.1) in this project 
the third route was chosen since it has been reported that high molecular weight PLA 
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is easily synthesised in the presence of tin, zinc, aluminum, and other heavy metal 
catalysts with tin(II) and zinc yielding the purest polymers [157]. The catalyst utilised 
in this project is tin(II) octoate due to its solubility in many lactones, low toxicity, 
FDA approval, high catalytic activity, and ability to give high molecular weight 
polymers with low racemisation. L-lactide was the chosen monomer in order to 
achieve better mechanical property. 1,4 butanediol was used to modify the structure to 
produce all hydroxyl groups. We term the resultant polymer as PLA-diol (PLAD) 
since it has 2 hydroxy groups. ICPTES was used as the coupling agent to react with 
the hydroxyl groups on PLAD by its isocyano group. A solvent was then required to 
incorporate the functionalised polymer into the sol-gel process to synthesis a hybrid. 
6.2 Materials and methods 
6.2.1 Materials 
Materials for synthesis: L-lactide (98%), 1,4-butandiol (99%), Tin(II) 2-
ethylhexanoate (Sn(Oct)2 95%), hexane (95%), ICPTES  (95%) and TEOS (98%) 
were purchased from Sigma-Aldrich. Chloroform (99.6%) was purchased from VWR.  
Materials as solvents: Toluene (99.5%) was purchased from VWR. 1,4-dioxane (99%), 
tetrahydrofuran (THF, 99%), and dimethyl sulfoxide (DMSO, 99.6%) were purchased 
from Sigma-Aldrich. Acetonitrile (MeCN, 99.8%,) and dimethylformamide (DMF, 
99.8%) were purchased from Bioproducts Ltd. 
6.2.2 Polymer synthesis 
6.2.2.1 Poly(lactide diol) synthesis 
Two methods were used for polylactide synthesis. The second method (using a 
Schlenk, glove box and nitrogen line) was applied since the polymer synthesised via 
the first method (use round bottom flask and condenser) could not reach as high a 
molecular weight as expected. 
PLAD synthesis method 1 
The equipment was assembled as shown in Figure 6.2. All the conjunctions points 
were sealed with shelves and parafilm. The left end of the three-neck-round bottom 
flask was connected with a three-way valve, which connected to a nitrogen cylinder 
and a vacuum pump. The top end of the equipment also connected with a two-way 
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valve, which further connected to a bubbling device. The three-neck round bottom 
flask was immersed in the thermostatic oil bath and the whole equipment was placed 
in a fume hood. 
 
Figure 6.2 Illustration of the experimental setup for method 1 for poly(lactide diol) synthesis. The 
figure was adopted under the permission of Dr. Poologasundarampillai [158]. 
In order to produce a high molecular weight PLA, the proportion of coupling agent to 
L-lactide used in ring-opening polymerisation was 1:1000. The unpurified L-Lactide 
was dissolved in toluene together with coupling agent 1,4-butandiol and catalyst 
Sn(Oct)2. The mixture was placed in the three-neck-round bottom flask, which was 
immersed in a thermostatic oil bath at 80 °C Running water and nitrogen gas ran 
through the whole apparatus. After 8 h reaction, the product was poured into hexane 
to gain the precipitation, which was then further filtered and dissolved in chloroform. 
This was repeated three times and the product was dried at 40 °C in vacuum for 48h. 
The result polymer was labelled as PLAD 0. 
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PLAD synthesis method 2 
A Schlenk (Figure 6.3) was utilised. L-Lactide was added to a small quantity of dry 
toluene and heated by a heat gun to dissolve it. It was then cooled to room 
temperature to recrystallise it.  After that a cannula was used to remove the solvent 
and dry the lactide under vacuum. The whole process was carried out in a Schlenk and 
was repeated three times. Afterwards, the lactide was put into a sublimator and heated 
to 110 °C to sublime it under vacuum. After all the lactide sublimated, it was scraped 
from the sublimator finger in a glove box. After cleaning the sublimator, the lactide 
was resublimed. This was repeated three times. The final product was kept under 
nitrogen atmosphere. 
 
Figure 6.3 Illustration of the experimental setup for method 2 
The chemicals were placed into the Schlenk through the top mouth. A cap was used to 
close the mouth during the reaction. The neck with a valve was used to connect to a 
nitrogen line which was used to degas or refill the vessel. The Schlenk was immersed 
in a thermostatic oil bath and all the equipments are placed in a fume hood. 
The purified L-lactide was added to a Schlenk which had been kept in 140 °C oven 
and equipped with a magnetic stirring bar, which is operated in a glove box. Toluene 
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solution of 1,4-butanediol and Sn(Oct)2 was then transferred into the Schlenk via 
syringes. The reaction vessel was immersed into a thermostatic oil bath maintained at 
80 °C for 48h. The whole reaction takes place under nitrogen atmosphere. The 
reaction product was precipitated into hexane, filtered and dissolved in chloroform 
again. Then reprecipitated into hexane and filtered. It was repeated three times and the 
product was dried at 40 °C in vacuum for 48h. The two batches of result polymer 
were labelled as PLAD 1 and PLAD 2, respectively. 
Polymer functionalisation 
PLA-diol (PLAD) was dissolved in a small quality of solvent followed by adding 
certain quality of ICPTES. Different solvents were tested to dissolve the PLAD. The 
molar ratio of PLAD to ICPTES was 1:2 because ICPTES can functionalise the 
polymer via reaction with hydroxyl groups. The initial aim was to functionalise all 
available OH groups. The mixture was placed in a Schlenk which was immersed into 
a thermostatic oil bath maintained at 70 °C  for 24 h. The reaction was carried out 
under nitrogen atmosphere. 
6.2.2.2 Hybrid monolith synthesis 
Hydrochloric acid was added to water and mixed with a magnetic stirrer at room 
temperature. TEOS was then added slowly in fume hood to make sol. It was mixed 
for 1 h. The molar ratio of HCl : H2O : TEOS was 2 : 12 : 1. Calcium chloride (CaCl2) 
was used as calcium source to make 70S30C or 58S sol. 
The functionalised PLAD was dissolved in a solvent and then added into sol. HF (5 
vol%) was added as catalyst. The solvent selection is discussed in the results section 
6.3.2. The amounts of chemicals used for hybrid synthesis were determined after the 
solvent selection. After 1h, the mixture was poured into screw top teflon moulds and 
sealed. The monoliths were gelled at room temperature for 3 days. Sealed moulds 
were transferred to oven, gelled at 60 °C for 3 days and allowed to cool. Mould caps 
were unscrewed in extracted oven to allow drying and vapour release. Samples were 
dried at 60 °C for 3 days. 
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6.2.3 Characterisation 
Gel permeation chromatography  
Gel permeation chromatography (GPC) is a chromatographic method in which 
particles are separated based on their size, or in more technical terms, their 
hydrodynamic volume. Organic solvent is used as a mobile phase to carry the 
particles. A silica or cross-linked polystyrene medium is used as the stationary phase. 
Size exclusion is usually achieved with an apparatus called a column, which consists 
of a hollow tube tightly packed with extremely small porous polymer beads designed 
to have pores of different sizes. As the solution travels down the column, some 
particles enter into the pores and trapped. Larger particles cannot enter into as many 
pores and will traverse over a longer length of the column. The larger the particles are, 
the faster the elution is. The filtered solution collected at the end is termed as the 
eluate. The void volume includes the particles which are too large to enter the 
medium, and the solvent volume is termed as the column volume. 
In this project, GPC was used to measure the molecular weight of the synthesised 
polymers, which is achieved by measuring the distribution of polymer molecules. The 
polymer samples were firstly dissolved in D-chloroform and placed in small glass 
containers and the measurements were then carried out by a Polymer labs SEC 60 
instrument. Polystyrene was run as a standard and then a calibration curve was created 
to determine the sizes of polymer molecules of interest. Due to the difference in size 
of two polymers with identical molecular weights, the information on the size and 
polydispersity of the sample was achieved; the molecular weight was calculated by a 
correction factor of 0.58 was applied to the number average molecular weight (Mn) 
obtained as outlined in the literature [159]. 
FTIR 
Fourier Transform Infrared Spectroscopy (FTIR) was performed on a PerkinElmer 
Spectrum
TM
 100 Series spectrometer in the range of 600 – 4000 cm-1. The polymer 
samples were directly placed under the detector of the instrument during the 
measurements. 
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NMR 
Solution
 1
H NMR was carried out in order to prove the structure of the synthesised 
polymer. The polymer samples were dissolved in a long narrow glass tube using D-
chloroform (CDCl3).  NMR spectra collected at 400 MHz were performed on a 
Bruker AV400 instrument at Chemistry Department of Imperial College by Dr. 
Charlotte Williams‘ group. 
SEM 
SEM was used to characterise the surface of the hybrid samples. It was performed on 
a Leo1525 SEM instrument with Gemini column fitted with a field emission gun at 5 
kV. The working distance was between 5-10 mm and the aperture of SEI was 30 µm. 
All the samples were coated with chromium and attached on aluminium sample 
holders via carbon tape.  
Nitrogen Sorption 
Porosity was analysed by using nitrogen adsorption which was performed on a six 
port Quantachrome AS6B-KR Autosorb gas sorption system using N2 gas. All the 
samples for this characterisation were degassed at room temperature over night. This 
is done to remove physically adsorbed gases in particular water vapour from the 
samples surfaces. The specific surface areas were estimated in relation to the mass of 
the outgassed samples. The surface area and pore size distribution were calculated 
form BET and BJH methods, respectively. 
6.3 Results and discussion 
6.3.1 Polymer characterisation 
GPC 
Mn was obtained relative to the standard cross-linked polystyrene. Thereby, the real 
molecular weight was Mn   0.58, the results have been listed in Table 6.1. 
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Table 6.1 Molecular weight of polymer samples: PLAD 0 was PLA-dial prepared via method 1; 
PLAD 1 and PLAD 2 were PLA-diol prepared via method 2;  PLA cup was PLA directly from a 
PLA drinking cup. 
Sample name 
Molecular number 
(Mn) 
Molecular weight 
(Mw) 
Prepared method 
PLAD 0 3908 2266.64 Method 1 
PLAD 1 131841 76467.78 Method 2 
PLAD 2 220345 127800.10 Method 2 
PLA cup 243807 141408.06 From PLA cup 
 
The polymer (PLAD 0) prepared by method 1 had a significant lower molecular 
weight compared to the polymers (PLAD 1 & PLAD 2) prepared by method 2. This is 
because of the high moisture sensitivity of the polymer preparation process. Thereby, 
the hermetic conditions in method 2 were better than method 1. In method 1, the 
moisture in air can go into the vessel, affecting the condensation of lactide (the water 
will hydrolyse the ester bond and effectively degrading the polymer as it forms). 
Furthermore, the presence of water will strongly reduce the activity of the catalyst 
Sn(Oct)2, which will directly affect the ring opening step of lactide, and further 
influence the whole polymerisation process, leading to low molecular weight products. 
The unpurified lactide used in method 1 is another reason for low molecular products. 
The unpurified lactide contains impurities such as water and lactic acid reduce the 
molecular weight of the products. 
The molecular weight of PLAD 2 was also higher than that of PLAD 1. The only 
difference between these two processes was the amount of solvent used in the 
polymerisation reaction. The solvent used for producing PLAD 2 (1 g lactide to 4.65 
ml toluene) was less than that for PLAD 1 (1 g lactide to 6.94 ml toluene). High 
concentration of polymer in solvent not only increases the reaction rate of ring-
opening polymerisation but it also leads to high cross-linking structure which might 
be the reason for higher molecular weight. The polymer (PLA cup) from a PLA 
drinking cup has similar molecular weight comparing to PLAD 2. 
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FTIR 
 
Figure 6.4 FTIR spectra of polymer samples: PLAD 1 and PLAD 2 were PLA-diol prepared via 
method 2;  PLA cup was PLA directly from a PLA drinking cup. 
Since PLAD 0 had low molecular weight it was eliminated as a polymer candidate. 
After that, FTIR was applied to identify the polymer structure. Figure 6.4 shows the 
FTIR spectra of PLAD 1 and PLAD 2 and compares them to a polylactide drinking 
cup. The peaks around 2989 and 2939 are the C-H stretching in methyl group. In the 
C=O region, the 1760 cm
-1
 band for carbonyl shifts to 1745 cm
-1
. The peak around 
1179 is assigned to the C-C(=O)-O stretching vibration and the peak around 1125 is 
assigned to the C-O stretching. All three samples have very similar spectra, which are 
typical of PLA or PLAD, therefore the synthesised polymers are likely to be PLA. 
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NMR 
 
Figure 6.5 
1
H NMR spectrum of PLAD 2 
Nuclear magnetic resonance (NMR) spectrum further proves the structure of the 
PLAD 2 (Fig. 6.5). The peaks on the graph indicate the protons at different sites of 
polymer structure respectively: (a) proton in –CH2CH2CH2CH2– which is derived 
from 1,4-butandiol; (b) proton in the methyl group and (c) proton in –CH– group in 
the repeat units derived from lactide; the proton in –CH– group should be detected 
around 4.4 ppm but is not present, which may due to the extreme long chain of the 
polymer. The proportion of (a) and (c) is around 8 to 1000, which indicates one 
polymer has about 1000 repeat unit (R, as shown in Figure 6.5). 
6.3.2 Hybrid monolith characterisation 
Solvent selection 
The main issue of the hybrid synthesis method was finding a suitable solvent for 
mixing the sol and polymer. The solvents tested are listed in Table 6.2. The polymer 
solubility in each solvent was tested and the solvents with relative higher solubility 
and water miscibility were tested for further mixture of the sol. These solvents were 
1,4-dioxane and THF. But when adding the sol into the polymer solution, the polymer 
R R
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precipitated out from the solution. The weight proportion of Si to polymer was less 
than 1%.  
Table 6.2 Solvents that have been tried for mixing sol and PLAD (H=high, M=middle, L=low) 
Solvent 
Boiling point 
(°C) 
PLA 
solubility 
PLAD 
solubility 
Water miscibility 
(%w/w) 
Toluene  111 H M 0.05 
Chloroform 61 H H 0.82 
1,4-dioxane 101 H M 100.00 
Tetrahydrofuran (THF) 66 H M 100.00 
Acetonitrile (MeCN) 82 H L 100.00 
Dimethylformamide (DMF) 153 L L 100.00 
Dimethyl sulfoxide (DMSO) 189 L L 100.00 
 
Alternatively, dry toluene was trialled as a solvent though its water miscibility is very 
low. The polymer did not precipitate out from the solvent but the mixture was very 
cloudy. The proportion of polymer to toluene was 1 g per 10 ml, and the weight 
proportion of polymer to SiO2 was 10 %. HF was added in the proportion of 1 ml 5 
vol% HF per 50 ml solution. The solution gelled in 15 s. HCl and HNO3 were tested 
as catalysts for the sol-gel process. The samples were left to complete gelation at 
room temperature for 3 d and the dried in vacuum oven at 60 °C for 4 d. The hybrid 
produced with HCl was semitransparent whereas the hybrid produced with HNO3 was 
white. Though toluene was not water miscible, the silica network still had chance to 
bond to the functionalised polymer due to the high –OH group content of the silica 
network. The mixture was relatively more homogeneous using toluene compared to 
chloroform and dioxane, therefore toluene was chosen as the solvent. 
SEM 
The SEM images (Figure. 6.6) of the calcium-free hybrid synthesised with HNO3 and 
HCl show that white dots were found on the surface of hybrid. These dots might be 
the polymer particles which were not relate to the glass homogeneously. An example        
of a larger block is present on the right of Figure. 6.6b. This is likely to be due to 
some polymer separating out during mixing with the sol. These results illustrate that 
the toluene is not an ideal solvent for producing a homogeneous polymer/sol solution. 
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Figure 6.6 SEM graphs of PLAD/Silica (Ca free) samples synthesised with different acids: (a) and 
(b) are made with HNO3; (c) and (d) are made with HCl. 
Nitrogen Sorption 
   
Figure 6.7 Nitrogen sorption isothem of 70S30C-CaCl2-PLAD 
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Figure 6.8 Nitrogen sorption isothem of 58S-CaCl2-PLAD 
According to the of nitrogen sorption isotherms (Figure 6.7 and Figure 6.8), 58S-
CaCl2-PLAD hybrid sample had little affinity for nitrogen sorption and therefore 
nearly no porosity whereas 70S30C-CaCl2-PLAD hybrid sample had slight nitrogen 
adsorption capability. The poor porosities of the samples might be because the 
polymer filled most of the pores. The nitrogen sorption data are summarised in table 
6.3. 
        Table 6.3 Nitrogen sorption data 
Composition 
BET Surface 
Area (m≤/g) 
BJH Cumulative 
Desorption Pore 
Volume (cc/g) 
Modal Pore 
Diameter 
( nm) 
70S30C-CaCl2-PLAD 110.90 0.11 - 
58S-CaCl2-PLAD 15.34 0.03 - 
 
The design of PLA/silica hybrid followed the same strategy as used for PGA/silica 
hybrid synthesis, however it was not successful. The following factors were 
considered as the main reasons of failure: (1) the lactide used to synthesis PLAD was 
L-lactide. As a result, the synthesised polymer PLAD was a semicrystalline polymer 
and difficult to be dissolved in solvent. Synthesis PLAD with both D & L isomers 
may improve the solubility of the polymer. (2) The molecular weight of synthesised 
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PLAD was too high to be dissolved in solvent, however a high molecular weight 
polymer was required to provide mechanical properties for the hybrid. (3) The 
functional groups of PLAD were too few to be used as ―attachment points‖ to 
conventionally bond with the silica phase. (4) The synthesised polymer PLAD might 
be crosslinked during the ring-opening polymerisation, which made it difficult to be 
functionalised by the coupling agent ICPTS. (5) A suitable solvent was not found to 
incorporate the functionalised PLAD into the sol-gel process.  
6.4 Summary 
The functioned polymer PLAD of high molecular weight have been synthesised and 
its structure was shown by NMR and FTIR spectroscopy. The organic/inorganic 
hybrid was not synthesised as expected due to no ideal solvent being found to mix the 
polymer and sol homogeneously during the sol-gel process. 
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7 Conclusion and further work 
7.1 Conclusion 
Three calcium precursors (calcium nitrate, calcium chloride and CME) were tested as 
calcium sources for the synthesis of sol-gel derived bioactive glasses and hybrids. The 
structures and properties of those samples were characterised by various techniques. 
The results show that when sol-gel glasses are synthesised with calcium nitrate, the 
calcium only enters the network above 400 ˚C and when calcium chloride is used as 
an alternative, calcium is not incorporated at any temperature. Calcium salts are 
therefore not useful calcium sources for low temperature synthesis, such as hybrid 
synthesis, where the final processing temperature is 60 ˚C. Calcium was found to 
enter the glassy network at room temperature when calcium methoxyethoxide was 
used as the calcium source, producing the 70S30C composition. Conversely when 
using the calcium chloride precursor, calcium failed to enter the glassy network prior 
to crystallisation of the glass. The use of HF as a gelation catalyst did not affect 
calcium incorporation although some calcium fluoride was formed. 
CME was then tested as calcium source for γ-PGA/silica hybrid, with calcium 
chloride used as the calcium source in a control material. CME was successfully 
introduced into -PGA/silica hybrid materials. The data showed CME increased the 
network connectivity between the organic and inorganic phase, thus enhancing the 
mechanical properties of the γ-PGA/silica hybrid materials compared with the 
samples made with calcium chloride. Compressive strength was similar to 70S30C 
monoliths sintered to 800 C, but with a large extension to failure, showing improved 
toughness. Calcium containing crystals were not found on the surface of the samples 
made with CME. The cell study also shows the PGA/silica hybrid materials made 
with CME were nontoxic and safe to the cells. 
In order to create a PLA/silica hybrid with high mechanical properties, PLAD was 
successfully synthesised with high molecular weight, which was confirmed by NMR, 
FTIR and GPC, and it was successfully functionalised. But the creation of PLA/silica 
hybrid was not successful, which may be due to no suitable solvent being found for 
the introduction of the polymer into the sol-gel process during synthesis. 
150 
 
 
This thesis has highlighted the need for a new calcium source that can be used for low 
temperature sol-gel synthesis for improved homogeneity of calcium distribution in 
sol-gel derived bioactive glasses and to allow calcium incorporation into hybrids that 
have a final processing temperature of 60 C. Sol-gel derived bioactive glasses made 
with CME were been synthesised and characterised. The results indicate that calcium 
from CME incorporated into the silica network at 60 °C. The creation of hybrid 
material using PLA as polymer source was not successful due to lack of a suitable 
solvent. However CME was successfully introduced into a γ-PGA/ silica hybrid, 
which showed improved mechanical properties over glasses and other hybrid 
materials.  
7.2 Further work 
7.2.1 New sol-gel derived bioactive glasses 
The bioactive glasses made with CME can be further prepared as 3D porous scaffolds 
by foaming or other fabrication technologies. Characterisations methods can be 
applied to those foams to further investigate the potential of using CME as calcium 
source for bioactive materials. Benzyl alcohol could be trialled instead of water to 
slow down the hydrolysis of CME, and adjust the gelation time and further control the 
foaming process. 
7.2.2 -PGA/silica/ CME hybrid materials  
The properties of PGA/CME hybrid materials can be further optimised by adjust the 
amount of coupling agent or the proportion of organic and inorganic species. The -
PGA/silica/ CME hybrid materials could be processed into 3D porous scaffolds by 
foaming or other fabrication technologies. Again benzyl alcohol can be tried instead 
of water to slow down the hydrolysis speed of CME, and adjust the gelation time and 
further control the foaming process. CME could be used in other hybrid materials as 
calcium source, although attention must be paid to its sensitivity to water. 
7.2.3 PLA hybrid materials 
Since PLLA is a semicrystalline polymer and difficult to be dissolved in solution, a 
DL-PLA synthesised with D & L isomers may have high solubility, which may help 
to incorporate the polymer into the sol-gel process. Lowering the molecular weight of 
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the polymer may also increase the solubility in the solvent. This can be achieved by 
decreasing the ratio of isomer and co-initiator (1,4-butandiol). Reducing the reaction 
time of the ring-opening polymerisation may lower the crosslinking of polymer, 
increasing the solubility and the grade of functionalisation. A suitable solvent may be 
found to mix all the reagents and finally create a PLA/silica hybrid potentially for 
bone regeneration. 
Since the connection of polymer and bioactive glass is achieved through the reaction 
of hydroxyl groups, a polymer with more hydroxyl groups may also help the mix of 
polymer solution and sol. The strategy is to synthesise polylactides in the presence of 
co-initiators with different numbers of hydroxyl groups such as pentaerythritol or 
polyglycerine. Polyglycerol (PGL) maybe also a potential co-initiator since it is water 
soluble and has tens of hydroxyl groups in the ends, as illustrated in Figure 7.1. Then 
try to create the hybrid via previous method.  
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Figure 7.1 schematic structure of proposed star gel polylactide synthesised using PGL as co-
initiator. 
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9 Appendix 
Solid state 
29
Si MAS NMR was carried out to calculate the network connectivity and 
identify some structures of all the glass samples prepared in this work. The results 
were mainly used as reference to the other characterisations and the 
29
Si NMR data of 
Q species are summarised in Table 9.1 and Table 9.2. Several crystals structures were 
detected up by NMR: a: Q
2
(Ca) in three-ring silicate ions in pseudo-wollastonite (α-
CaSiO3); b: Q
2(Ca) in chain silicate ions in wollastonite (β-CaSiO3); c: Q
1
(Ca) in 
cuspidine (Ca4Si2O7F2); d was not identified [85, 160]. 
 
 
  
Table 9.1 
29
Si MAS NMR data for 70S30C samples, giving the spectral deconvolution into different Q
n
 species. 
70S30C 
Sample 
  ,    
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
70S30C Ca(NO3)2 700 °C - - - –79.5 11.4 10 –90.0 12.4 24 –98.8 10.1 26 –109.1 13.6 40 
70S30C Ca(NO3)2 700 °C HF - - - –81.0 10.5 6 –90.0 10.7 12 –98.8 10.7 30 –108.9 12.1 52 
70S30C Ca(NO3)2 800 °C - - - –81.1 11.1 7 –90.7 11.3 14 –100.1 10.2 26 –109.8 11.8 53 
70S30C Ca(NO3)2 800 °C HF - - - 
–89.1b 
–84.0a 
–78.9 
4.4 
4.0 
6.8 
12 
9 
3 
- - - –100.3 13.2 17 –110.7 11.5 59 
70S30C CaCl2 60 °C - - - - - - - - - - - - - - - 
70S30C CaCl2 60 °C HF - - - - - - - - - - - - - - - 
70S30C CaCl2 700 °C - - - - - - 
–95.9 
–91.3 
4.6 
4.3 
4 
2 
–101.1d 5.8 10 –110.8 11.8 84 
70S30C CaCl2 700 °C HF - - - - - - –97.3 4.9 5 –101.2
d
 2.4 6 
–111.8 
–103.4 
11.5 
5.8 
82 
7 
70S30C CaCl2 800 °C - - - - - - –96.5 5.1 9 –101.3
 d
 3.1 19 
–112.8 
–106.2 
8.8 
7.3 
52 
20 
70S30C CaCl2 800 °C HF - - - - - - –97.9 3.4 7 
–104.3 
–101.4 d 
3.4 
2.8 
8 
47 
–114.0 
–109.3 
7.0 
6.1 
20 
18 
70S30C CME 60 °C - - - - - - - - - - - - - - - 
70S30C CME 60 °C HF –71.0 5.3 3 
–83.6 
–76.8 
8.8 
5.2 
18 
4 
–91.8 10.1 39 –99.1 8.4 23 –108.3 9.4 13 
70S30C CME 700 °C - - - 
–82.6 
–75.4 
7.8 
8.4 
12 
5 
–90.1 9.2 19 –98.9 10.7 43 –108.0 9.9 21 
70S30C CME 700 °C HF 
–79.9c 
–76.5 
 
2.8 
6.6 
1 
4 
–89.8b 
–87.2b 
–83.6 
2.3 
3.0 
5.8 
1 
2 
6 
–92.0 8.1 10 –99.8 8.6 23 –110.0 11.3 53 
70S30C CME 800 °C –71.8 9.2 4 
–84.2a 
78.8 
4.4 
10.6 
5 
17 
–88.5 10.2 11 –97.1 9.9 11 –109.5 12.3 52 
70S30C CME 800 °C HF 
–79.8c 
–68.7 
3.1 
5.2 
 
2 
2 
–88.6b 
–83.8a 
–75.6 
3.8 
3.8 
4.2 
8 
3 
2 
–92.0 6.1 4 –99.8 8.6 23 –111.2 10.8 61 
1
CaQ
2
CaQ
3
C aQ
2
HQ
3
HQ
4Q
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Table 9.2 
29
Si MAS NMR data for 58S samples, giving the spectral deconvolution into different Q
n
 species. 
58S 
Sample 
  ,    
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
δ 
(ppm) 
FWHM 
(ppm) 
I 
(%) 
58S Ca(NO3)2 700 °C –76.2 6.7 2 –82.5 7.0 4 –91.9 10.9 14 –100.3 8.9 24 –109.8 11.8 56 
58S Ca(NO3)2 700 °C HF –76.9 6.2 2 –84.1 7.1 4 –90.9 7.6 6 –99.6 10.9 29 –110.0 12.1 59 
58S Ca(NO3)2 800 °C - - - –84.6 6.4 2 –91.3 5.0 2 –100.1 9.8 24 –109.8 12.2 72 
58S Ca(NO3)2 800 °C HF - - - –79.6 10.7 3 –91.0 11.1 6 –100.3 9.7 17 –110.3 12.5 74 
58S CaCl2 60 °C - - - - - - - - - - - - - - - 
58S CaCl2 60 °C HF - - - - - - - - - - - - - - - 
58S CaCl2 700 °C - - - –85.7 7.6 2 –93.4 7.0 4 –101.8 8.3 16 –111.5 11.5 78 
58S CaCl2 700 °C HF - - - - - - –91.7 4.3 2 –101.1
d 
3.2 7 –111.5 11.7 91 
58S CaCl2 800 °C - - - - - - - - - - - - - - - 
58S CaCl2 800 °C HF - - - - - - –93.5 4.4 5 
–104.3 
–101.0d 
–98.1 
4.8 
2.6 
3.5 
7 
42 
8 
–110.8 10.0 38 
58S CME 60 °C –71.2 6.5 2 –79.1 7.8 13 –87.1 8.6 47 –97.6 11.6 32 –111.4 11.6 7 
58S CME 60 °C HF - - - –77.7 12.5 15 –87.2 11.6 50 –96.4 11.4 28 –108.5 13.0 7 
58S CME 700 °C –66.8 7.9 3 –77.2 9.1 11 –86.7 10.4 36 –97.5 12.0 40 –108.8 9.5 10 
58S CME 700 °C HF - - - –82.0 13.4 14 –90.6 5.5 3 –99.2 10.5 19 –109.9 –120.1 
12.8 
9.8 
62 
2 
58S CME 800 °C –72.4 7.3 4 
–79.4 
–83.7a 
6.6 
4.4 
13 
6 
–88.1 6.7 11 –96.9 10.9 15 –110.1 13.3 51 
58S CME 800 °C HF 
–72.9 
–80.0c 
8.3 
4.3 
7 
8 
–84.1 
–89.5b 
4.6 
4.0 
2 
6 
- - - –100.0 9.0 14 
–110.6 
–117.7 
11.0 
7.0 
60 
3 
FWHM, δ and I represent the linewidth full-width half-maximum, 29Si chemical shift and relative intensity, respectively. 
                                          Errors associated with measurements are — FWHM ± 1 ppm, δ ± 2 ppm and Integral ±2%. 
 
1
CaQ
2
CaQ
3
C aQ
2
HQ
3
HQ
4Q
